e10vk
UNITED STATES SECURITIES AND
EXCHANGE COMMISSION
Washington, D.C.
20549
Form 10-K
|
|
|
(Mark One)
|
|
|
þ
|
|
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
|
|
|
FOR THE FISCAL YEAR ENDED
DECEMBER 31,
2010
|
OR
|
o
|
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
|
|
|
FOR THE TRANSITION PERIOD
FROM TO
|
COMMISSION FILE NUMBER:
814-00802
HORIZON TECHNOLOGY FINANCE
CORPORATION
(Exact name of registrant as
specified in its charter)
|
|
|
DELAWARE
|
|
27-2114934
|
(State or other jurisdiction of
incorporation or organization)
|
|
(I.R.S. Employer
Identification No.)
|
|
|
|
76 Batterson Park Road,
Farmington, CT
|
|
06032
|
(Address of principal executive
offices)
|
|
(Zip Code)
|
Registrants telephone number, including area code
(860) 676-8654
Securities registered pursuant to Section 12(b) of the
Act:
|
|
|
Title of Each Class
|
|
Name of Each Exchange on Which Registered
|
|
Common Stock, par value $0.001 per share
|
|
The NASDAQ Global Market
|
Securities registered pursuant to Section 12(g) of the
Act:
None
Indicate by check mark if the registrant is a well-known
seasoned issuer, as defined in Rule 405 of the Securities
Act. Yes o No þ.
Indicate by check mark if the registrant is not required to file
reports pursuant to Section 13 or Section 15(d) of the
Act. Yes o No þ.
Indicate by check mark whether the registrant (1) has filed
all reports required to be filed by Section 13 or 15(d) of
the Securities Exchange Act of 1934 during the preceding
12 months (or for such shorter period that the registrant
was required to file such reports), and (2) has been
subject to such filing requirements for the past
90 days. Yes þ
No o.
Indicate by check mark whether the registrant has submitted
electronically and posted on its corporate Web site, if any,
every Interactive Data File required to be submitted and posted
pursuant to Rule 405 of
Regulation S-T
(§ 232.405 of this chapter) during the preceding
12 months (or for such shorter period that the registrant
was required to submit and post such
files). Yes o
No o
Indicate by check mark if disclosure of delinquent filers
pursuant to Item 405 of
Regulation S-K
is not contained herein, and will not be contained, to the best
of Registrants knowledge, in definitive proxy or
information statements incorporated by reference in
Part III of this
Form 10-K
or any amendment to this
Form 10-K. þ
Indicate by check mark whether the registrant is a large
accelerated filer, an accelerated filer, or a non-accelerated
filer. See definition of accelerated filer and large
accelerated filer in
Rule 12b-2
of the Exchange Act. (Check one):
|
|
|
|
|
|
|
Large accelerated
filer o
|
|
Accelerated
filer o
|
|
Non-accelerated
filer þ
|
|
Smaller Reporting Company o
|
|
|
(Do not check if a smaller
reporting company)
|
Indicate by check mark whether the registrant is a shell company
(as defined in
Rule 12b-2
of the Exchange
Act). Yes o No þ.
As of June 30, 2010 (the last business day of the
Registrants most recently completed second fiscal
quarter), the Registrants common stock was not listed on
any exchange or
over-the-counter
market. The Registrants common stock began trading on the
Nasdaq Global Market on October 29, 2010. The aggregate
market value of common stock held by non-affiliates of the
Registrant on March 1, 2011 based on the closing price on
that date of $15.79 on the NASDAQ Global Select Market was
approximately $119.1 million. For the purposes of
calculating this amount only, all directors and executive
officers of the Registrant have been treated as affiliates.
There were 7,593,422 shares of the Registrants common
stock outstanding as of March 1, 2011.
Documents Incorporated by Reference: Portions of the
Registrants Proxy Statement relating to the
Registrants 2011 Annual Meeting of Stockholders to be
filed not later than 120 days after the end of the fiscal
year covered by this Annual Report on
Form 10-K
are incorporated by reference into Part III of this Annual
Report on
Form 10-K.
HORIZON
TECHNOLOGY FINANCE CORPORATION
FORM 10-K
FOR THE
YEAR ENDED DECEMBER 31, 2010
TABLE OF
CONTENTS
2
Forward-Looking
Statements
This annual report on
Form 10-K,
including the Managements Discussion and Analysis of
Financial Condition and Results of Operations, contains
statements that constitute forward-looking statements, which
relate to future events or our future performance or financial
condition. These forward-looking statements are not historical
facts, but rather are based on current expectations, estimates
and projections about our industry, our beliefs and our
assumptions. The forward-looking statements contained in this
annual report on
Form 10-K
involve risks and uncertainties, including statements as to:
|
|
|
|
|
our future operating results, including the performance of our
existing loans and warrants;
|
|
|
|
the introduction, withdrawal, success and timing of business
initiatives and strategies;
|
|
|
|
changes in political, economic or industry conditions, the
interest rate environment or financial and capital markets,
which could result in changes in the value of our assets;
|
|
|
|
the relative and absolute investment performance and operations
of our Advisor;
|
|
|
|
the impact of increased competition;
|
|
|
|
the impact of investments we intend to make and future
acquisitions and divestitures;
|
|
|
|
the unfavorable resolution of legal proceedings;
|
|
|
|
our business prospects and the prospects of our portfolio
companies;
|
|
|
|
the impact, extent and timing of technological changes and the
adequacy of intellectual property protection;
|
|
|
|
our regulatory structure and tax status;
|
|
|
|
the adequacy of our cash resources and working capital;
|
|
|
|
the timing of cash flows, if any, from the operations of our
portfolio companies;
|
|
|
|
the impact of interest rate volatility on our results,
particularly if we use leverage as part of our investment
strategy;
|
|
|
|
the ability of our portfolio companies to achieve their
objective;
|
|
|
|
our ability to cause a subsidiary to become a licensed SBIC;
|
|
|
|
the impact of legislative and regulatory actions and reforms and
regulatory supervisory or enforcement actions of government
agencies relating to us or our Advisor;
|
|
|
|
our contractual arrangements and relationships with third
parties;
|
|
|
|
our ability to access capital and any future financings by us;
|
|
|
|
the ability of our Advisor to attract and retain highly talented
professionals; and
|
|
|
|
the impact of changes to tax legislation and, generally, our tax
position.
|
We use words such as anticipates,
believes, expects, intends,
seeks and similar expressions to identify
forward-looking statements. Undue influence should not be placed
on the forward looking statements as our actual results could
differ materially from those projected in the forward-looking
statements for any reason, including the factors in Risk
Factors and elsewhere in this annual report on
Form 10-K.
We have based the forward-looking statements included in this
report on information available to us on the date of this
report, and we assume no obligation to update any such
forward-looking statements. Although we undertake no obligation
to revise or update any forward-looking statements in this
annual report on
Form 10-K,
whether as a result of new information, future events or
otherwise, you are advised to consult any additional disclosures
that we may make directly to you or through reports that we in
the future may file with the SEC, including, reports on
Form 10-Q
and current reports on
Form 8-K.
3
PART I
In this annual report on
Form 10-K,
except where the context suggests otherwise, the terms
we, us, our and
Horizon Technology Finance refer to Horizon
Technology Finance Corporation and its consolidated
subsidiaries; Horizon Technology Finance Management
LLC or the Advisor or the
Administrator refer to Horizon Technology Finance
Management LLC. Some of the statements in this annual report
constitute forward-looking statements, which apply to both us
and our consolidated subsidiaries and relate to future events,
future performance or financial condition. The forward-looking
statements involve risks and uncertainties for both us and our
consolidated subsidiaries and actual results could differ
materially from those projected in the forward-looking
statements for any reason, including those factors discussed in
Risk Factors and elsewhere in this annual report on
Form 10-K.
General
We are a specialty finance company that lends to and invests in
development-stage companies in the technology, life science,
healthcare information and services, and cleantech industries,
which we refer to as our Target Industries. Our
investment objective is to generate current income from the
loans we make and capital appreciation from the warrants we
receive when making such loans. We make secured loans, which we
refer to as Technology Loans, to companies backed by
established venture capital and private equity firms in our
Target Industries, which we refer to as Technology
Lending. We also selectively lend to publicly traded
companies in our Target Industries.
We are an externally managed, closed-end, non-diversified
management investment company that has elected to be regulated
as a business development company under the Investment Company
Act of 1940, or the 1940 Act. As a business development company,
we are required to comply with regulatory requirements,
including limitations on our use of debt. We are permitted to,
and expect to, finance our investments through borrowings.
However, as a business development company, we are only
generally allowed to borrow amounts such that our asset
coverage, as defined in the 1940 Act, equals at least 200% after
such borrowing. The amount of leverage that we employ will
depend on our assessment of market conditions and other factors
at the time of any proposed borrowing.
Since our inception and through December 31, 2010, we have
funded 54 portfolio companies and have invested
$251.0 million in loans (including 22 loans that have been
repaid). As of December 31, 2010, our total investment
portfolio consisted of 32 loans which totaled
$130.2 million and our net assets were $127.2 million.
As of December 31, 2010, our debt portfolio consisted of 31
secured term loans in the aggregate amount of
$127.9 million, and one secured equipment loan in the
aggregate amount of $2.3 million. All of our existing loans
are secured by all or a portion of the tangible and intangible
assets of the applicable portfolio company. The loans in our
loan portfolio will generally not be rated by any rating agency.
For the year ended December 31, 2010, our loan portfolio
had a dollar-weighted average annualized yield of approximately
14.6% (excluding any yield from warrants). As of
December 31, 2010, our loan portfolio had a dollar-weighted
average term of approximately 40 months from inception and
a dollar-weighted average remaining term of approximately
30 months. In addition, we held warrants to purchase either
common stock or preferred stock in 43 portfolio companies. As of
December 31, 2010, our loans had an original committed
principal amount of between $1 million and
$12 million, repayment terms of between 30 and
48 months, and bore current pay interest at annual interest
rates of between 10% and 14%.
We will elect to be treated for federal income tax purposes as a
regulated investment company, or RIC, under Subchapter M of the
Internal Revenue Code, or the Code. As a RIC, we generally will
not have to pay corporate-level federal income taxes on any net
ordinary income or capital gains that we distribute to our
stockholders if we meet certain
source-of-income,
distribution, asset diversification and other requirements.
We are externally managed and advised by our Advisor, Horizon
Technology Finance Management LLC. Our Advisor manages our
day-to-day
operations and also provides all administrative services
necessary for us to operate.
Our principal executive office is located at 76 Batterson Park
Road, Farmington, Connecticut 06032 and our telephone number is
(860) 676-8654,
and our internet address is
www.horizontechnologyfinancecorp.com. We
4
make available, free of charge, on our website our annual report
on
Form 10-K,
quarterly reports on
Form 10-Q,
current reports on
Form 8-K
and amendments to those reports as soon as reasonably
practicable after we electronically file such material with, or
furnish it to, the U.S. Securities and Exchange Commission,
or SEC. Information contained on our website is not incorporated
by reference into this annual report on
Form 10-K
and you should not consider information contained on our website
to be part of this annual report on
Form 10-K
or any other report we file with the SEC.
Our
Advisor
Our investment activities are managed by Horizon Technology
Finance Management LLC and we expect to continue to benefit from
our Advisors ability to identify attractive investment
opportunities, conduct diligence on and value prospective
investments, negotiate investments and manage our diversified
portfolio of investments. In addition to the experience gained
from the years that they have worked together both at our
Advisor and prior to the formation by our Advisor of the
Company, the members of our investment team have broad lending
backgrounds, with substantial experience at a variety of
commercial finance companies, technology banks and private debt
funds, and have developed a broad network of contacts within the
venture capital and private equity community. This network of
contacts provides a principal source of investment opportunities.
Our Advisor is led by five senior managers, including its two
co-founders, Robert D. Pomeroy, Jr., our Chief Executive
Officer, and Gerald A. Michaud, our President. The other senior
managers include Christopher M. Mathieu, our SVP and Chief
Financial Officer, John C. Bombara, our SVP, General Counsel and
Chief Compliance Officer, and Daniel S. Devorsetz, our SVP and
Chief Credit Officer.
Our
Strategy
Our investment objective is to maximize our investment
portfolios total return by generating current income from
the loans we make and capital appreciation from the warrants we
receive when making such loans. To further implement our
business strategy, our Advisor will continue to employ the
following core strategies:
|
|
|
|
|
Structured Investments in the Venture Capital and Private
Equity Markets. We make loans to
development-stage companies within our Target Industries
typically in the form of secured amortizing loans. The secured
amortizing debt structure provides a lower risk strategy, as
compared to equity investments, to participate in the emerging
technology markets, because the debt structures we typically
utilize provide collateral against the downside risk of loss,
provide return of capital in a much shorter timeframe through
current pay interest and amortization of loan principal and have
a senior position in the capital structure to equity in the case
of insolvency, wind down or bankruptcy. Unlike venture capital
and private equity investments, our investment returns and
return of our capital do not require equity investment exits
such as mergers and acquisitions or initial public offerings.
Instead, we receive returns on our loans primarily through
regularly scheduled payments of principal and interest and, if
necessary, liquidation of the collateral supporting the loan.
Only the potential gains from warrants are dependent upon exits.
|
|
|
|
Enterprise Value Lending. We take
an enterprise value approach to the loan structuring and
underwriting process. We secure a senior or subordinated lien
position against the enterprise value of a portfolio company.
|
|
|
|
Creative Products with Attractive Risk-Adjusted
Pricing. Each of our existing and prospective
portfolio companies has its own unique funding needs for the
capital provided from the proceeds of our Technology Loans.
These funding needs include, but are not limited to, funds for
additional development runways, funds to hire or retain sales
staff, or funds to invest in research and development in order
to reach important technical milestones in advance of raising
additional equity. Our loans include current pay interest,
commitment fees, pre-payment fees and non-utilization fees. We
believe we have developed pricing tools, structuring techniques
and valuation metrics that satisfy our portfolio companies
requirements while mitigating risk and maximizing returns on our
investments.
|
|
|
|
Opportunity for Enhanced Returns. To enhance
our loan portfolio returns, in addition to interest and fees, we
obtain warrants to purchase the equity of our portfolio
companies, as additional consideration for making
|
5
|
|
|
|
|
loans. The warrants we obtain generally include a cashless
exercise provision to allow us to exercise these rights
without requiring us to make any additional cash investment.
Obtaining warrants in our portfolio companies has allowed us to
participate in the equity appreciation of our portfolio
companies, which we expect will enable us to generate higher
returns for our investors.
|
|
|
|
|
|
Direct Origination. We originate transactions
directly with technology, life science, healthcare information
and services, and cleantech companies. These transactions are
referred to our Advisor from a number of sources, including
referrals from, or direct solicitation of, venture capital and
private equity firms, portfolio company management teams, legal
firms, accounting firms, investment banks and other lenders that
represent companies within our Target Industries. Our Advisor
has been the sole or lead originator in substantially all
transactions in which the funds it manages have invested.
|
|
|
|
Disciplined and Balanced Underwriting and Portfolio
Management. We use a disciplined underwriting
process that includes obtaining information validation from
multiple sources, extensive knowledge of our Target Industries,
comparable industry valuation metrics, and sophisticated
financial analysis related to development-stage companies. Our
Advisors due diligence on investment prospects includes
obtaining and evaluating information on the prospective
portfolio companys technology, market opportunity,
management team, fund raising history, investor support,
valuation considerations, financial condition and projections.
We seek to balance our investment portfolio to reduce the risk
of down market cycles associated with any particular industry or
sector, development-stage or geographic area. Our Advisor
employs a hands on approach to portfolio management
requiring private portfolio companies to provide monthly
financial information and to participate in regular updates on
performance and future plans.
|
|
|
|
Use of Leverage; SBA Debenture Program. Since
our inception, we have employed leverage to increase returns on
equity through a revolving credit facility provided by WestLB
AG, which we refer to as the Credit Facility. The
Credit Facility allowed us to borrow up to $125 million,
and we were able to request advances under the Credit Facility
through March 4, 2011. As of the date hereof, we are no
longer able to request advances under the Credit Facility, as
described in Item 7 below, Managements
Discussion and Analysis of Financial Condition and Results of
Operations Liquidity and Capital Resources.
|
In addition, on December 21, 2010 the Investment Division
of the Small Business Administration, which we refer to as the
SBA, accepted our Application submission for our
continuing effort to obtain a license to operate a small
business investment company, or SBIC. In
anticipation of receiving an SBIC license, we formed a
subsidiary which, when licensed, will issue SBA-guaranteed
debentures at long-term fixed rates. An SBIC generally may have
outstanding debentures in an aggregate amount of up to twice its
regulatory capital. We have applied for exemptive relief from
the Securities and Exchange Commission, which we refer to as the
SEC, to permit us to exclude the debt of the SBIC
subsidiary from the consolidated asset coverage ratio. However,
there can be no assurance that we will be granted an SBIC
license, or that, if granted, it will be granted in a timely
manner or that we will receive the exemptive relief from the SEC.
Market
Opportunity
We focus our investments primarily in four key industries of the
emerging technology market: technology, life science, healthcare
information and services, and cleantech. The technology sectors
we focus on include communications, networking, wireless
communications, data storage, software, cloud computing,
semiconductor, internet and media, and consumer-related
technologies. Life science sectors we focus on include
biotechnology, drug delivery, bioinformatics, and medical
devices. Healthcare information and services sectors we focus on
include diagnostics, medical record services and software, and
other healthcare related services and technologies that improve
efficiency and quality of administered healthcare. Cleantech
sectors we focus on include alternative energy, water
purification, energy efficiency, green building materials, and
waste recycling.
6
We believe that Technology Lending has the potential to achieve
enhanced returns that are attractive notwithstanding the
increased level of risk associated with lending to
development-stage companies. Potential benefits include:
|
|
|
|
|
interest rates that typically exceed rates that would be
available to portfolio companies if they could borrow in
traditional commercial financing transactions;
|
|
|
|
the loan support provided by cash proceeds from equity capital
invested by venture capital and private equity firms;
|
|
|
|
relatively rapid amortization of loans;
|
|
|
|
senior ranking to equity and collateralization of loans to
minimize potential loss of capital; and
|
|
|
|
potential equity appreciation through warrants.
|
We believe that Technology Lending also provides an attractive
financing source for portfolio companies, their management teams
and their equity capital investors, as it:
|
|
|
|
|
is typically less dilutive to the equity holders than additional
equity financing;
|
|
|
|
extends the time period during which a portfolio company can
operate before seeking additional equity capital or pursuing a
sale transaction or other liquidity event; and
|
|
|
|
allows portfolio companies to better match cash sources with
uses.
|
Competitive
Strengths
We believe that we, together with our Advisor, possess
significant competitive strengths, including:
Consistently Execute Commitments and Close
Transactions. Our Advisor and its senior
management and investment professionals have an extensive track
record of originating, underwriting and closing Technology
Loans. Our Advisor has directly originated, underwritten, and
managed more than 120 Technology Loans with an aggregate
original principal amount of $740 million since it
commenced operations in 2004. In our experience, prospective
portfolio companies prefer lenders that have demonstrated their
ability to deliver on their commitments.
Robust Direct Origination Capabilities. Our
Advisors managing directors each have significant
experience originating Technology Loans in our Target
Industries. This experience has given each managing director a
deep knowledge of our Target Industries and an extensive base of
transaction sources and references. Our Advisors brand
name recognition in our market has resulted in a steady flow of
high quality investment opportunities that are consistent with
the strategic vision and expectations of our Advisors
senior management.
Access to Capital. Since it commenced
operations in 2004, our Advisor has always had access to capital
which allowed it to consistently offer Technology Loans to
companies in our Target Industries, including offering loans
during the difficult economic markets of 2008 and 2009. With the
completion of our IPO we have enhanced our ability to make
Technology Loans without interruption in all market conditions,
thus making our Advisor a trusted source for Technology Loans to
companies, their management teams and their venture capital and
private equity investors.
Highly Experienced and Cohesive Management
Team. Our Advisor has had the same senior
management team of experienced professionals since its
inception. This consistency allows companies, their management
teams and their investors to rely on consistent and predictable
service, loan products and terms and underwriting standards.
Relationships with Venture Capital and Private Equity
Investors. Our Advisor has developed strong
relationships with venture capital and private equity firms and
their partners. The strength and breadth of our Advisors
venture capital and private equity relationships would take
considerable time and expense to develop.
7
Well-Known Brand Name. Our Advisor has
originated Technology Loans to more than 120 companies in
our Target Industries under the Horizon Technology
Finance brand. Each of these companies is backed by one or
more venture capital or private equity firms. We believe that
the Horizon Technology Finance brand as a competent,
knowledgeable and active participant in the Technology Lending
marketplace will continue to result in a significant number of
referrals and prospective investment opportunities in our Target
Industries.
Competition
We compete for investments with other business development
companies and investment funds, as well as traditional financial
services companies such as commercial banks and other financing
sources. Some of our competitors are larger and have greater
financial, technical, marketing and other resources than we
have. For example, some competitors may have a lower cost of
funds and access to funding sources that are not available to
us. Furthermore, many of our competitors are not subject to
the regulatory restrictions that the 1940 Act imposes on us as a
business development company or that the Code will impose on us
as a RIC. We believe we compete effectively with these entities
primarily on the basis of the experience, industry knowledge and
contacts of our Advisors investment professionals, its
responsiveness and efficient investment analysis and
decision-making processes, its creative financing products and
highly customized investment terms. We do not intend to compete
primarily on the interest rates we offer and believe that some
competitors make loans with rates that are comparable or lower
than our rates. For additional information concerning the
competitive risks see Risk Factors Risks
Related to Our Business and Structure We operate in
a highly competitive market for investment opportunities, and if
we are not able to compete effectively, our business, results of
operations and financial condition may be adversely affected and
the value of your investment in us could decline.
Investment
Criteria
We have identified several criteria that we believe have proven,
and will prove, important in achieving our investment objective.
These criteria provide general guidelines for our investment
decisions. However, we caution you that not all of these
criteria are met by each portfolio company in which we choose to
invest.
Portfolio Composition. We make investments in
companies that are diversified by their stage of development,
their Target Industries and sectors of Target Industries, and
their geographical location, as well as by the venture capital
and private equity sponsors that support our portfolio companies.
Continuing Support from One or More Venture Capital and
Private Equity Investors. We typically invest in
companies in which one or more established venture capital and
private equity investors have previously invested and continue
to make a contribution to the management of the business. We
believe that established venture capital and private equity
investors can serve as a committed partner and will assist their
portfolio companies and their management teams in creating value.
Company Stage of Development. While we invest
in companies at various stages of development, we require that
prospective portfolio companies be beyond the seed stage of
development and have received at least their first round of
venture capital or private equity financing. We expect a
prospective portfolio company to demonstrate its ability to
advance technology and increase its revenue and operating cash
flow over time.
Operating Plan. We generally require that a
prospective portfolio company, in addition to having sufficient
access to capital to support leverage, demonstrate an operating
plan capable of generating cash flows or the ability to raise
the additional capital necessary to cover its operating expenses
and service its debt. We expect that the enterprise value of a
prospective portfolio company should substantially exceed the
principal balance of debt borrowed by the company.
Liquidation Value of Assets. The prospective
liquidation value of the assets collateralizing our loans is an
important factor in our credit analysis. We emphasize both
tangible assets, such as accounts receivable, inventory,
equipment and real estate, and intangible assets, such as
intellectual property, networks and databases and future revenue
streams. In some cases, rather than obtaining a lien on
intellectual property we may receive a negative pledge covering
a companys intellectual property.
8
Terms. Although terms vary based on the
portfolio company and other conditions, the typical repayment
term is between 24 and 48 months. The amortization schedule
will vary, but there is typically some form of an interest only
period and, in some cases, there is a balloon payment at the end
of the term.
Warrants and Equity Participation Rights. We
generally receive warrants having terms consistent with the most
recent or next round of venture capital and private equity
capital financing. We do not view the upside appreciation
potential of warrants as a means to mitigate risk, but rather to
ensure that the compensation we receive is appropriate for the
level of risk being undertaken. We also may seek to receive
equity participation rights to invest in a future round of a
portfolio companys equity capital financing through direct
capital investments in our portfolio companies. These
opportunities to invest are at our option and we are not
obligated to make such investments.
Experienced Management of Portfolio
Companies. We generally require that our
portfolio companies have a successful and experienced management
team. We also require the portfolio companies to have in place
proper incentives to induce management to succeed and to act in
concert with our interests as investors.
Exit Strategy. We analyze the potential for a
company to increase the liquidity of its equity through a future
event that would enable us to realize appreciation in the value
of our warrants or other equity interests. Liquidity events
typically include an IPO or a sale of the company.
Investment
Process
Our Advisor has created an integrated approach to the loan
origination, underwriting, approval and documentation process
that effectively combines all of the skills of our
Advisors professionals. This process allows our Advisor to
achieve an efficient and timely closing of an investment from
the initial contact with a prospective portfolio company through
the investment decision, close of documentation and funding of
the investment, while ensuring that our Advisors rigorous
underwriting standards are consistently maintained. Our board of
directors has delegated authority for all investment decisions
to our Advisor. We believe that the high level of involvement by
our Advisors staff in the various phases of the investment
process allows us to minimize the credit risk while delivering
superior service to our portfolio companies.
Portfolio
Management and Reporting
Our Advisor maintains a hands on approach to
maintain communication with our portfolio companies. At least
quarterly, our Advisor contacts our portfolio companies for
operational and financial updates by phone and performs onsite
reviews on an annual basis. Our Advisor may contact portfolio
companies deemed to have greater credit risk on a monthly basis.
Our Advisor requires all private companies to provide financial
statements on a monthly basis. For public companies, our Advisor
typically relies on publicly reported quarterly financials. Our
Advisor also typically receives copies of bank and security
statements, as well as any other information required to verify
reported financial information. Among other things, this allows
our Advisor to identify any unexpected developments in the
financial performance or condition of the company.
Our Advisor has developed a proprietary credit rating system to
analyze the quality of our loans. Using this system, our Advisor
analyzes and then rates the credit risk within the portfolio on
a monthly basis. Each portfolio company is rated on a 1 through
4 scale, with 3 representing the rating for a standard level of
risk. A rating of 4 represents an improved and better credit
quality. A rating of 2 or 1 represents a deteriorating credit
quality and increasing risk. Newly funded investments are
typically assigned a rating of 3, unless extraordinary
circumstances require otherwise. These investment ratings are
generated internally by our Advisor, and we cannot guarantee
that others would assign the same ratings to our portfolio
investments or similar portfolio investments.
Our Advisor closely monitors portfolio companies rated a 1 or 2
for adverse developments. In addition, our Advisor has regular
contact with the management, board of directors and major equity
holders of these portfolio companies in order to discuss
strategic initiatives to correct the deterioration of the
portfolio company (e.g., cost reductions, new equity issuance or
strategic sale of the business).
9
The table below describes each rating level:
|
|
|
Rating
|
|
|
|
4
|
|
The portfolio company has performed in excess of our
expectations at underwriting as demonstrated by exceeding
revenue milestones, clinical milestones, or other operating
metrics or as a result of raising capital well in excess of our
underwriting assumptions. Generally the portfolio company
displays one or more of the following: its enterprise value
greatly exceeds our loan balance; it has achieved cash flow
positive operations or has sufficient cash resources to cover
the remaining balance of the loan; there is strong potential for
warrant gains from our warrants; and there is a high likelihood
that the borrower will receive favorable future financing to
support operations. Loans rated 4 are the lowest risk profile in
our portfolio and there is no expected risk of principal loss.
|
|
|
|
3
|
|
The portfolio company has performed to our expectations at
underwriting as demonstrated by hitting revenue milestones,
clinical milestones, or other operating metrics. It has raised,
or is expected to raise, capital consistent with our
underwriting assumptions. Generally the portfolio company
displays one or more of the following: its enterprise value
comfortably exceeds our loan balance; it has sufficient cash
resources to operate per its plan; it is expected to raise
additional capital as needed; and there continues to be
potential for warrant gains from our warrants. All new loans are
rated 3 when approved and thereafter 3 rated loans represent a
standard risk profile, with no loss currently expected.
|
|
|
|
2
|
|
The portfolio company has performed below our expectations at
underwriting as demonstrated by missing revenue milestones,
delayed clinical progress, or otherwise failing to meet
projected operating metrics. It may have raised capital in
support of the poorer performance but generally on less
favorable terms than originally contemplated at the time of
underwriting. Generally the portfolio company displays one or
more of the following: its enterprise value exceeds our loan
balance but at a lower multiple than originally expected; it has
sufficient cash to operate per its plan but liquidity may be
tight; and it is planning to raise additional capital but there
is uncertainty and the potential for warrant gains from our
warrants are possible, but unlikely. Loans rated 2 represent an
increased level of risk. While no loss is currently anticipated
for a 2 rated loan, there is potential for future loss of
principal.
|
|
|
|
1
|
|
The portfolio company has performed well below plan as
demonstrated by materially missing revenue milestones, delayed
or failed clinical progress, or otherwise failing to meet
operating metrics. The portfolio company has not raised
sufficient capital to operate effectively or retire its debt
obligation to us. Generally the portfolio company displays one
or more of the following: its enterprise value may not exceed
our loan balance; it has insufficient cash to operate per its
plan and liquidity may be tight; and there are uncertain plans
to raise additional capital or the portfolio company is being
sold under distressed conditions. There is no potential for
warrant gains from our warrants. Loans rated 1 are generally put
on non-accrual and represent a high degree of risk of loss. The
fair value of 1 rated loans is reduced to the amount that is
expected to be recovered from liquidation of the collateral.
|
Managerial
Assistance
We offer managerial assistance to our portfolio companies. As a
business development company, we are required to make available
such managerial assistance within the meaning of section 55
of the 1940 Act. See Regulation for more information.
Employees
We do not have any employees. Each of our executive officers is
an employee of our Advisor. The
day-to-day
investment operations will be managed by our Advisor. As of
December 31, 2010, our Advisor had 13 employees,
including investment and portfolio management professionals,
operations and accounting professionals, legal counsel and
administrative staff. In addition, we reimburse our Advisor for
our allocable portion of expenses incurred by it in performing
its obligations under the Administration Agreement with Horizon
Technology Finance Management LLC as Administrator, which we
refer to as the Administration Agreement, including
our allocable portion of the cost of our Chief Financial Officer
and Chief Compliance Officer and their respective staffs.
10
Investment
Management Agreement
We have entered into an investment management agreement, which
we refer to as the Investment Management Agreement,
with our Advisor under which our Advisor, subject to the overall
supervision of our board of directors, manages the
day-to-day
operations of and provides investment advisory services to us.
Under the terms of our Investment Management Agreement, our
Advisor:
|
|
|
|
|
determines the composition of our portfolio, the nature and
timing of the changes to our portfolio and the manner of
implementing such changes;
|
|
|
|
identifies, evaluates and negotiates the structure of the
investments we make (including performing due diligence on our
prospective portfolio companies); and
|
|
|
|
closes and monitors the investments we make.
|
Our Advisors services under our Investment Management
Agreement are not exclusive to us, and it is free to furnish
similar services to other entities without the prior approval of
our stockholders or our board of directors, so long as its
services to us are not impaired. Our board of directors will
monitor any potential conflicts that may arise upon such a
development. For providing these services, our Advisor receives
a fee from us, consisting of two components a base
management fee and an incentive fee, which we collectively refer
to as Management Fees.
Organization
of the Advisor
Our Advisor is a Delaware limited liability company that is a
registered investment advisor under the Advisors Act of
1940. The principal executive address of our Advisor is 76
Batterson Park Road, Farmington, Connecticut 06032.
Investment
Advisory Fees
Pursuant to our Investment Management Agreement, we pay our
Advisor a fee for investment advisory and management services
consisting of a base management fee and an incentive fee.
Base Management Fee. The base management fee
is calculated at an annual rate of 2.00% of our gross assets,
payable monthly in arrears. For purposes of calculating the base
management fee, the term gross assets includes any
assets acquired with the proceeds of leverage.
Incentive Fee. The incentive fee has two
parts, as follows:
The first part is calculated and payable quarterly in arrears
based on our pre-incentive fee net investment income for the
immediately preceding calendar quarter. For this purpose,
pre-incentive fee net investment income means interest income,
dividend income and any other income (including any other fees
(other than fees for providing managerial assistance), such as
commitment, origination, structuring, diligence and consulting
fees and fees for providing significant managerial assistance or
other fees that we receive from portfolio companies) accrued
during the calendar quarter, minus our operating expenses for
the quarter (including the base management fee, expenses payable
under the Administration Agreement, and any interest expense and
any dividends paid on any issued and outstanding preferred
stock, but excluding the incentive fee). Pre-incentive fee net
investment income includes, in the case of investments with a
deferred interest feature (such as original issue discount, debt
instruments with
payment-in-kind
interest and zero coupon securities), and accrued income that we
have not yet received in cash. The incentive fee with respect to
our pre-incentive fee net income will be 20.00% of the amount,
if any, by which our pre-incentive fee net investment income for
the immediately preceding calendar quarter exceeds a 1.75%
(which is 7.00% annualized) hurdle rate and a
catch-up
provision measured as of the end of each calendar quarter. Under
this provision, in any calendar quarter, our Advisor receives no
incentive fee until our net investment income equals the hurdle
rate of 1.75%, but then receives, as a
catch-up,
100.00% of our pre-incentive fee net investment income with
respect to that portion of such pre-incentive fee net investment
income, if any, that exceeds the hurdle rate but is less than
2.1875%. The effect of this provision is that, if pre-incentive
fee net investment income exceeds 2.1875% in any calendar
quarter, our Advisor will receive 20.00% of our pre-incentive
fee net investment income as if a hurdle rate did not apply.
11
Pre-incentive fee net investment income does not include any
realized capital gains, realized capital losses or unrealized
capital appreciation or depreciation. Because of the structure
of the incentive fee, it is possible that we may pay an
incentive fee in a quarter where we incur a loss. For example,
if we receive pre-incentive fee net investment income in excess
of the quarterly minimum hurdle rate, we will pay the applicable
incentive fee even if we have incurred a loss in that quarter
due to realized and unrealized capital losses. Our net
investment income used to calculate this part of the incentive
fee is also included in the amount of our gross assets used to
calculate the 2.00% base management fee. These calculations will
be appropriately pro-rated for any period of less than three
months and adjusted for any share issuances or repurchases
during the current quarter.
The following is a graphical representation of the calculation
of the income-related portion of the incentive fee:
Quarterly
Incentive Fee Based on Net Investment Income
Pre-incentive fee net investment income
(expressed as a percentage of the value of net assets)
Percentage
of pre-incentive fee net investment income allocated to first
part of incentive fee
The second part of the incentive fee will be determined and
payable in arrears as of the end of each calendar year (or upon
termination of the Investment Management Agreement, as of the
termination date), commencing on December 31, 2010, and
will equal 20% of our realized capital gains, if any, on a
cumulative basis from October 28, 2010 (the date of our
election to be a business development company), through the end
of each calendar year, computed net of all realized capital
losses and unrealized capital depreciation on a cumulative
basis, less all previous amounts paid in respect of the capital
gain incentive fee provided that the incentive fee determined as
of December 31, 2010 will be calculated for a period of
shorter than twelve calendar months to take into account any
realized capital gains computed net of all realized capital
losses and unrealized capital depreciation for the period
beginning on October 28, 2010 and ending December 31,
2010.
Examples
of Incentive Fee Calculation
Example
1: Income Related Portion of Incentive Fee for Each Fiscal
Quarter
Alternative
1
Assumptions:
Investment income (including interest, dividends, fees, etc.) =
1.25%
Hurdle rate(1) = 1.75%
Management fee(2) = 0.50%
Other expenses (legal, accounting, custodian, transfer agent,
etc.)(3) = 0.20%
Pre-Incentive Fee Net Investment Income
(investment income) - (management fee + other expenses) = 0.55%
Pre-Incentive Fee Net Investment Income does not exceed hurdle
rate; therefore, there is no income-related incentive fee.
12
Alternative
2
Assumptions:
Investment income (including interest, dividends, fees, etc.) =
2.80%
Hurdle rate(1) = 1.75%
Management fee(2) = 0.50%
Other expenses (legal, accounting, custodian, transfer agent,
etc.)(3) = 0.20%
Pre-Incentive Fee Net Investment Income
(investment income) - (management fee + other expenses) = 2.10%
Incentive fee = 100.00% × Pre-Incentive Fee Net Investment
Income (subject to
catch-up)(4)
= 100.00% × (2.10% - 1.75%)
= 0.35%
Pre-Incentive Fee Net Investment Income exceeds the hurdle rate,
but does not fully satisfy the
catch-up
provision; therefore, the income related portion of the
incentive fee is 0.35%.
Alternative
3
Assumptions:
Investment income (including interest, dividends, fees, etc.) =
3.00%
Hurdle rate(1) = 1.75%
Management fee(2) = 0.50%
Other expenses (legal, accounting, custodian, transfer agent,
etc.)(3) = 0.20%
Pre-Incentive Fee Net Investment Income
(investment income) - (management fee + other expenses) = 2.30%
Incentive fee = 100.00% × Pre-Incentive Fee Net Investment
Income (subject to
catch-up)(4)
Incentive fee = 100.00% ×
catch-up
+ (20.00% × (Pre-Incentive Fee Net Investment Income -
2.1875%))
Catch up = 2.1875% - 1.75%
= 0.4375%
Incentive fee = (100.00% × 0.4375%) + (20.00% × (2.30%
- 2.1875%))
= 0.4375% + (20.00% × 0.1125%)
= 0.4375% + 0.0225%
= 0.46%
Pre-Incentive Fee Net Investment Income exceeds the hurdle rate,
and fully satisfies the
catch-up
provision; therefore, the income related portion of the
incentive fee is 0.46%.
|
|
|
(1) |
|
Represents 7.00% annualized hurdle rate. |
|
(2) |
|
Represents 2.00% annualized base management fee. |
|
(3) |
|
Excludes organizational and offering expenses. |
|
(4) |
|
The
catch-up
provision is intended to provide our Advisor with an incentive
fee of 20.00% on all Pre-Incentive Fee Net Investment Income as
if a hurdle rate did not apply when our net investment income
exceeds 2.1875% in any fiscal quarter. |
Example
2: Capital Gains Portion of Incentive Fee
Alternative
1
Assumptions:
Year 1: $20 million investment made in Company A
(Investment A), and $30 million investment made
in Company B (Investment B)
13
Year 2: Investment A sold for $50 million and fair market
value (FMV) of Investment B determined to be
$32 million
Year 3: FMV of Investment B determined to be $25 million
Year 4: Investment B sold for $31 million
The capital gains portion of the incentive fee, if any, would be:
Year 1: None (No sales transaction)
Year 2: Capital gains incentive fee of $6 million
($30 million realized capital gains on sale of Investment A
multiplied by 20%)
Year 3: None; $5 million (20% multiplied by
($30 million cumulative capital gains less $5 million
cumulative capital depreciation)) less $6 million (previous
capital gains fee paid in Year 2)
Year 4: Capital gains incentive fee of $200,000;
$6.2 million ($31 million cumulative realized capital
gains multiplied by 20%) less $6 million (capital gains
incentive fee taken in Year 2)
Alternative
2
Assumptions:
Year 1: $20 million investment made in Company A
(Investment A), $30 million investment made in
Company B (Investment B) and $25 million
investment made in Company C (Investment C)
Year 2: Investment A sold for $50 million, FMV of
Investment B determined to be $25 million and FMV of
Investment C determined to be $25 million
Year 3: FMV of Investment B determined to be $27 million
and Investment C sold for $30 million
Year 4: FMV of Investment B determined to be $35 million
Year 5: Investment B sold for $20 million
The capital gains incentive fee, if any, would be:
Year 1: None (no sales transaction)
Year 2: $5 million capital gains incentive fee (20%
multiplied by $25 million ($30 million realized
capital gains on Investment A less unrealized capital
depreciation on Investment B))
Year 3: $1.4 million capital gains incentive fee(1)
($6.4 million (20% multiplied by $32 million
($35 million cumulative realized capital gains less
$3 million unrealized capital depreciation)) less
$5 million capital gains incentive fee received in Year 2
Year 4: None (no sales transaction)
Year 5: None ($5 million (20% multiplied by
$25 million (cumulative realized capital gains of
$35 million less realized capital losses of
$10 million)) less $6.4 million cumulative capital
gains incentive fee paid in Year 2 and Year 3(2)
The hypothetical amounts of returns shown are based on a
percentage of our total net assets and assume no leverage. There
is no guarantee that positive returns will be realized and
actual returns may vary from those shown in this example.
|
|
|
(1) |
|
As illustrated in Year 3 of Alternative 1 above, if we were to
be wound up on a date other than its fiscal year end of any
year, we may have paid aggregate capital gains incentive fees
that are more than the amount of such fees that would be payable
if we had been wound up on its fiscal year end of such year. |
|
(2) |
|
As noted above, it is possible that the cumulative aggregate
capital gains fee received by the Investment Manager
($6.4 million) is effectively greater than $5 million
(20.00% of cumulative aggregate realized capital gains less net
realized capital losses or net unrealized depreciation
($25 million)). |
14
Payment
of Our Expenses
All investment professionals and staff of our Advisor, when and
to the extent engaged in providing investment advisory and
management services, and the compensation and routine overhead
expenses of its personnel allocable to such services, will be
provided and paid for by our Advisor. We will bear all other
costs and expenses of our operations and transactions,
including, without limitation, those relating to:
|
|
|
|
|
our organization;
|
|
|
|
calculating our net asset value (including the cost and expenses
of any independent valuation firms);
|
|
|
|
expenses, including travel expense, incurred by our Advisor or
payable to third parties performing due diligence on prospective
portfolio companies, monitoring our investments and, if
necessary, enforcing our rights;
|
|
|
|
interest payable on debt, if any, incurred to finance our
investments;
|
|
|
|
the costs of future offerings of our common stock and other
securities, if any;
|
|
|
|
the base management fee and any incentive management fee;
|
|
|
|
distributions on our shares;
|
|
|
|
administration fees payable under our Administration Agreement;
|
|
|
|
the allocated costs incurred by Advisor as our Administrator in
providing managerial assistance to those portfolio companies
that request it;
|
|
|
|
amounts payable to third parties relating to, or associated
with, making investments;
|
|
|
|
transfer agent and custodial fees;
|
|
|
|
registration fees;
|
|
|
|
listing fees;
|
|
|
|
fees and expenses associated with marketing efforts;
|
|
|
|
taxes;
|
|
|
|
independent director fees and expenses;
|
|
|
|
brokerage commissions;
|
|
|
|
costs of preparing and filing reports or other documents with
the SEC;
|
|
|
|
the costs of any reports, proxy statements or other notices to
our stockholders, including printing costs;
|
|
|
|
our allocable portion of the fidelity bond;
|
|
|
|
directors and officers/errors and omissions liability insurance,
and any other insurance premiums;
|
|
|
|
indemnification payments;
|
|
|
|
direct costs and expenses of administration, including audit and
legal costs; and
|
|
|
|
all other expenses incurred by us or the Administrator in
connection with administering our business, such as the
allocable portion of overhead under our Administration
Agreement, including rent, the fees and expenses associated with
performing compliance functions, and our allocable portion of
the costs of compensation and related expenses of our chief
compliance officer and our chief financial officer and their
respective staffs.
|
We will reimburse our Advisor for costs and expenses incurred by
our Advisor for office space rental, office equipment and
utilities allocable to the performance by our Advisor of its
duties under the Investment Management Agreement, as well as any
costs and expenses incurred by our Advisor relating to any
non-investment advisory,
15
administrative or operating services provided by our Advisor to
us or in the form of managerial assistance to portfolio
companies that request it.
From time to time, our Advisor may pay amounts owed by us to
third party providers of goods or services. We will subsequently
reimburse our Advisor for such amounts paid on our behalf.
Generally, our expenses will be expensed as incurred in
accordance with GAAP. To the extent we incur costs that should
be capitalized and amortized into expense we will also do so in
accordance with GAAP, which may include amortizing such amount
on a straight line basis over the life of the asset or the life
of the services or product being performed or provided.
Limitation
of Liability and Indemnification
The investment management agreement provides that our Advisor
and its officers, managers, partners, agents, employees,
controlling persons and any other person or entity affiliated
with our Advisor will not be liable to us for any act or
omission by it in the supervision or management of our
investment activities or for any loss sustained by us except for
acts or omissions constituting willful misfeasance, bad faith,
gross negligence or reckless disregard of its obligations under
the investment management agreement. The investment management
agreement also provides for indemnification by us of our Advisor
and its officers, managers, partners, agents, employees,
controlling persons and any other person or entity affiliated
with our Advisor for liabilities incurred by them in connection
with their services to us (including any liabilities associated
with an action or suit by or in the right of us or our
stockholders), but excluding liabilities for acts or omissions
constituting willful misfeasance, bad faith or gross negligence
or reckless disregard of their duties under the investment
management agreement to certain conditions.
Board
Approval of the Investment Management Agreement
Our board of directors held an in-person meeting on
October 25, 2010, in order to consider and approve our
investment management agreement. In its consideration of the
investment management agreement, the board of directors focused
on information it had received relating to, among other things:
(a) the nature, quality and extent of the advisory and
other services to be provided to us by our Advisor;
(b) comparative data with respect to advisory fees or
similar expenses paid by other business development companies
with similar investment objectives; (c) our projected
operating expenses and expense ratio compared to business
development companies with similar investment objectives;
(d) any existing and potential sources of indirect income
to our Advisor or the Administrator from their relationships
with us and the profitability of those relationships;
(e) information about the services to be performed and the
personnel performing such services under the investment
management agreement; (f) the organizational capability and
financial condition of our Advisor and its affiliates;
(g) our Advisors practices regarding the selection
and compensation of brokers that may execute our portfolio
transactions and the brokers provision of brokerage and
research services to our Advisor; and (h) the possibility
of obtaining similar services from other third party service
providers or through an internally managed structure.
Based on the information reviewed and the discussions, the board
of directors, including a majority of the non-interested
directors, concluded that the investment management fee rates
were reasonable in relation to the services to be provided.
Duration
and Termination
The Investment Management Agreement was approved by our board of
directors on October 25, 2010. Unless terminated earlier as
described below, it will continue in effect for a period of
2 years from its effective date. It will remain in effect
from year to year thereafter if approved annually by our board
of directors or by the affirmative vote of the holders of a
majority of our outstanding voting securities, including, in
either case, approval by a majority of our directors who are not
interested persons. The Investment Management Agreement will
automatically terminate in the event of its assignment. The
Investment Management Agreement may be terminated by either
party without penalty by delivering upon not more than
60 days written notice to the other. See Risk
Factors Risks Related to our Business and
Structure Our Advisor can resign on
60 days notice, and we may not be able to find a
suitable replacement within that time, resulting in a disruption
in our operations that could adversely affect our business,
results or operations or financial condition. We are
dependent upon senior management personnel of our Advisor
16
for our future success, and if our Advisor is unable to hire and
retain qualified personnel or if our Advisor loses any member of
its senior management team, our ability to achieve our
investment objective could be significantly harmed.
Administration
Agreement
Pursuant to the Administration Agreement, the Administrator
furnishes us with office facilities, equipment and clerical,
bookkeeping and record keeping services at such facilities.
Under our Administration Agreement, the Administrator performs,
or oversees the performance of, our required administrative
services, which include, among other things, being responsible
for the financial records which we are required to maintain and
preparing reports to our stockholders and reports filed with the
SEC. In addition, the Administrator assists us in determining
and publishing our net asset value, oversees the preparation and
filing of our tax returns and the printing and dissemination of
reports to our stockholders, and generally oversees the payment
of our expenses and the performance of administrative and
professional services rendered to us by others. Payments under
our Administration Agreement are equal to an amount based upon
our allocable portion of the Administrators overhead in
performing its obligations under our Administration Agreement,
including rent and our allocable portion of the cost of
compensation and related expenses of our Chief Compliance
Officer and Chief Financial Officer and their respective staffs.
To the extent that our Administrator outsources any of its
functions, we will pay the fees associated with such functions
on a direct basis without profit to the Administrator.
License
Agreement
We have entered into a license agreement with Horizon Technology
Finance, LLC pursuant to which such entity agreed to grant us a
non-exclusive, royalty-free right and license to use the service
mark Horizon Technology Finance. Under this
agreement, we have a right to use the Horizon Technology
Finance service mark for so long as the Investment
Management Agreement with our Advisor is in effect. Other than
with respect to this limited license, we will have no legal
right to the Horizon Technology Finance service mark.
Regulation
We have elected to be regulated as a business development
company under the 1940 Act and will elect to be treated as a RIC
under Subchapter M of the Code. As with other companies
regulated by the 1940 Act, a business development company must
adhere to certain substantive regulatory requirements. The 1940
Act contains prohibitions and restrictions relating to
transactions between business development companies and their
affiliates (including any investment advisers or
sub-advisers),
principal underwriters and affiliates of those affiliates or
underwriters and requires that a majority of the directors be
persons other than interested persons, as that term
is defined in the 1940 Act. In addition, the 1940 Act provides
that we may not change the nature of our business so as to cease
to be, or to withdraw our election as, a business development
company unless approved by a majority of our outstanding
voting securities as defined in the 1940 Act. A majority
of the outstanding voting securities of a company is defined
under the 1940 Act as the lesser of: (i) 67% or more of
such companys shares present at a meeting if more than 50%
of the outstanding shares of such company are present and
represented by proxy or (ii) more than 50% of the
outstanding shares of such company. Our bylaws provide for the
calling of a special meeting of stockholders at which such
action could be considered upon written notice of not less than
ten or more than sixty days before the date of such meeting.
We may invest up to 100% of our assets in securities acquired
directly from issuers in privately negotiated transactions. With
respect to such securities, we may, for the purpose of public
resale, be deemed an underwriter as that term is
defined in the Securities Act of 1933, or the Securities Act. We
also do not intend to acquire securities issued by any
investment company that exceed the limits imposed by the 1940
Act. Under these limits, except for registered money market
funds, we generally cannot acquire more than 3% of the voting
stock of any investment company, invest more than 5% of the
value of our total assets in the securities of one investment
company or invest more than 10% of the value of our total assets
in the securities of more than one investment company. With
regard to that portion of our portfolio invested in securities
issued by investment companies, it should be noted that such
investments might subject our stockholders to additional
expenses. None of our investment policies are fundamental and
any may be changed without stockholder approval.
17
We may also be prohibited under the 1940 Act from knowingly
participating in certain transactions with our affiliates
without the prior approval of our board of directors who are not
interested persons and, in some cases, prior approval by the
SEC. For example, under the 1940 Act, absent receipt of
exemptive relief from the SEC, we and our affiliates may be
precluded from co-investing in private placements of securities.
As a result of one or more of these situations, we may not be
able to invest as much as we otherwise would in certain
investments or may not be able to liquidate a position as
quickly.
We expect to be periodically examined by the SEC for compliance
with the 1940 Act.
We are required to provide and maintain a bond issued by a
reputable fidelity insurance company to protect us against
larceny and embezzlement. Furthermore, as a business development
company, we are prohibited from protecting any director or
officer against any liability to us or our stockholders arising
from willful misfeasance, bad faith, gross negligence or
reckless disregard of the duties involved in the conduct of such
persons office.
We and our Advisor have adopted and implemented written policies
and procedures reasonably designed to prevent violation of the
federal securities laws and will review these policies and
procedures annually for their adequacy and the effectiveness of
their implementation. We and our Advisor have designated a chief
compliance officer to be responsible for administering the
policies and procedures.
Qualifying
Assets
Under the 1940 Act, a business development company may not
acquire any asset other than assets of the type listed in
section 55(a) of the 1940 Act, which are referred to as
qualifying assets, unless, at the time the acquisition is made,
qualifying assets represent at least 70% of the companys
total assets. The principal categories of qualifying assets
relevant to our proposed business are the following:
|
|
|
|
|
Securities purchased in transactions not involving any public
offering from the issuer of such securities, which issuer
(subject to certain limited exceptions) is an eligible portfolio
company, or from any person who is, or has been during the
preceding 13 months, an affiliated person of an eligible
portfolio company, or from any other person, subject to such
rules as may be prescribed by the SEC. An eligible portfolio
company is defined in the 1940 Act as any issuer which:
|
|
|
|
|
|
is organized under the laws of, and has its principal place of
business in, the United States;
|
|
|
|
is not an investment company (other than a small business
investment company wholly owned by the business development
company) or a company that would be an investment company but
for certain exclusions under the 1940 Act; and
|
|
|
|
satisfies any of the following:
|
|
|
|
|
|
has a market capitalization of less than $250 million or
does not have any class of securities listed on a national
securities exchange;
|
|
|
|
is controlled by a business development company or a group of
companies including a business development company, the business
development company actually exercises a controlling influence
over the management or policies of the eligible portfolio
company, and, as a result thereof, the business development
company has an affiliated person who is a director of the
eligible portfolio company; or
|
|
|
|
is a small and solvent company having total assets of not more
than $4 million and capital and surplus of not less than
$2 million.
|
|
|
|
|
|
Securities of any eligible portfolio company which we control.
|
|
|
|
Securities purchased in a private transaction from a
U.S. issuer that is not an investment company or from an
affiliated person of the issuer, or in transactions incident
thereto, if the issuer is in bankruptcy and subject to
reorganization or if the issuer, immediately prior to the
purchase of its securities was unable to meet its obligations as
they came due without material assistance other than
conventional lending or financing arrangements.
|
18
|
|
|
|
|
Securities of an eligible portfolio company purchased from any
person in a private transaction if there is no ready market for
such securities and we already own 60% of the outstanding equity
of the eligible portfolio company.
|
|
|
|
Securities received in exchange for or distributed on or with
respect to securities described above, or pursuant to the
exercise of warrants or rights relating to such securities.
|
|
|
|
Cash, cash equivalents, U.S. Government securities or
high-quality debt securities maturing in one year or less from
the time of investment.
|
The regulations defining qualifying assets may change over time.
We may adjust our investment focus as needed to comply with
and/or take
advantage of any regulatory, legislative, administrative or
judicial actions in this area.
Managerial
Assistance to Portfolio Companies
A business development company must have been organized and have
its principal place of business in the United States and must be
operated for the purpose of making investments in the types of
securities described in Qualifying
assets above. However, in order to count portfolio
securities as qualifying assets for the purpose of the 70% test,
the business development company must either control the issuer
of the securities or must offer to make available to the issuer
of the securities (other than small and solvent companies
described above) significant managerial assistance. Where the
business development company purchases such securities in
conjunction with one or more other persons acting together, the
business development company will satisfy this test if one of
the other persons in the group makes available such managerial
assistance. Making available managerial assistance means, among
other things, any arrangement whereby the business development
company, through its directors, officers or employees, offers to
provide, and, if accepted, does so provide, significant guidance
and counsel concerning the management, operations or business
objectives and policies of a portfolio company.
Issuance
of Additional Shares
We are not generally able to issue and sell our common stock at
a price below net asset value per share. We may, however, issue
and sell our common stock, at a price below the current net
asset value of the common stock, or issue and sell warrants,
options or rights to acquire such common stock, at a price below
the current net asset value of the common stock if our board of
directors determines that such sale is in our best interest and
in the best interests of our stockholders, and our stockholders
have approved our policy and practice of making such sales
within the preceding 12 months. In any such case, the price
at which our securities are to be issued and sold may not be
less than a price which, in the determination of our board of
directors, closely approximates the market value of such
securities.
Temporary
Investments
Pending investment in other types of qualifying
assets, as described above, our investments may consist of
cash, cash equivalents, U.S. Government securities or
high-quality debt securities maturing in one year or less from
the time of investment, which we refer to, collectively, as
temporary investments, so that 70% of our assets are qualifying
assets. Typically, we invest in highly rated commercial paper,
U.S. Government agency notes, U.S. Treasury bills or
in repurchase agreements relating to such securities that are
fully collateralized by cash or securities issued by the
U.S. Government or its agencies. A repurchase agreement
involves the purchase by an investor, such as us, of a specified
security and the simultaneous agreement by the seller to
repurchase it at an
agreed-upon
future date and at a price which is greater than the purchase
price by an amount that reflects an
agreed-upon
interest rate. There is no percentage restriction on the
proportion of our assets that may be invested in such repurchase
agreements. However, subject to certain exceptions, if more than
25% of our total assets constitute repurchase agreements from a
single counterparty, we would not meet the diversification tests
in order to qualify as a RIC for federal income tax purposes.
Thus, we do not intend to enter into repurchase agreements with
a single counterparty in excess of this limit. Our Advisor will
monitor the creditworthiness of the counterparties with which we
enter into repurchase agreement transactions.
19
Senior
Securities; Derivative Securities
We are permitted, under specified conditions, to issue multiple
classes of indebtedness and one class of stock senior to our
common stock if our asset coverage, as defined in the 1940 Act,
is at least equal to 200% immediately after each such issuance.
In addition, while any senior securities are outstanding, we
must make provisions to prohibit any distribution to our
stockholders or the repurchase of such securities or shares
unless we meet the applicable asset coverage ratios at the time
of the distribution or repurchase. We may also borrow amounts up
to 5% of the value of our total assets for temporary or
emergency purposes without regard to asset coverage. For a
discussion of the risks associated with leverage, see Risk
Factors Risks Related to our Business and
Structure We will borrow money, which will magnify
the potential for gain or loss on amounts invested and may
increase the risk of investing in us.
The 1940 Act also limits the amount of warrants, options and
rights to common stock that we may issue and the terms of such
securities. We do not have, and do not anticipate having,
outstanding derivative securities relating to our common shares.
Code
of Ethics
We and our Advisor have each adopted a code of ethics pursuant
to
Rule 17j-1
under the 1940 Act and Rule 204A-1 under the Advisers Act,
respectively, that establishes procedures for personal
investments and restricts certain personal securities
transactions. Personnel subject to each code may invest in
securities for their personal investment accounts, including
securities that may be purchased or held by us, so long as such
investments are made in accordance with the codes
requirements. You may read and copy the code of ethics at the
SECs Public Reference Room in Washington, D.C. You
may obtain information on the operation of the Public Reference
Room by calling the SEC at
(202) 942-8090.
In addition, each code of ethics is attached as an exhibit to
this annual report on
Form 10-K,
and is available on the SECs Internet site at
http://www.sec.gov.
You may also obtain copies of the code of ethics, after paying a
duplicating fee, by electronic request at the following
e-mail address: publicinfo@sec.gov,
or by writing the SECs Public Reference Section,
Washington, D.C.
20549-0102.
Proxy
Voting Policies and Procedures
We have delegated our proxy voting responsibility to our
Advisor. The Proxy Voting Policies and Procedures of our Advisor
are set forth below. The guidelines are reviewed periodically by
our Advisor and our independent directors, and, accordingly, are
subject to change.
Introduction
Our Advisor is registered with the SEC as an investment adviser
under the Investment Advisers Act of 1940, which we refer to as
the Advisers Act. As an investment adviser registered under the
Advisers Act, our Advisor has fiduciary duties to us. As part of
this duty, our Advisor recognizes that it must vote client
securities in a timely manner free of conflicts of interest and
in our best interests and the best interests of our
stockholders. Our Advisors Proxy Voting Policies and
Procedures have been formulated to ensure decision-making
consistent with these fiduciary duties.
These policies and procedures for voting proxies are intended to
comply with Section 206 of, and
Rule 206(4)-6
under, the Advisers Act.
Proxy
policies
Our Advisor votes proxies relating to our portfolio securities
in what our Advisor perceives to be the best interest of our
stockholders. Our Advisor reviews on a
case-by-case
basis each proposal submitted to a stockholder vote to determine
its effect on the portfolio securities held by us. Although our
Advisor will generally vote against proposals that may have a
negative effect on our portfolio securities, our Advisor may
vote for such a proposal if there exist compelling long-term
reasons to do so.
20
Our Advisors proxy voting decisions are made by those
senior officers who are responsible for monitoring each of our
investments. To ensure that a vote is not the product of a
conflict of interest, our Advisor requires that (1) anyone
involved in the decision-making process disclose to our Chief
Compliance Officer any potential conflict that he or she is
aware of and any contact that he or she has had with any
interested party regarding a proxy vote and (2) employees
involved in the decision-making process or vote administration
are prohibited from revealing how we intend to vote on a
proposal in order to reduce any attempted influence from
interested parties.
Proxy
Voting Records
You may obtain information about how we voted proxies by making
a written request for proxy voting information to:
Chief
Compliance Officer
Horizon Technology Finance Corporation
76 Batterson Park Road
Farmington, Connecticut 06032
Sarbanes-Oxley
Act of 2002
The Sarbanes-Oxley Act of 2002 imposes a wide variety of
regulatory requirements on publicly held companies and their
insiders. Many of these requirements affect us. For example:
|
|
|
|
|
pursuant to
Rule 13a-14
under the Exchange Act, our principal executive officer and
principal financial officer must certify the accuracy of the
financial statements contained in our periodic reports;
|
|
|
|
pursuant to Item 307 under
Regulation S-K,
our periodic reports must disclose our conclusions about the
effectiveness of our disclosure controls and procedures;
|
|
|
|
pursuant to
Rule 13a-15
under the Exchange Act, our management must prepare an annual
report regarding its assessment of our internal control over
financial reporting, which must be audited by our independent
registered public accounting firm; and
|
|
|
|
pursuant to Item 308 of
Regulation S-K
and
Rule 13a-15
under the Exchange Act, our periodic reports must disclose
whether there were significant changes in our internal controls
over financial reporting or in other factors that could
significantly affect these controls subsequent to the date of
their evaluation, including any corrective actions with regard
to significant deficiencies and material weaknesses.
|
The Sarbanes-Oxley Act requires us to review our current
policies and procedures to determine whether we comply with the
Sarbanes-Oxley Act and the regulations promulgated under the
act. We will continue to monitor our compliance with all
regulations that are adopted under the Sarbanes-Oxley Act and
will take actions necessary to ensure that we are in compliance
therewith.
Small
Business Investment Company Regulations
On December 21, 2010 the Investment Division of the SBA
accepted our Application submission for our continuing effort to
obtain a license to operate a small business investment company,
or SBIC. In anticipation of receiving an SBIC
license, we formed a subsidiary which, when licensed, will issue
SBA-guaranteed debentures at long-term fixed rates. We have
applied for exemptive relief from the SEC to permit us to
exclude the debt of the SBIC subsidiary from the consolidated
asset coverage ratio. However, there can be no assurance that we
will be granted an SBIC license, or that, if granted, it will be
granted in a timely manner or that we will receive the exemptive
relief from the SEC.
SBICs are designed to stimulate the flow of private equity
capital to eligible small businesses. Under SBA regulations,
SBICs may make loans to eligible small businesses, invest in the
equity securities of such businesses and provide them with
consulting and advisory services. Under present SBA regulations,
eligible small businesses generally include businesses that
(together with their affiliates) have a tangible net worth not
exceeding $18 million and have average annual net income
after U.S. federal income taxes not exceeding
$6 million (average net income
21
to be computed without benefit of any carryover loss) for the
two most recent fiscal years. In addition, an SBIC must devote
20% of its investment activity to smaller concerns
as defined by the SBA. A smaller concern generally includes
businesses that have a tangible net worth not exceeding
$6 million and have average annual net income after
U.S. federal income taxes not exceeding $2 million
(average net income to be computed without benefit of any net
carryover loss) for the two most recent fiscal years. SBA
regulations also provide alternative size standard criteria to
determine eligibility for designation as an eligible small
business or smaller concern, which criteria depend on the
primary industry in which the business is engaged and are based
on such factors as the number of employees and gross revenue.
However, once an SBIC has invested in a company, it may continue
to make follow on investments in the company, regardless of the
size of the company at the time of the follow on investment, up
to the time of the companys initial public offering, if
any.
The SBA prohibits an SBIC from providing funds to small
businesses for certain purposes, such as relending or investing
outside the United States, to businesses engaged in a few
prohibited industries and to certain passive (i.e.,
non-operating) companies. In addition, without prior SBA
approval, an SBIC may not invest an amount equal to more than
approximately 30% of the SBICs regulatory capital in any
one company and its affiliates.
The SBA places certain limitations on the financing terms of
investments by SBICs in portfolio companies (such as limiting
the permissible interest rate on debt securities held by an SBIC
in a portfolio company). Although prior regulations prohibited
an SBIC from controlling a small business concern except in
limited circumstances, regulations adopted by the SBA in 2002
now allow an SBIC to exercise control over a small business for
a period of up to seven years from the date on which the SBIC
initially acquires its control position. This control period may
be extended for an additional period of time with the SBAs
prior written approval.
The SBA restricts the ability of an SBIC to lend money to any of
its officers, directors and employees or to invest in affiliates
thereof. The SBA also prohibits, without prior SBA approval, a
change of control of an SBIC or transfers that would
result in any person (or a group of persons acting in concert)
owning 10% or more of a class of capital stock of a licensed
SBIC. A change of control is any event which would
result in the transfer of the power, direct or indirect, to
direct the management and policies of an SBIC, whether through
ownership, contractual arrangements or otherwise. To the extent
that we form an SBIC subsidiary, this would prohibit a change of
control of us without prior SBA approval.
An SBIC (or group of SBICs under common control) may generally
have outstanding debentures guaranteed by the SBA in amounts up
to twice the amount of the privately raised funds of the
SBIC(s). The SBIC regulations currently limit the amount that
the SBIC subsidiary would be permitted to borrow up to a maximum
of $150 million. This means that the SBIC subsidiary could
access the full $150 million maximum available if it were
to have $75 million in regulatory capital. However, we
would not be required to capitalize our SBIC subsidiary with
$75 million and may determine to capitalize it with a
lesser amount. In addition, if we are able to obtain financing
under the SBIC program, the SBIC subsidiary will be subject to
regulation and oversight by the SBA, including requirements with
respect to maintaining certain minimum financial ratios and
other covenants. Debentures guaranteed by the SBA have a
maturity of ten years, require semi-annual payments of interest
and do not require any principal payments prior to maturity.
SBICs must invest idle funds that are not being used to make
loans in investments permitted under SBIC regulations in the
following limited types of securities: (1) direct
obligations of, or obligations guaranteed as to principal and
interest by, the U.S. government, which mature within
15 months from the date of the investment;
(2) repurchase agreements with federally insured
institutions with a maturity of seven days or less (and the
securities underlying the repurchase obligations must be direct
obligations of or guaranteed by the federal government);
(3) certificates of deposit with a maturity of one year or
less, issued by a federally insured institution; (4) a
deposit account in a federally insured institution that is
subject to a withdrawal restriction of one year or less;
(5) a checking account in a federally insured institution;
or (6) a reasonable petty cash fund.
SBICs are periodically examined and audited by the SBAs
staff to determine their compliance with SBIC regulations and
are periodically required to file certain forms with the SBA.
Neither the SBA nor the U.S. government or any of its
agencies or officers has approved any ownership interest to be
issued by us or any obligation that we or any of our
subsidiaries may incur.
22
NASDAQ
Global Market Corporate Governance Regulations
The NASDAQ Global Market has adopted corporate governance
regulations that listed companies must comply with. We intend to
be in compliance with these corporate governance listing
standards. We intend to monitor our compliance with all future
listing standards and to take all necessary actions to ensure
that we are in compliance therewith.
Privacy
Principles
We are committed to maintaining the privacy of stockholders and
to safeguarding our non-public personal information. The
following information is provided to help you understand what
personal information we collect, how we protect that information
and why, in certain cases, we may share information with select
other parties.
Generally, we do not receive any nonpublic personal information
relating to our stockholders, although certain nonpublic
personal information of our stockholders may become available to
us. We do not disclose any nonpublic personal information about
our stockholders or former stockholders to anyone, except as
permitted by law or as is necessary in order to service
stockholder accounts (for example, to a transfer agent or third
party administrator).
We restrict access to nonpublic personal information about our
stockholders to our Advisors employees with a legitimate
business need for the information. We maintain physical,
electronic and procedural safeguards designed to protect the
nonpublic personal information of our stockholders.
Election
to be Taxed as a RIC
We will elect to be taxed, and intend to qualify annually to
maintain our election to be taxed, as a RIC under Subchapter M
of the Code. To maintain RIC tax benefits, we must, among other
requirements, meet certain
source-of-income
and quarterly asset diversification requirements (as described
below). We also must annually distribute dividends of at least
90% of the sum of our ordinary income and realized net
short-term capital gains, if any, out of the assets legally
available for distribution, which we refer to as the
Annual Distribution Requirement. Although not
required for us to maintain our RIC tax status, in order to
preclude the imposition of a 4% nondeductible federal excise tax
imposed on RICs, we may distribute during each calendar year an
amount at least equal to the sum of (1) 98% of our ordinary
income for the calendar year, (2) 98% (or, for our taxable
years beginning in 2011, 98.2%) of our capital gain net income
for the one-year period ending on October 31 of the calendar
year and (3) any ordinary income and net capital gains for
preceding years that were not distributed during such years (the
Excise Tax Avoidance Requirement). In addition,
although we may distribute realized net capital gains (i.e., net
long-term capital gains in excess of short-term capital losses),
if any, at least annually out of the assets legally available
for such distributions, we may decide to retain such net capital
gains or ordinary income to provide us with additional liquidity.
In order to qualify as a RIC for federal income tax purposes
under Section 851(a) of the Code, we must:
|
|
|
|
|
maintain an election to be treated as a business development
company under the 1940 Act at all times during each taxable year;
|
|
|
|
meet any applicable securities law requirements, including
capital structure requirements;
|
|
|
|
derive in each taxable year at least 90% of our gross income
from distributions, interest, payments with respect to certain
securities loans, gains from the sale of stock or other
securities, net income from certain qualified publicly traded
partnerships or other income derived with respect to our
business of investing in such stock or securities (the 90%
Income Test); and
|
|
|
|
diversify our holdings so that at the end of each quarter of the
taxable year:
|
|
|
|
|
|
at least 50% of the value of our assets consists of cash, cash
equivalents, U.S. Government securities, securities of
other RICs, and other securities if such other securities of any
one issuer neither represent
|
23
|
|
|
|
|
more than 5% of the value of our assets nor more than 10% of the
outstanding voting securities of the issuer; and
|
|
|
|
|
|
no more than 25% of the value of our assets is invested in the
securities, other than U.S. Government securities or
securities of other RICs, of one issuer or of two or more
issuers that are controlled, as determined under applicable tax
rules, by us and that are engaged in the same or similar or
related trades or businesses or in certain qualified publicly
traded partnerships (the Diversification Tests).
|
Taxation
as a RIC
If we qualify as a RIC under Section 851(a) of the Code,
and satisfy the Annual Distribution Requirement, then we will
not be subject to federal income tax on the portion of our
investment company taxable income and net capital gain (i.e.,
realized net long-term capital gains in excess of realized net
short-term capital losses) we distribute to stockholders. We
will be subject to U.S. federal income tax at the regular
corporate rates on any income or capital gain not distributed
(or deemed distributed) to our stockholders.
We may be required to recognize taxable income in circumstances
in which we do not receive cash. For example, if we hold debt
obligations that are treated under applicable tax rules as
having original issue discount (such as debt instruments with
pay in kind interest or, in certain cases, increasing interest
rates or issued with warrants), we must include in income each
year a portion of the original issue discount that accrues over
the life of the obligation, regardless of whether cash
representing such income is received by us in the same taxable
year. Because any original issue discount accrued will be
included in our investment company taxable income for the year
of accrual, we may be required to make a distribution to our
stockholders in order to satisfy the Annual Distribution
Requirement, even though we will not have received any
corresponding cash amount.
Gain or loss realized by us from warrants acquired by us as well
as any loss attributable to the lapse of such warrants generally
will be treated as capital gain or loss. Such gain or loss
generally will be long-term or short-term, depending on how long
we held a particular warrant.
Although we do not presently expect to do so, we are authorized
to borrow funds and to sell assets in order to satisfy
distribution requirements. However, under the 1940 Act, we are
not permitted to make distributions to our stockholders while
our debt obligations and other senior securities are outstanding
unless certain asset coverage tests are met.
Moreover, our ability to dispose of assets to meet our
distribution requirements may be limited by (1) the
illiquid nature of our portfolio
and/or
(2) other requirements relating to our status as a RIC,
including the Diversification Tests. If we dispose of assets in
order to meet the Annual Distribution Requirement or the Excise
Tax Avoidance Requirement, we may make such dispositions at
times that, from an investment standpoint, are not advantageous.
Failure
to Qualify as a RIC
If we fail to satisfy the Annual Distribution Requirement or
fail to qualify as a RIC in any taxable year, assuming we do not
qualify for or take advantage of certain remedial provisions, we
will be subject to tax in that year on all of our taxable
income, regardless of whether we make any distributions to our
stockholders. In that case, all of our income will be subject to
corporate-level federal income tax, reducing the amount
available to be distributed to our stockholders. In contrast,
assuming we qualify as a RIC, our corporate-level federal income
tax should be substantially reduced or eliminated. See
Election to be Taxed as a RIC above.
If we are unable to maintain our status as a RIC, we would be
subject to tax on all of our taxable income at regular corporate
rates. We would not be able to deduct distributions to
stockholders, nor would they be required to be made.
Distributions would generally be taxable to our stockholders as
ordinary distribution income eligible for the 15% maximum rate
to the extent of our current and accumulated earnings and
profits. Subject to certain limitations under the Code,
dividends paid by us to corporate distributees would be eligible
for the dividends received deduction. Distributions in excess of
our current and accumulated earnings and profits would be
treated first as a return of capital to the extent of the
stockholders tax basis in our common stock, and any
remaining distributions would be treated as a capital gain.
24
Investing in our common stock involves a number of
significant risks. In addition to the other information
contained in this annual report on
Form 10-K,
you should consider carefully the following information before
making an investment in our common stock. The risks set out
below are not the only risks we face. Additional risks and
uncertainties not presently known to us or not presently deemed
material by us might also impair our operations and performance.
If any of the following events occur, our business, financial
condition and results of operations could be materially and
adversely affected. In such case, our net asset value and the
trading price of our common stock could decline, and you may
lose part or all of your investment.
Risks
Relating to Our Business and Structure
We
have a limited operating history and may not be able to achieve
our investment objective or generate sufficient revenue to make
or sustain distributions to our stockholders and your investment
in us could decline substantially.
We commenced operations in March 2008 and became a public
company in October 2010. As a result of our limited operating
history, we are subject to certain business risks and
uncertainties associated with any recently formed business
enterprise, including the risk that we will not achieve our
investment objective and that the value of your investment in us
could decline substantially. As a public company, we are subject
to the regulatory requirements of the SEC, in addition to the
specific regulatory requirements applicable to business
development companies under the 1940 Act and RICs under the
Code. Our management and our Advisor have limited experience
operating under this regulatory framework, because we have been
public since October 28, 2010, and we may incur substantial
additional costs, and expend significant time or other
resources, to do so. From time to time our Advisor may pursue
investment opportunities, like equity investments, in which our
Advisor has more limited experience. We may also be unable to
replicate the historical performance of prior investment funds.
In addition, we may be unable to generate sufficient revenue
from our operations to make or sustain distributions to our
stockholders.
We may
not replicate the historical results achieved by other entities
managed or sponsored by members of our Advisor or its
affiliates.
We may be unable to replicate the historical results achieved by
our Advisor or its affiliates, and our investment returns could
be substantially lower than the returns achieved by them in
prior periods. In particular, our Advisors returns from
several of its other investment vehicles may not be comparable
because they were capital call funds and their respective
returns were not negatively impacted by uninvested cash. We also
may not be able to replicate the performance of our warrants and
may not have returns on warrants from our existing portfolio
that we hold. Neither our Advisor nor its affiliates were
subject to the same tax and regulatory conditions that we intend
to operate under following the offering. Furthermore, none of
the prior results were from public reporting companies.
Additionally, all or a portion of these prior results may have
been achieved in particular market conditions which may never be
repeated. We are not a capital call fund and, as a result, may
have more limited access to cash for investment opportunities
than our Advisor historically experienced which could impair our
ability to make future investments. Moreover, current or future
market volatility and regulatory uncertainty may also have an
adverse impact on our future performance.
We and
our Advisor have limited experience operating under the
constraints imposed on a business development company or
managing an investment company, which may affect our ability to
manage our business and impair your ability to assess our
prospects.
Prior to becoming a public company, we did not operate as a
business development company or manage an investment company
under the 1940 Act. As a result, we have limited operating
results under this regulatory framework that can demonstrate to
you either its effect on our business or our ability to manage
our business within this framework. The 1940 Act imposes
numerous constraints on the operations of business development
companies. For example, business development companies are
required to invest at least 70% of their total assets in
specified types of securities, primarily securities of
eligible portfolio companies (as defined in the 1940
Act), cash, cash equivalents, U.S. government securities
and other high quality debt investments that mature in one year
or less. See
25
Regulation in Item 1 above. Our Advisors
lack of experience in managing a portfolio of assets under these
constraints may hinder our ability to take advantage of
attractive investment opportunities and, as a result, could
impair our ability to achieve our investment objective.
Furthermore, if we are unable to comply with the requirements
imposed on business development companies by the 1940 Act, the
SEC could bring an enforcement action against us
and/or we
could be exposed to claims of private litigants. In addition, we
could be regulated as a closed-end management investment company
under the 1940 Act, which could further decrease our operating
flexibility and may prevent us from operating our business,
either of which could have a material adverse effect on our
business, results of operations or financial condition.
We are
dependent upon key personnel of our Advisor and our
Advisors ability to hire and retain qualified
personnel.
We depend on the members of our Advisors senior
management, particularly Mr. Pomeroy, our Chairman and
Chief Executive Officer, and Mr. Michaud, our President, as
well as other key personnel for the identification, evaluation,
final selection, structuring, closing and monitoring of our
investments. These employees have critical industry experience
and relationships that we will rely on to implement our business
plan to originate Technology Loans in our Target Industries. Our
future success will depend on the continued service of
Messrs. Pomeroy and Michaud as well as the other senior
members of our Advisors management team. If our Advisor
were to lose the services of either Mr. Pomeroy or
Mr. Michaud or any of the other senior members of our
Advisors management team, we may not be able to operate
our business as we expect, and our ability to compete could be
harmed, either of which could cause our business, results of
operations or financial condition to suffer. In addition, if
either of Mr. Pomeroy or Mr. Michaud ceases to be
employed by us, the lender under our Credit Facility could,
absent a waiver or cure, demand repayment of any outstanding
obligations under the Credit Facility. Our future success will
also depend, in part, on our Advisors ability to identify,
attract and retain sufficient numbers of highly skilled
employees. Absent exemptive or other relief granted by the SEC
and for so long as we remain externally managed, the 1940 Act
will prevent us from granting options to our employees and
adopting a profit sharing plan, which may make it more difficult
for us to attract and retain highly skilled employees. If we are
not successful in identifying, attracting and retaining these
employees, we may not be able to operate our business as we
expect. Moreover, we cannot assure you that our Advisor will
remain our investment Advisor or that we will continue to have
access to our Advisors investment professionals or its
relationships. For example, our Advisor may in the future manage
investment funds with investment objectives similar to ours
thereby diverting the time and attention of its investment
professionals that we rely on to implement our business plan.
We
operate in a highly competitive market for investment
opportunities, and if we are not able to compete effectively,
our business, results of operations and financial condition may
be adversely affected and the value of your investment in us
could decline.
A number of entities compete with us to make the types of
investments that we plan to make in prospective portfolio
companies in our Target Industries. We compete with other
business development companies and a large number of venture
capital and private equity firms, as well as other investment
funds, investment banks and other sources of financing,
including traditional financial services companies such as
commercial banks and finance companies. Some of our competitors
are larger and have greater financial, technical, marketing and
other resources than we have. For example, some competitors may
have a lower cost of funds and access to funding sources that
are not available to us. This may enable these competitors to
make commercial loans with interest rates that are comparable
to, or lower than, the rates we typically offer. We may lose
prospective portfolio companies if we do not match our
competitors pricing, terms and structure. If we do match
our competitors pricing, terms or structure, we may
experience decreased net interest income and increased risk of
credit losses. In addition, some of our competitors may have
higher risk tolerances or different risk assessments, which
could allow them to consider a wider variety of investments,
establish more relationships than us and build their market
shares. Furthermore, many of our competitors are not subject to
the regulatory restrictions that the 1940 Act imposes on us as a
business development company or that the Code imposes on us as a
RIC. If we are not able to compete effectively, we may not be
able to identify and take advantage of attractive investment
opportunities that we identify and may not be able to fully
invest our available capital. If this occurs, our business,
financial condition and results of operations could be
materially adversely affected.
26
We
borrow money, which magnifies the potential for gain or loss on
amounts invested and may increase the risk of investing in
us.
Leverage is generally considered a speculative investment
technique, and we intend to continue to borrow money as part of
our business plan. The use of leverage will magnify the
potential for gain or loss on amounts invested and, therefore,
increases the risks associated with investing in us. We expect
to borrow from and issue senior debt securities to banks and
other lenders. Such senior debt securities include those under
the Credit Facility pursuant to which we may borrow up to
$125 million on or before March 4, 2011. As of
December 31, 2010, we had outstanding indebtedness of
$87.4 million. We also intend to issue debt securities
guaranteed by the SBA and sold in the capital markets, to the
extent that we or one of our subsidiaries becomes licensed by
the SBA. The SBIC regulations, subject to certain regulatory
capital requirements among other things, currently permit an
SBIC subsidiary to borrow up to $150 million. Lenders of
senior debt securities, including the SBA, will have fixed
dollar claims on our assets that will be superior to the claims
of our common stockholders. If the value of our assets
increases, then leveraging would cause the net asset value
attributable to our common stock to increase more sharply than
it would have had we not leveraged. However, any decrease in our
income would cause net income to decline more sharply than it
would have had we not leveraged. This decline could adversely
affect our ability to make common stock dividend payments. In
addition, because our investments may be illiquid, we may be
unable to dispose of them or to do so at a favorable price in
the event we need to do so if we are unable to refinance any
indebtedness upon maturity, and, as a result, we may suffer
losses.
Our ability to service any debt that we incur depends largely on
our financial performance and is subject to prevailing economic
conditions and competitive pressures. Moreover, as our
Advisors management fee is payable to our Advisor based on
our gross assets, including those assets acquired through the
use of leverage, our Advisor may have a financial incentive to
incur leverage which may not be consistent with our
stockholders interests. In addition, holders of our common
stock bear the burden of any increase in our expenses, as a
result of leverage, including any increase in the management fee
payable to our Advisor.
Illustration: The following table illustrates the effect
of leverage on returns from an investment in our common stock
assuming various annual returns, net of expenses. The
calculations in the table below are hypothetical and actual
returns may be higher or lower than those appearing in the table
below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Assumed Return on Our Portfolio
|
|
|
(Net of Expenses)
|
|
|
(10%)
|
|
(5%)
|
|
0%
|
|
5%
|
|
10%
|
|
Corresponding return to stockholder(1)
|
|
|
(19
|
%)
|
|
|
(11
|
%)
|
|
|
(2
|
%)
|
|
|
6
|
%
|
|
|
15
|
%
|
|
|
|
(1) |
|
Assumes $216 million in total assets, $87 million in
debt outstanding, $127 million in stockholders
equity, and an average cost of funds of 3.16%. Assumptions are
based on our financial condition and our average costs of funds
at December 31, 2010. Actual interest payments may be
different. |
If we
are unable to comply with the covenants or restrictions in the
Credit Facility, our business could be materially adversely
affected.
Our wholly owned subsidiary, Horizon Credit I LLC, which we
refer to as Credit I, is party to our Credit
Facility with WestLB AG. This Credit Facility includes covenants
that, among other things, restrict the ability of Compass
Horizon and Credit I to make loans to, or investments in, third
parties (other than Technology Loans and warrants or other
equity participation rights), pay dividends and distributions,
incur additional indebtedness and engage in mergers or
consolidations. The Credit Facility also restricts the ability
of Compass Horizon, Credit I, and our Advisor to create
liens on the collateral securing the Credit Facility, permit
additional negative pledges on such collateral and change the
business currently conducted by them. The Credit Facility also
includes provisions that permit our lender to refuse to advance
funds under the facility in the event of a change of control of
us or Compass Horizon. For this purpose a change of control
generally means a merger or other consolidation, a liquidation,
a sale of all or substantially all of our assets, or a
transaction in which any person or group acquires more than 50%
of our shares. In addition, the Credit Facility also requires
Compass Horizon, Credit I and our Advisor to comply with various
financial covenants, including, among other covenants,
maintenance by Compass Horizon and our Advisor of a minimum
tangible net worth and limitations on the value of, and
modifications to, the loan collateral that
27
secures the Credit Facility. See Item 7 below,
Managements Discussion and Analysis of Financial
Condition and Results of Operations Liquidity and
Capital Resources. Complying with these restrictions may
prevent us from taking actions that we believe would help us to
grow our business or are otherwise consistent with our
investment objective. These restrictions could also limit our
ability to plan for or react to market conditions or meet
extraordinary capital needs or otherwise restrict corporate
activities or could result in our failing to qualify as a RIC
and thus becoming subject to corporate-level income tax. See
Item 7 below, Managements Discussion and
Analysis of Financial Condition and Results of
Operations Liquidity and Capital Resources for
additional information regarding our credit arrangements.
The breach of certain of the covenants or restrictions unless
cured within the applicable grace period, would result in a
default under the Credit Facility that would permit the lender
to declare all amounts outstanding to be due and payable. In
such an event, we may not have sufficient assets to repay such
indebtedness and the lender may exercise rights available to it
under the security interest granted in the assets of
Credit I, including, to the extent permitted under
applicable law, the seizure of such assets without adjudication.
As a result, any default could have serious consequences to our
financial condition. An event of default or an acceleration
under the Credit Facility could also cause a cross-default or
cross-acceleration of another debt instrument or contractual
obligation, which would adversely impact our liquidity. We may
not be granted waivers or amendments to the Credit Facility if
for any reason we are unable to comply with it, and we may not
be able to refinance the Credit Facility on terms acceptable to
us, or at all.
Because
we will distribute all or substantially all of our income and
any realized net short-term capital gains over realized net
long-term capital losses to our stockholders, we will need
additional capital to finance our growth, if any. If additional
funds are unavailable or not available on favorable terms, our
ability to grow will be impaired.
To satisfy the requirements applicable to a RIC, to avoid
payment of excise taxes and to minimize or avoid payment of
corporate-level federal income taxes, we intend to distribute to
our stockholders all or substantially all of our net ordinary
income and realized net short-term capital gains over realized
net long-term capital losses except that we may retain certain
net long-term capital gains, pay applicable income taxes with
respect thereto, and elect to treat such retained capital gains
as deemed distributions to our stockholders. As a business
development company, we generally are required to meet a
coverage ratio of total assets to total senior securities, which
includes all of our borrowings and any preferred stock we may
issue in the future, of at least 200%. This requirement limits
the amount that we may borrow. Because we will continue to need
capital to grow our loan and investment portfolio, this
limitation may prevent us from incurring debt and require us to
raise additional equity at a time when it may be disadvantageous
to do so. We cannot assure you that debt and equity financing
will be available to us on favorable terms, or at all, and debt
financings may be restricted by the terms of any of our
outstanding borrowings. In addition, as discussed below, as a
business development company, we are limited in our ability to
issue equity securities priced below net asset value. If
additional funds are not available to us, we could be forced to
curtail or cease new lending and investment activities, and our
net asset value could decline.
If we
are unable to obtain additional debt financing, our business
could be materially adversely affected.
We may want to obtain additional debt financing, or need to do
so upon maturity of the Credit Facility, in order to obtain
funds which may be made available for investments. The Credit
Facility matures in March 2015. We were able to request advances
under the Credit Facility through March 4, 2011. We may not
request new advances and we must repay the outstanding advances
under the Credit Facility as of such date at such times and in
such amounts as are necessary to maintain compliance with the
terms and conditions of the Credit Facility, particularly the
condition that the principal balance of the Credit Facility does
not exceed 75% of the aggregate principal balance of our
eligible loans to our portfolio companies. All outstanding
advances under the Credit Facility are due and payable on
March 4, 2015, unless such date is extended upon Credit
Is request and upon mutual agreement of WestLB and Credit
I. If we are unable to increase, renew or replace any such
facility and enter into a new debt financing facility on
commercially reasonable terms, our liquidity may be reduced
significantly. In addition, if we are unable to repay amounts
outstanding under any such facilities and are declared in
default or are unable to renew or refinance these facilities, we
may not be able to make new investments or operate our business
in the normal course. These
28
situations may arise due to circumstances that we may be unable
to control, such as lack of access to the credit markets, a
severe decline in the value of the U.S. dollar, a further
economic down turn or an operational problem that affects third
parties or us, and could materially damage our business.
If we
do not receive qualification from the SBA to form an SBIC or we
are unable to comply with SBA regulations after our SBIC
subsidiary is formed, our business plan and investment objective
could be materially adversely affected.
We are currently seeking qualification as an SBIC for Longview
SBIC LP, our wholly owned subsidiary, which will be regulated by
the SBA. On July 14, 2009, our Advisor received
notification from the SBA that invited our Advisor to continue
with the application process for licensing this subsidiary as an
SBIC. On December 6, 2010 our subsidiary filed an
application for a license to operate as a small business
investment company. On December 21, 2010 we received a
letter from the SBA that it had accepted our application for
filing. However, the application to license this subsidiary as
an SBIC is subject to SBA approval. If we do not receive SBA
approval to license an SBIC our business plan and investment
objective could be materially adversely affected. If our
subsidiary receives this qualification, it will become subject
to SBA regulations that may constrain our activities or our
subsidiary. We may need to make allowances in our investment
activity or the investment activity of our subsidiaries to
comply with SBA regulations. In addition, SBA regulations may
impose parameters on our business operations and investment
objectives that are different than what we otherwise would do if
we were not subject to these regulations. Failure to comply with
the SBA regulations could result in the loss of the SBIC license
and the resulting inability to participate in the SBA-sponsored
debenture program. The SBA also limits the maximum amount that
may be borrowed by any single SBIC. The SBA prohibits, without
prior SBA approval, a change of control of an SBIC
or transfers that would result in any person (or a group of
persons acting in concert) owning 10% or more of a class of
capital stock of a licensed SBIC. A change of
control is any event which would result in the transfer of
the power, direct or indirect, to direct the management and
policies of an SBIC, whether through ownership, contractual
arrangements or otherwise. To the extent that our subsidiary
receives a license to operate as an SBIC, this would prohibit a
change of control of us without prior SBA approval. If we are
unable to comply with SBA regulations, our business plan and
growth strategy could be materially adversely affected.
Changes
in interest rates may affect our cost of capital and net
investment income.
Because we currently incur indebtedness to fund our investments,
a portion of our income depends upon the difference between the
interest rate at which we borrow funds and the interest rate at
which we invest these funds. Some of our investments have fixed
interest rates, while our borrowings have floating interest
rates. As a result, a significant change in interest rates could
have a material adverse effect on our net investment income. In
periods of rising interest rates, our cost of funds could
increase, which would reduce our net investment income. We may
hedge against interest rate fluctuations by using hedging
instruments such as swaps, futures, options and forward
contracts, subject to applicable legal requirements, including,
without limitation, all necessary registrations (or exemptions
from registration) with the Commodity Futures Trading
Commission. These activities may limit our ability to benefit
from lower interest rates with respect to the hedged portfolio.
We also have limited experience in entering into hedging
transactions, and we will initially have to rely on the advice
of outside parties with respect to the use of these financial
instruments or develop this expertise internally. Adverse
developments resulting from changes in interest rates or hedging
transactions or any adverse developments from our use of hedging
instruments could have a material adverse effect on our
business, financial condition and results of operations. In
addition, we may be unable to enter into appropriate hedging
transactions when desired and any hedging transactions we enter
into may not be effective.
Because
many of our investments typically are not and will not be in
publicly traded securities, the value of our investments may not
be readily determinable, which could adversely affect the
determination of our net asset value.
Our investments consist, and we expect our future investments to
consist, primarily of loans or securities issued by privately
held companies. As a result, the fair value of these investments
that are not publicly traded may not be readily determinable. In
addition, we are not permitted to maintain a general reserve for
anticipated loan losses.
29
Instead, we are required by the 1940 Act to specifically value
each investment and record an unrealized gain or loss for any
asset that we believe has increased or decreased in value. We
value these investments on a quarterly basis, or more frequently
as circumstances require, in accordance with our valuation
policy consistent with generally accepted accounting principles.
Our board of directors employs an independent third-party
valuation firm to assist them in arriving at the fair value of
our investments. The board of directors will discuss valuations
and determine the fair value in good faith based on the input of
our Advisor and the third-party valuation firm. The factors that
may be considered in fair value pricing our investments include
the nature and realizable value of any collateral, the portfolio
companys earnings and its ability to make payments on its
indebtedness, the markets in which the portfolio company does
business, comparisons to publicly traded companies, discounted
cash flow and other relevant factors. Because such valuations
are inherently uncertain and may be based on estimates, our
determinations of fair value may differ materially from the
values that would be assessed if a ready market for these
securities existed. Our net asset value could be adversely
affected if our determinations regarding the fair value of our
investments are materially higher than the values that we
ultimately realize upon the disposal of these investments.
Disruption
in the capital markets and the credit markets could adversely
affect our business.
Without sufficient access to the capital markets or credit
markets, we may be forced to curtail our business operations or
we may not be able to pursue new investment opportunities.
Beginning in 2007, the global capital markets entered into a
period of disruption and extreme volatility and, accordingly,
there has been and will continue to be uncertainty in the
financial markets in general. Ongoing disruptive conditions in
the financial industry could restrict our business operations
and could adversely impact our results of operations and
financial condition. We are unable to predict when economic and
market conditions may become more favorable. Even if these
conditions improve significantly over the long term, adverse
conditions in particular sectors of the financial markets could
adversely impact our business.
We may
not realize gains from our equity investments.
All of our investments that we have made in the past include,
and investments we may make in the future are expected to
include, warrants. In addition, we may from time to time make
non-control, equity co-investments in companies in conjunction
with private equity sponsors. Our goal with respect to these
equity investments is to ultimately realize gains upon
disposition. The equity interests we receive may not appreciate
in value and, in fact, may decline in value. Accordingly, we may
not be able to realize gains from our equity interests, and any
gains that we do realize on the disposition of any equity
interests may not be sufficient to offset any other losses we
experience. We also may be unable to realize any value if a
portfolio company does not have a liquidity event, such as a
sale of the business, refinancing or public offering, which
would allow us to sell the underlying equity interests. In
addition, the time and attention of the investment personnel of
our Advisor could be diverted from managing our debt portfolio
in order to manage any equity investments we receive thereby
impacting the value of our remaining portfolio, and our
Advisors significant experience in Technology Lending may
not result in returns on our equity investments.
From time to time we may also acquire equity participation
rights in connection with an investment which will allow us, at
our option, to participate in future rounds of equity financing
through direct capital investments in our portfolio companies.
Our Advisor will determine whether to exercise any of these
rights. Accordingly, you will have no control over whether or to
what extent these rights are exercised, if at all. If we
exercise these rights, we will be making an additional
investment completely in the form of equity which will subject
us to significantly more risk than our Technology Loans and we
may not receive the returns that are anticipated with respect to
these investments.
We may
not realize expected returns on warrants received in connection
with our debt investments.
As discussed above, we generally receive warrants in connection
with our debt investments. If we do not receive the returns that
are anticipated on the warrants, our investment returns on our
portfolio companies, and the value of your investment in us, may
be lower than expected.
30
Regulations
governing our operation as a business development company affect
our ability to, and the way in which, we raise additional
capital, which may expose us to additional risks.
Our business plans contemplate a need for a substantial amount
of capital in addition to our current amount of capital. We may
obtain additional capital through the issuance of debt
securities, other indebtedness or preferred stock, and we may
borrow money from banks or other financial institutions, which
we refer to collectively as senior securities, up to
the maximum amount permitted by the 1940 Act. Moreover, in
connection with the filing of the SBA license application, we
expect to seek exemptive relief from the SEC to permit us to
exclude the debt of the SBIC subsidiary guaranteed by the SBA
from the 200% consolidated asset coverage ratio requirements. If
we issue senior securities, we would be exposed to typical risks
associated with leverage, including an increased risk of loss.
In addition, if we issue preferred stock, it would rank
senior to common stock in our capital structure and
preferred stockholders would have separate voting rights and may
have rights, preferences or privileges more favorable than those
of holders of our common stock.
The 1940 Act permits us to issue senior securities in amounts
such that our asset coverage ratio, as defined in the 1940 Act,
equals at least 200% after each issuance of senior securities.
If our asset coverage ratio is not at least 200%, we will not be
permitted to pay dividends or issue additional senior
securities. If the value of our assets declines, we may be
unable to satisfy this asset coverage test. If that happens, we
may be required to liquidate a portion of our investments and
repay a portion of our indebtedness at a time when we may be
unable to do so or to do so on favorable terms.
As a business development company, we generally are not able to
issue our common stock at a price below net asset value without
first obtaining the approval of our stockholders and our
independent directors. This requirement will not apply to stock
issued upon the exercise of options, warrants or rights that we
may issue from time to time. If we raise additional funds by
issuing more common stock or senior securities convertible into,
or exchangeable for, our common stock, the percentage ownership
of our stockholders at that time would decrease, and you may
experience dilution.
If we
are unable to satisfy the requirements under the Code for
qualification as a RIC, we will be subject to corporate-level
federal income tax.
To qualify as a RIC under the Code, we must meet certain
source-of-income,
diversification and other requirements contained in Subchapter M
of the Code and maintain our election to be regulated as a
business development company under the 1940 Act. We must also
meet the Annual Distribution Requirement to avoid
corporate-level federal income tax in that year on all of our
taxable income, regardless of whether we make any distributions
to our stockholders.
The
source-of-income
requirement is satisfied if we derive in each taxable year at
least 90% of our gross income from dividends, interest
(including tax-exempt interest), payments with respect to
certain securities loans, gains from the sale or other
disposition of stock, securities or foreign currencies, other
income (including but not limited to gain from options, futures
or forward contracts) derived with respect to our business of
investing in stock, securities or currencies, or net income
derived from an interest in a qualified publicly traded
partnership. The status of certain forms of income we
receive could be subject to different interpretations under the
Code and might be characterized as non-qualifying income that
could cause us to fail to qualify as a RIC, assuming we do not
qualify for or take advantage of certain remedial provisions,
and, thus, may cause us to be subject to corporate-level federal
income taxes.
The annual distribution requirement for a RIC is satisfied if we
distribute to our stockholders on an annual basis an amount
equal to at least 90% of our net ordinary income and realized
net short-term capital gains in excess of realized net long-term
capital losses, if any. If we borrow money, we may be subject to
certain asset coverage ratio requirements under the 1940 Act and
loan covenants that could, under certain circumstances, restrict
us from making distributions necessary to qualify as a RIC. If
we are unable to obtain cash from other sources, we may fail to
qualify as a RIC, assuming we do not qualify for or take
advantage of certain remedial provisions, and, thus, may be
subject to corporate-level income tax.
31
To qualify as a RIC, we must also meet certain asset
diversification requirements at the end of each calendar
quarter. Failure to meet these tests may result in our having to
(i) dispose of certain investments quickly; (ii) raise
additional capital to prevent the loss of RIC status; or
(iii) engage in certain remedial actions that may entail
the disposition of certain investments at disadvantageous prices
that could result in substantial losses, and the payment of
penalties, if we qualify to take such actions. Because most of
our investments are and will be in development-stage companies
within our Target Industries, any such dispositions could be
made at disadvantageous prices and may result in substantial
losses. If we raise additional capital to satisfy the asset
diversification requirements, it could take a longer time to
invest such capital. During this period, we will invest in
temporary investments, such as cash and cash equivalents, which
we expect will earn yields substantially lower than the interest
income that we anticipate receiving in respect of our
investments in secured and amortizing loans.
If we were to fail to qualify for the federal income tax
benefits allowable to RICs for any reason and become subject to
a corporate-level federal income tax, the resulting taxes could
substantially reduce our net assets, the amount of income
available for distribution to our stockholders, and the actual
amount of our distributions. Such a failure would have a
material adverse effect on us, the net asset value of our common
stock and the total return, if any, obtainable from your
investment in our common stock. In addition, we could be
required to recognize unrealized gains, pay substantial taxes
and interest and make substantial distributions before
requalifying as a RIC. See Regulation.
We may
have difficulty paying our required distributions if we
recognize taxable income before or without receiving
cash.
We may be required to recognize taxable income in circumstances
in which we do not receive cash. For example if we hold debt
instruments that are treated under applicable tax rules as
having original issue discount (such as debt instruments with
payment-in-kind
interest or, in certain cases, increasing interest rates or
issued with warrants), we must include in taxable income each
year a portion of the original issue discount that accrues over
the life of the debt instrument, regardless of whether cash
representing such income is received by us in the same taxable
year. Because in certain cases we may recognize taxable income
before or without receiving cash representing such income, we
may have difficulty meeting the requirement that we distribute
an amount equal to at least 90% of our net ordinary income and
realized net short-term capital gains in excess of realized
long-term capital losses, if any (the Annual Distribution
Requirement). For example, the proportion of our income
that resulted from original issue discount for both of the years
ended December 31, 2010 and December 31, 2009 was
approximately 8.2%.
Accordingly, we may need to sell some of our assets at times
that we would not consider advantageous, raise additional debt
or equity capital or forego new investment opportunities or
otherwise take actions that are disadvantageous to our business
(or be unable to take actions that we believe are necessary or
advantageous to our business) in order to satisfy the Annual
Distribution Requirement. If we are unable to obtain cash from
other sources to satisfy the Annual Distribution Requirement, we
may fail to qualify for the federal income tax benefits
allowable to RICs and, thus, become subject to a corporate-level
federal income tax on all our income.
If we
do not invest a sufficient portion of our assets in qualifying
assets, we could fail to qualify as a business development
company or be precluded from investing according to our current
business strategy.
As a business development company, we are prohibited from
acquiring any assets other than qualifying assets
unless, at the time of and after giving effect to such
acquisition, at least 70% of our total assets are qualifying
assets. Substantially all of our assets are qualifying assets
and we expect that substantially all of our assets that we may
acquire in the future will be qualifying assets,
although we may decide to make other investments that are not
qualifying assets to the extent permitted by the
1940 Act. If we acquire debt or equity securities from an issuer
that has outstanding marginable securities at the time we make
an investment, these acquired assets may not be treated as
qualifying assets. This result is dictated by the definition of
eligible portfolio company under the 1940 Act, which
in part looks to whether a company has outstanding marginable
securities. See Item 1 above, Regulation
Qualifying Assets. If we do not invest a sufficient
portion of our assets in qualifying assets, we could lose our
status as a business development company, which would have a
material adverse effect on our business, financial condition and
results of operations.
32
Changes
in laws or regulations governing our business could adversely
affect our business, results of operations and financial
condition.
Changes in the laws or regulations or the interpretations of the
laws and regulations that govern business development companies,
RICs, SBICs or non-depository commercial lenders could
significantly affect our operations, our cost of doing business
and our investment strategy. We are subject to federal, state
and local laws and regulations and judicial and administrative
decisions that affect our operations, including our loan
originations, maximum interest rates, fees and other charges,
disclosures to portfolio companies, the terms of secured
transactions, collection and foreclosure procedures, portfolio
composition and other trade practices. If these laws,
regulations or decisions change, or if we expand our business
into jurisdictions that have adopted more stringent
requirements, we may incur significant expenses to comply with
these laws, regulations or decisions or we might have to
restrict our operations or alter our investment strategy. For
example, any change to the SBAs current debenture SBIC
program could have a significant impact on our ability to obtain
lower-cost leverage and our ability to compete with other
finance companies. In addition, if we do not comply with
applicable laws, regulations and decisions, we may lose licenses
needed for the conduct of our business and be subject to civil
fines and criminal penalties, any of which could have a material
adverse effect upon our business, results of operations or
financial condition.
Our
Advisor has significant potential conflicts of interest with us
and our stockholders.
As a result of our arrangements with our Advisor, there may be
times when our Advisor has interests that differ from those of
our stockholders, giving rise to a potential conflict of
interest. Our executive officers and directors, as well as the
current and future executives and employees of our Advisor,
serve or may serve as officers, directors or principals of
entities that operate in the same or a related line of business
as we do. Accordingly, they may have obligations to investors in
those entities, the fulfillment of which might not be in the
best interests of our stockholders. In addition, our Advisor may
manage other funds in the future that may have investment
objectives that are similar, in whole or in part, to ours. Our
Advisor may determine that an investment is appropriate for us
and for one or more of those other funds. In such an event,
depending on the availability of the investment and other
appropriate factors, our Advisor will endeavor to allocate
investment opportunities in a fair and equitable manner. It is
also possible that we may not be given the opportunity to
participate in these other investment opportunities.
We pay management and incentive fees to our Advisor and
reimburse our Advisor for certain expenses it incurs. As a
result, investors in our common stock invest on a
gross basis and receive distributions on a
net basis after expenses, resulting in a lower rate
of return than an investor might achieve through direct
investments. Also, the incentive fee payable by us to our
Advisor may create an incentive for our Advisor to pursue
investments on our behalf that are riskier or more speculative
than would be the case in the absence of such compensation
arrangements.
We have entered into a license agreement with Horizon Technology
Finance, LLC, pursuant to which it has agreed to grant us a
non-exclusive, royalty-free right and license to use the service
mark Horizon Technology Finance. Under this
agreement, we have a right to use the Horizon Technology
Finance service mark for so long as the Investment
Management Agreement is in effect between us and our Advisor. In
addition, we pay our Advisor, our allocable portion of overhead
and other expenses incurred by our Advisor in performing its
obligations under the Administration Agreement, including rent,
the fees and expenses associated with performing compliance
functions, and our allocable portion of the compensation of our
chief financial officer and any administrative support staff.
Any potential conflict of interest arising as a result of our
arrangements with our Advisor could have a material adverse
effect on our business, results of operations and financial
condition.
Our
incentive fee may impact our Advisors structuring of our
investments, including by causing our Advisor to pursue
speculative investments.
The incentive fee payable by us to our Advisor may create an
incentive for our Advisor to pursue investments on our behalf
that are riskier or more speculative than would be the case in
the absence of such compensation arrangement. The incentive fee
payable to our Advisor is calculated based on a percentage of
our return on invested capital. This may encourage our Advisor
to use leverage to increase the return on our investments. Under
certain
33
circumstances, the use of leverage may increase the likelihood
of default, which would impair the value of our common stock. In
addition, our Advisor receives the incentive fee based, in part,
upon net capital gains realized on our investments. Unlike that
portion of the incentive fee based on income, there is no hurdle
rate applicable to the portion of the incentive fee based on net
capital gains. As a result, our Advisor may have a tendency to
invest more capital in investments that are likely to result in
capital gains as compared to income-producing securities. Such a
practice could result in our investing in more speculative
securities than would otherwise be the case, which could result
in higher investment losses, particularly during economic
downturns. In addition, the incentive fee may encourage our
Advisor to pursue different types of investments or structure
investments in ways that are more likely to result in warrant
gains or gains on equity investments, including upon exercise of
equity participation rights, which are inconsistent with our
investment strategy and disciplined underwriting process.
The incentive fee payable by us to our Advisor also may induce
our Advisor to pursue investments on our behalf that have a
deferred interest feature, even if such deferred payments would
not provide cash necessary to enable us to pay current
distributions to our stockholders. Under these investments, we
would accrue interest over the life of the investment but would
not receive the cash income from the investment until the end of
the term. Our net investment income used to calculate the income
portion of our investment fee, however, includes accrued
interest. Thus, a portion of this incentive fee would be based
on income that we have not yet received in cash. In addition,
the
catch-up
portion of the incentive fee may encourage our Advisor to
accelerate or defer interest payable by portfolio companies from
one calendar quarter to another, potentially resulting in
fluctuations in the timing and amounts of dividends. Our
governing documents do not limit the number of loans we may make
with deferred interest features or the proportion of our income
we derive from such loans. For the years ended December 31,
2010 and 2009, we derived approximately 4.3% and 3.4%,
respectively, of our income from the deferred interest component
of our loans and approximately 4.0% and 4.8%, respectively, of
our income from discount accretion associated with warrants we
have received in connection with the making of our loans.
If we
are unable to manage our future growth effectively, we may be
unable to achieve our investment objective, which could
adversely affect our business, results of operations and
financial condition and cause the value of your investment in us
to decline.
Our ability to achieve our investment objective depends on our
ability to achieve and sustain growth, which depends, in turn,
on our Advisors direct origination capabilities and
disciplined underwriting process in identifying, evaluating,
financing, investing in and monitoring suitable companies that
meet our investment criteria. Accomplishing this result on a
cost-effective basis is largely a function of our Advisors
marketing capabilities, management of the investment process,
ability to provide efficient services and access to financing
sources on acceptable terms. In addition to monitoring the
performance of our existing investments, our Advisor may also be
called upon to provide managerial assistance to our portfolio
companies. These demands on their time may distract them or slow
the rate of investment. If we fail to manage our future growth
effectively, our business, results of operations and financial
condition could be materially adversely affected and the value
of your investment in us could decrease.
Our
board of directors may change our operating policies and
strategies, including our investment objective, without prior
notice or stockholder approval, the effects of which may
adversely affect our business.
Our board of directors may modify or waive our current operating
policies and strategies, including our investment objectives,
without prior notice and without stockholder approval (provided
that no such modification or waiver may change the nature of our
business so as to cease to be, or withdraw our election as, a
business development company as provided by the 1940 Act without
stockholder approval at a special meeting called upon written
notice of not less than ten or more than sixty days before the
date of such meeting). We cannot predict the effect any changes
to our current operating policies and strategies would have on
our business, results of operations or financial condition or on
the value of our stock. However, the effects of any changes
might adversely affect our business, any or all of which could
negatively impact our ability to pay dividends or cause you to
lose all or part of your investment in us.
34
Our
quarterly and annual operating results may fluctuate due to the
nature of our business.
We could experience fluctuations in our quarterly and annual
operating results due to a number of factors, some of which are
beyond our control, including: our ability to make investments
in companies that meet our investment criteria, the interest
rate payable on our loans, the default rate on these
investments, the level of our expenses, variations in, and the
timing of, the recognition of realized and unrealized gains or
losses, the degree to which we encounter competition in our
markets and general economic conditions. For example, we have
historically experienced greater investment activity during the
second and fourth quarters relative to other periods. As a
result of these factors, you should not rely on the results for
any prior period as being indicative of our performance in
future periods.
Our
business plan and growth strategy depends to a significant
extent upon our Advisors referral relationships. If our
Advisor is unable to develop new or maintain existing
relationships, or if these relationships fail to generate
investment opportunities, our business could be materially
adversely affected.
We have historically depended on our Advisors referral
relationships to generate investment opportunities. For us to
achieve our future business objectives, members of our Advisor
will need to maintain these relationships with venture capital
and private equity firms and management teams and legal firms,
accounting firms, investment banks and other lenders, and we
will rely to a significant extent upon these relationships to
provide us with investment opportunities. If they fail to
maintain their existing relationships or develop new
relationships with other firms or sources of investment
opportunities, we may not be able to grow our investment
portfolio. In addition, persons with whom our Advisor has
relationships are not obligated to provide us with investment
opportunities, and, therefore, there is no assurance that such
relationships will lead to the origination of debt or other
investments.
Our
Advisor can resign on 60 days notice and we may not
be able to find a suitable replacement within that time,
resulting in a disruption in our operations that could adversely
affect our business, results of operations or financial
condition.
Under our Investment Management Agreement, our Advisor has the
right to resign at any time, including during the first two
years following the Investment Management Agreements
effective date, upon not more than 60 days written
notice, whether we have found a replacement or not. If our
Advisor resigns, we may not be able to find a new investment
Advisor or hire internal management with similar expertise and
ability to provide the same or equivalent services on acceptable
terms within 60 days, or at all. If we are unable to do so,
our operations are likely to be disrupted, our business, results
of operations and financial condition and our ability to pay
distributions may be adversely affected and the market price of
our shares may decline. In addition, the coordination of our
internal management and investment activities is likely to
suffer if we are unable to identify and reach an agreement with
a single institution or group of executives having the expertise
possessed by our Advisor and its affiliates. Even if we are able
to retain comparable management, whether internal or external,
the integration of new management and their lack of familiarity
with our investment objective may result in additional costs and
time delays that may adversely affect our business, results of
operations or financial condition.
Our
ability to enter into transactions with our affiliates is
restricted.
As a business development company, we are prohibited under the
1940 Act from participating in certain transactions with our
affiliates without the prior approval of our independent
directors and, in some cases, the SEC. Any person that owns,
directly or indirectly, 5% or more of our outstanding voting
securities is considered our affiliate for purposes of the 1940
Act. We are generally prohibited from buying or selling any
security from or to an affiliate, absent the prior approval of
our independent directors. The 1940 Act also prohibits certain
joint transactions with an affiliate, which could
include investments in the same portfolio company (whether at
the same or different times), without prior approval of our
independent directors. If a person acquires more than 25% of our
voting securities, we are prohibited from buying or selling any
security from or to that person or certain of that persons
affiliates, or entering into prohibited joint transactions with
those persons, absent the prior approval of the SEC. Similar
restrictions limit our ability to transact business with our
officers or directors or their affiliates.
35
We
incur significant costs as a result of being a publicly traded
company.
As a publicly traded company, we incur legal, accounting and
other expenses, including costs associated with the periodic
reporting requirements applicable to a company whose securities
are registered under the Securities Exchange Act of 1934, as
amended, or the Exchange Act, as well as additional corporate
governance requirements, including requirements under the
Sarbanes-Oxley Act of 2002, and other rules implemented by the
SEC.
Terrorist
attacks and other catastrophic events may disrupt the businesses
in which we invest and harm our operations and our
profitability.
Terrorist attacks and threats, escalation of military activity
or acts of war may significantly harm our results of operations
and your investment. We cannot assure you that there will not be
further terrorist attacks against the United States or United
States businesses. Such attacks or armed conflicts in the United
States or elsewhere may impact the businesses in which we invest
directly or indirectly, by undermining economic conditions in
the United States or elsewhere. In addition, because many of our
portfolio companies operate and rely on network infrastructure
and enterprise applications and internal technology systems for
development, marketing, operational, support and other business
activities, a disruption or failure of any or all of these
systems in the event of a major telecommunications failure,
cyber-attack, fire, earthquake, severe weather conditions or
other catastrophic event could cause system interruptions,
delays in product development and loss of critical data and
could otherwise disrupt their business operations. Losses
resulting from terrorist attacks are generally uninsurable.
Risks
Related to our Investments
We
have not yet identified many of the potential investment
opportunities for our portfolio.
We have not yet identified many of the potential investment
opportunities for our portfolio. Our future investments will be
selected by our Advisor, subject to the approval of its
investment committee. Our stockholders do not have input into
our Advisors investment decisions. As a result, our
stockholders are unable to evaluate any of our future portfolio
company investments. These factors increase the uncertainty, and
thus the risk, of investing in our shares of common stock.
If our
investments do not meet our performance expectations, you may
not receive distributions.
We intend to make distributions of income on a quarterly basis
to our stockholders. We may not be able to achieve operating
results that will allow us to make distributions at a specific
level or increase the amount of these distributions from time to
time. In addition, due to the asset coverage test applicable to
us as a business development company, we may be limited in our
ability to make distributions. See Regulation above.
Also, restrictions and provisions in any existing or future
credit facilities may limit our ability to make distributions.
If we do not distribute a certain percentage of our income
annually, we will suffer adverse tax consequences, including
failure to obtain, or possible loss of, the federal income tax
benefits allowable to RICs.
Most
of our portfolio companies will need additional capital, which
may not be readily available.
Our portfolio companies typically require substantial additional
financing to satisfy their continuing working capital and other
capital requirements and service the interest and principal
payments on our investments. We cannot predict the circumstances
or market conditions under which our portfolio companies will
seek additional capital. Each round of institutional equity
financing is typically intended to provide a company with only
enough capital to reach the next stage of development. It is
possible that one or more of our portfolio companies will not be
able to raise additional financing or may be able to do so only
at a price or on terms that are unfavorable to the portfolio
company, either of which would negatively impact our investment
returns. Some of these companies may be unable to obtain
sufficient financing from private investors, public capital
markets or lenders thereby requiring these companies to cease or
curtail business operations. Accordingly, investing in these
types of companies generally entails a higher risk of loss than
investing in companies that do not have significant incremental
capital raising requirements.
36
Economic
recessions or downturns could adversely affect our business and
that of our portfolio companies which may have an adverse effect
on our business, results of operations and financial
condition.
General economic conditions may affect our activities and the
operation and value of our portfolio companies. Economic
slowdowns or recessions may result in a decrease of
institutional equity investment, which would limit our lending
opportunities. Furthermore, many of our portfolio companies may
be susceptible to economic slowdowns or recessions and may be
unable to repay our loans during these periods. Therefore, our
non-performing assets are likely to increase and the value of
our portfolio is likely to decrease during these periods.
Adverse economic conditions also may decrease the value of
collateral securing some of our loans and the value of our
equity investments. Economic slowdowns or recessions could lead
to financial losses in our portfolio and a decrease in revenues,
net income and assets. Unfavorable economic conditions also
could increase our funding costs, limit our access to the
capital markets or result in a decision by lenders not to extend
credit to us.
A portfolio companys failure to satisfy financial or
operating covenants imposed by us or other lenders could lead to
defaults and, potentially, termination of its loans and
foreclosure on its secured assets, which could trigger
cross-defaults under other agreements and jeopardize the
portfolio companys ability to meet its obligations under
the loans that we hold. We may incur expenses to the extent
necessary to recover our investment upon default or to negotiate
new terms with a defaulting portfolio company. These events
could harm our financial condition and operating results.
Our
investment strategy focuses on investments in development-stage
companies in our Target Industries, which are subject to many
risks, including volatility, intense competition, shortened
product life cycles and periodic downturns, and are typically
rated below investment grade.
We intend to invest, under normal circumstances, most of the
value of our total assets (including the amount of any
borrowings for investment purposes) in development-stage
companies, which may have relatively limited operating
histories, in our Target Industries. Many of these companies may
have narrow product lines and small market shares, compared to
larger established publicly-owned firms, which tend to render
them more vulnerable to competitors actions and market
conditions, as well as general economic downturns. The revenues,
income (or losses) and valuations of development-stage companies
in our Target Industries can and often do fluctuate suddenly and
dramatically. For these reasons, investments in our portfolio
companies, if rated by one or more ratings agency, would
typically be rated below investment grade, which
refers to securities rated by ratings agencies below the four
highest rating categories. These companies may also have more
limited access to capital and higher funding costs. In addition,
development-stage technology markets are generally characterized
by abrupt business cycles and intense competition, and the
competitive environment can change abruptly due to rapidly
evolving technology. Therefore, our portfolio companies may face
considerably more risk than companies in other industry sectors.
Accordingly, these factors could impair their cash flow or
result in other events, such as bankruptcy, which could limit
their ability to repay their obligations to us and may
materially adversely affect the return on, or the recovery of,
our investments in these businesses.
Because of rapid technological change, the average selling
prices of products and some services provided by
development-stage companies in our Target Industries have
historically decreased over their productive lives. These
decreases could adversely affect their operating results and
cash flow, their ability to meet obligations under their debt
securities and the value of their equity securities. This could,
in turn, materially adversely affect our business, financial
condition and results of operations.
Any
unrealized depreciation we experience on our loan portfolio may
be an indication of future realized losses, which could reduce
our income available for distribution.
As a business development company, we are required to carry our
investments at fair value which shall be the market value of our
investments or, if no market value is ascertainable, at the fair
value as determined in good faith pursuant to procedures
approved by our board of directors in accordance with our
valuation policy. We are not permitted to maintain a reserve for
loan losses. Decreases in the fair values of our investments are
recorded as unrealized depreciation. Any unrealized depreciation
in our loan portfolio could be an indication of a portfolio
37
companys inability to meet its repayment obligations to us
with respect to the affected loans. This could result in
realized losses in the future and ultimately reduces our income
available for distribution in future periods.
If the
assets securing the loans we make decrease in value, we may not
have sufficient collateral to cover losses and may experience
losses upon foreclosure.
We believe our portfolio companies generally will be able to
repay our loans from their available capital, from future
capital-raising transactions or from cash flow from operations.
However, to mitigate our credit risks, we typically take a
security interest in all or a portion of the assets of our
portfolio companies, including the equity interests of their
subsidiaries. There is a risk that the collateral securing our
loans may decrease in value over time, may be difficult to
appraise or sell in a timely manner and may fluctuate in value
based upon the business and market conditions, including as a
result of the inability of the portfolio company to raise
additional capital, and, in some circumstances, our lien could
be subordinated to claims of other creditors. In addition,
deterioration in a portfolio companys financial condition
and prospects, including its inability to raise additional
capital, may be accompanied by deterioration in the value of the
collateral for the loan. Consequently, although such loan is
secured, we may not receive principal and interest payments
according to the loans terms and the value of the
collateral may not be sufficient to recover our investment
should we be forced to enforce our remedies.
In addition, because we invest in development-stage companies in
our Target Industries, a substantial portion of the assets
securing our investment may be in the form of intellectual
property, if any, inventory, equipment, cash and accounts
receivables. Intellectual property, if any, which secures a loan
could lose value if the companys rights to the
intellectual property are challenged or if the companys
license to the intellectual property is revoked or expires. In
addition, in lieu of a security interest in the intellectual
property we may sometimes obtain a security interest in all
assets of the portfolio company other than intellectual property
and also obtain a commitment by the portfolio company not to
grant liens to any other creditor on the companys
intellectual property. In these cases, we may have additional
difficulty recovering our principal in the event of a
foreclosure. Similarly, any equipment securing our loan may not
provide us with the anticipated security if there are changes in
technology or advances in new equipment that render the
particular equipment obsolete or of limited value or if the
company fails to adequately maintain or repair the equipment.
Any one or more of the preceding factors could materially impair
our ability to recover principal in a foreclosure.
The
lack of liquidity in our investments may adversely affect our
business, and if we need to sell any of our investments, we may
not be able to do so at a favorable price. As a result, we may
suffer losses.
We plan to generally invest in loans with terms of up to four
years and hold such investments until maturity, unless earlier
prepaid, and we do not expect that our related holdings of
equity securities will provide us with liquidity opportunities
in the near-term. We expect to primarily invest in companies
whose securities are not publicly-traded, and whose securities
will be subject to legal and other restrictions on resale or
will otherwise be less liquid than publicly traded securities.
The illiquidity of these investments may make it difficult for
us to sell these investments when desired. We may also face
other restrictions on our ability to liquidate an investment in
a public portfolio company to the extent that we possess
material non-public information regarding the portfolio company.
In addition, if we are required to liquidate all or a portion of
our portfolio quickly, we may realize significantly less than
the value at which we had previously recorded these investments.
As a result, we do not expect to dispose of our investments in
the near term. However, we may be required to do so in order to
maintain our qualification as a business development company and
as a RIC if we do not satisfy one or more of the applicable
criteria under the respective regulatory frameworks. Because
most of our investments are illiquid, we may be unable to
dispose of them, in which case we could fail to qualify as a RIC
and/or BDC,
or we may not be able to dispose of them at favorable prices,
and as a result, we may suffer losses.
Our
portfolio companies may incur debt that ranks equally with, or
senior to, our investments in such companies.
We plan to invest primarily in loans issued by our portfolio
companies. Some of our portfolio companies are permitted to have
other debt that ranks equally with, or senior to, our loans in
the portfolio company. By their terms, these debt instruments
may provide that the holders thereof are entitled to receive
payment of interest or principal on
38
or before the dates on which we are entitled to receive payments
in respect of our loans. These debt instruments may prohibit the
portfolio companies from paying interest on or repaying our
investments in the event of, and during, the continuance of a
default under the debt instruments. In addition, in the event of
insolvency, liquidation, dissolution, reorganization or
bankruptcy of a portfolio company, holders of debt instruments
ranking senior to our investment in that portfolio company would
typically be entitled to receive payment in full before we
receive any payment in respect of our investment. After repaying
senior creditors, a portfolio company may not have any remaining
assets to use for repaying its obligation to us. In the case of
debt ranking equally with our loans, we would have to share on
an equal basis any distributions with other creditors holding
such debt in the event of an insolvency, liquidation,
dissolution, reorganization or bankruptcy.
There
may be circumstances where our loans could be subordinated to
claims of other creditors or we could be subject to lender
liability claims.
Even though certain of our investments are structured as senior
loans, if one of our portfolio companies were to go bankrupt,
depending on the facts and circumstances, including the extent
to which we actually provided managerial assistance to that
portfolio company, a bankruptcy court might recharacterize our
debt investment and subordinate all or a portion of our claim to
that of other creditors. We may also be subject to lender
liability claims for actions taken by us with respect to a
portfolio companys business, including in rendering
significant managerial assistance, or instances where we
exercise control over the portfolio company.
An
investment strategy focused primarily on privately held
companies presents certain challenges, including the lack of
available information about these companies, a dependence on the
talents and efforts of only a few key portfolio company
personnel and a greater vulnerability to economic
downturns.
We currently invest, and plan to invest, primarily in privately
held companies. Generally, very little public information exists
about these companies, and we are required to rely on the
ability of our Advisor to obtain adequate information to
evaluate the potential returns from investing in these
companies. If we are unable to uncover all material information
about these companies, we may not make a fully informed
investment decision, and we may lose money on our investments.
Also, privately held companies frequently have less diverse
product lines and a smaller market presence than larger
competitors. They are thus generally more vulnerable to economic
downturns and may experience substantial variations in operating
results. These factors could affect our investment returns.
In addition, our success depends, in large part, upon the
abilities of the key management personnel of our portfolio
companies, who are responsible for the
day-to-day
operations of our portfolio companies. Competition for qualified
personnel is intense at any stage of a companys
development. The loss of one or more key managers can hinder or
delay a companys implementation of its business plan and
harm its financial condition. Our portfolio companies may not be
able to attract and retain qualified managers and personnel. Any
inability to do so may negatively affect our investment returns.
Prepayments
of our debt investments by our portfolio companies could
adversely impact our results of operations and reduce our return
on equity.
We are subject to the risk that the investments we make in our
portfolio companies may be repaid prior to maturity. For
example, most of our debt investments have, historically, been
repaid prior to maturity by our portfolio companies. At the time
of a liquidity event, such as a sale of the business,
refinancing or public offering, many of our portfolio companies
have availed themselves of the opportunity to repay our loans
prior to maturity. Our investments generally allow for repayment
at any time subject to certain penalties. When this occurs, we
will generally reinvest these proceeds in temporary investments,
pending their future investment in new portfolio companies.
These temporary investments will typically have substantially
lower yields than the debt being prepaid, and we could
experience significant delays in reinvesting these amounts. Any
future investment in a new portfolio company may also be at
lower yields than the debt that was repaid. As a result, our
results of operations could be materially adversely affected if
one or more of our portfolio companies elects to prepay amounts
owed to us. Additionally, prepayments could negatively impact
our return on equity, which could result in a decline in the
market price of our common stock.
39
Our
business and growth strategy could be adversely affected if
government regulations, priorities and resources impacting the
industries in which our portfolio companies operate
change.
Some of our portfolio companies operate in industries that are
highly regulated by federal, state
and/or local
agencies. Changes in existing laws, rules or regulations, or
judicial or administrative interpretations thereof, or new laws,
rules or regulations could have an adverse impact on the
business and industries of our portfolio companies. In addition,
changes in government priorities or limitations on government
resources could also adversely impact our portfolio companies.
We are unable to predict whether any such changes in laws, rules
or regulations will occur and, if they do occur, the impact of
these changes on our portfolio companies and our investment
returns.
Our
portfolio companies operating in the life science industry are
subject to extensive government regulation and certain other
risks particular to that industry.
As part of our investment strategy, we have invested, and plan
to invest in the future, in companies in the life science
industry that are subject to extensive regulation by the Food
and Drug Administration, or FDA, and to a lesser extent, other
federal and state agencies. If any of these portfolio companies
fail to comply with applicable regulations, they could be
subject to significant penalties and claims that could
materially and adversely affect their operations. Portfolio
companies that produce medical devices or drugs are subject to
the expense, delay and uncertainty of the regulatory approval
process for their products and, even if approved, these products
may not be accepted in the marketplace. In addition, new laws,
regulations or judicial interpretations of existing laws and
regulations might adversely affect a portfolio company in this
industry. Portfolio companies in the life science industry may
also have a limited number of suppliers of necessary components
or a limited number of manufacturers for their products, and
therefore face a risk of disruption to their manufacturing
process if they are unable to find alternative suppliers when
needed. Any of these factors could materially and adversely
affect the operations of a portfolio company in this industry
and, in turn, impair our ability to timely collect principal and
interest payments owed to us.
If our
portfolio companies are unable to commercialize their
technologies, products, business concepts or services, the
returns on our investments could be adversely
affected.
The value of our investments in our portfolio companies may
decline if they are not able to commercialize their technology,
products, business concepts or services. Additionally, although
some of our portfolio companies may already have a commercially
successful product or product line at the time of our
investment, technology-related products and services often have
a more limited market or life span than products in other
industries. Thus, the ultimate success of these companies often
depends on their ability to continually innovate in increasingly
competitive markets. If they are unable to do so, our investment
returns could be adversely affected and their ability to service
their debt obligations to us over the life of the loan could be
impaired. Our portfolio companies may be unable to successfully
acquire or develop any new technologies and the intellectual
property they currently hold may not remain viable. Even if our
portfolio companies are able to develop commercially viable
products, the market for new products and services is highly
competitive and rapidly changing. Neither our portfolio
companies nor we will have any control over the pace of
technology development. Commercial success is difficult to
predict, and the marketing efforts of our portfolio companies
may not be successful.
If our
portfolio companies are unable to protect their intellectual
property rights, our business and prospects could be harmed, and
if portfolio companies are required to devote significant
resources to protecting their intellectual property rights, the
value of our investment could be reduced.
Our future success and competitive position depends in part upon
the ability of our portfolio companies to obtain, maintain and
protect proprietary technology used in their products and
services. The intellectual property held by our portfolio
companies often represents a substantial portion of the
collateral securing our investments
and/or
constitutes a significant portion of the portfolio
companies value that may be available in a downside
scenario to repay our loans. Our portfolio companies rely, in
part, on patent, trade secret and trademark law to protect that
technology, but competitors may misappropriate their
intellectual property, and disputes as to ownership of
intellectual property may arise. Portfolio companies may, from
time to time, be required to institute litigation to enforce
their patents, copyrights or other intellectual property rights,
protect their trade secrets,
40
determine the validity and scope of the proprietary rights of
others or defend against claims of infringement. Such litigation
could result in substantial costs and diversion of resources.
Similarly, if a portfolio company is found to infringe or
misappropriate a third partys patent or other proprietary
rights, it could be required to pay damages to the third party,
alter its products or processes, obtain a license from the third
party and/or
cease activities utilizing the proprietary rights, including
making or selling products utilizing the proprietary rights. Any
of the foregoing events could negatively affect both the
portfolio companys ability to service our debt investment
and the value of any related debt and equity securities that we
own, as well as any collateral securing our investment.
We do
not expect to control any of our portfolio
companies.
We do not control, or expect to control in the future, any of
our portfolio companies, even though our debt agreements may
contain certain restrictive covenants that limit the business
and operations of our portfolio companies. We also do not
maintain, or intend to maintain in the future, a control
position to the extent we own equity interests in any portfolio
company. As a result, we are subject to the risk that a
portfolio company in which we invest may make business decisions
with which we disagree and the management of such company, as
representatives of the holders of their common equity, may take
risks or otherwise act in ways that do not serve our interests
as debt investors. Due to the lack of liquidity of the
investments that we typically hold in our portfolio companies,
we may not be able to dispose of our investments in the event we
disagree with the actions of a portfolio company and we may
therefore, suffer a decrease in the value of our investments.
Risks
Related to our Common Stock
We
cannot assure you that the market price of shares of our common
stock will not decline.
Prior to our IPO, there was no public trading market for our
common stock. We cannot predict the prices at which our common
stock will trade. Shares of closed-end management investment
companies have in the past frequently traded at discounts to
their net asset values and our common stock has been and may
continue to be discounted in the market. This characteristic of
closed-end management investment companies is separate and
distinct from the risk that our net asset value per share may
decline. We cannot predict whether shares of our common stock
will trade above, at or below our net asset value. If our common
stock trades below its net asset value, we will generally not be
able to sell additional shares of our common stock to the public
at its market price without first obtaining the approval of our
stockholders (including our unaffiliated stockholders) and our
independent directors.
Subsequent
sales in the public market of substantial amounts of our common
stock issued to insiders or others may have an adverse effect on
the market price of our common stock.
We and our executive officers and directors and certain other
stockholders, including the selling stockholder in our initial
public offering made pursuant to our Prospectus dated
October 28, 2010, are subject to agreements with the
underwriters of our initial public offering that restrict our
and their ability to transfer our stock for a period of
180 days from October 28, 2010. Approximately one out
of every six of our publicly issued shares outstanding is
subject to such agreements. In the event that either
(a) during the last 17 days of the
180-day
restricted period, we issue an earnings release or material news
or a material event relating to us occurs or (b) prior to
the expiration of the
180-day
restricted period, we announce that we will release earnings
results during the
16-day
period beginning on the last day of the
180-day
period, the
lock-up
restrictions will continue to apply until the expiration of the
18-day
period beginning on the issuance of the earnings release or the
occurrence of the material news or material event. After the
lock-up
agreements expire, an aggregate of 1,305,124 additional shares
of our common stock will be eligible for sale in the public
market in accordance with Rule 144 under the Securities
Act. Sales of substantial amounts of our common stock or the
availability of such shares for sale, including by insiders,
could adversely affect the prevailing market prices for our
common stock. If this occurs and continues, our ability to raise
additional capital through the sale of equity securities could
be impaired should we desire to do so.
41
Our
common stock price may be volatile and may decrease
substantially.
The trading price of our common stock may fluctuate
substantially and the liquidity of our common stock may be
limited, in each case depending on many factors, some of which
are beyond our control and may not be directly related to our
operating performance. These factors include the following:
|
|
|
|
|
price and volume fluctuations in the overall stock market or in
the market for business development companies from time to time;
|
|
|
|
investor demand for our shares of common stock;
|
|
|
|
significant volatility in the market price and trading volume of
securities of registered closed-end management investment
companies, business development companies or other financial
services companies;
|
|
|
|
our inability to raise capital, borrow money or deploy or invest
our capital;
|
|
|
|
fluctuations in interest rates;
|
|
|
|
any shortfall in revenue or net income or any increase in losses
from levels expected by investors or securities analysts;
|
|
|
|
operating performance of companies comparable to us;
|
|
|
|
changes in regulatory policies or tax guidelines with respect to
RICs, business development companies or SBICs;
|
|
|
|
not electing or losing RIC status;
|
|
|
|
actual or anticipated changes in our earnings or fluctuations in
our operating results;
|
|
|
|
changes in the value of our portfolio of investments;
|
|
|
|
changes in the value of our portfolio of investments;
|
|
|
|
changes in the value of our portfolio of investments;
|
|
|
|
general economic conditions, trends and other external factors;
|
|
|
|
departures of key personnel; or
|
|
|
|
loss of a major source of funding.
|
In the past, following periods of volatility in the market price
of a companys securities, securities class action
litigation has often been brought against that company. Due to
the potential volatility of our stock price, we may therefore be
the target of securities litigation in the future. Securities
litigation could result in substantial costs and divert
managements attention and resources from our business.
We
currently invest a portion of our capital in high-quality
short-term investments, which generate lower rates of return
than those expected from investments made in accordance with our
investment objective.
We currently invest a portion of the net proceeds of our capital
in cash, cash equivalents, U.S. government securities and
other high-quality short-term investments. These securities may
earn yields substantially lower than the income that we
anticipate receiving once these proceeds are fully invested in
accordance with our investment objective.
Investing
in shares of our common stock may involve an above average
degree of risk.
The investments we make in accordance with our investment
objective may result in a higher amount of risk, volatility or
loss of principal than alternative investment options. Our
investments in portfolio companies may be highly speculative and
aggressive, and therefore, an investment in our common stock may
not be suitable for investors with lower risk tolerance.
42
Anti-takeover
provisions in our charter documents and other agreements and
certain provisions of the Delaware General Corporation Law could
deter takeover attempts and have an adverse impact on the price
of our common stock.
The Delaware General Corporation Law, our certificate of
incorporation and our bylaws contain provisions that may have
the effect of discouraging a third party from making an
acquisition proposal for us. Among other things, our certificate
of incorporation and bylaws:
|
|
|
|
|
provide for a classified board of directors, which may delay the
ability of our stockholders to change the membership of a
majority of our board of directors;
|
|
|
|
authorize the issuance of blank check preferred
stock that could be issued by our board of directors to thwart a
takeover attempt;
|
|
|
|
do not provide for cumulative voting;
|
|
|
|
provide that vacancies on the board of directors, including
newly created directorships, may be filled only by a majority
vote of directors then in office;
|
|
|
|
limit the calling of special meetings of stockholders;
|
|
|
|
provide that our directors may be removed only for cause;
|
|
|
|
require supermajority voting to effect certain amendments to our
certificate of incorporation and our bylaws; and
|
|
|
|
require stockholders to provide advance notice of new business
proposals and director nominations under specific procedures.
|
These anti-takeover provisions may inhibit a change in control
in circumstances that could give the holders of our common stock
the opportunity to realize a premium over the market price of
our common stock. Our Credit Facility also contains a covenant
that prohibits us from merging or consolidating with any other
person or selling all or substantially all of our assets without
the prior written consent of WestLB. If we were to engage in
such a transaction without such consent, WestLB could accelerate
our repayment obligations under,
and/or
terminate, our Credit Facility. In addition, the SBA prohibits,
without prior SBA approval, a change of control of
an SBIC. A change of control is any event which
would result in the transfer of power, direct or indirect, to
direct the management and policies of an SBIC, including through
ownership. To the extent that we receive a license for our SBIC
subsidiary, this would prohibit a change of control of us
without prior SBA approval.
|
|
Item 1B.
|
Unresolved
Staff Comments
|
None
As of December 31, 2010, we did not own any real estate or
other physical properties materially important to our operation.
We believe that the office facilities of our Advisor are
suitable and adequate for our business as it is conducted.
|
|
Item 3.
|
Legal
Proceedings
|
Neither we nor our Advisor are currently subject to any material
legal proceedings, nor, to our knowledge, is any material legal
proceeding threatened against us or against our Advisor. From
time to time, we or our Advisor may be a party to certain legal
proceedings in the ordinary course of business, including
proceedings relating to the enforcement of our rights under
contracts with our portfolio companies. While the outcome of
these legal proceedings cannot be predicted with certainty, we
do not expect that these proceedings will have a material effect
upon our financial condition or results of operations.
43
|
|
Item 4.
|
[Removed
and Reserved]
|
PART II
|
|
Item 5.
|
Market
for Registrants Common Equity, Related Stockholder Matters
and Issuer Purchases of Equity Securities
|
Price
Range of Common Stock
Our common stock began trading on October 29, 2010 and is
currently traded on the NASDAQ Global Market under the symbol
HRZN. The following table lists the high and low
closing sale price for our common stock, the closing sale price
as a percentage of net asset value, or NAV, and quarterly
dividends per share since shares of our common stock began being
regularly quoted on the NASDAQ Global Select Market.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
High Sales
|
|
Low Sales
|
|
|
|
|
|
|
Closing Sales Price
|
|
Price to
|
|
Price to
|
|
Dividends
|
Period
|
|
NAV(1)
|
|
High
|
|
Low
|
|
NAV(2)
|
|
NAV(2)
|
|
Declared
|
|
Year ended December 31, 2010
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fourth quarter(3)
|
|
$
|
16.75
|
|
|
$
|
15.59
|
|
|
$
|
13.83
|
|
|
|
93
|
%
|
|
|
83
|
%
|
|
$
|
0.22
|
|
|
|
|
(1) |
|
NAV per share is determined as of the last day in the relevant
quarter and therefore may not reflect the NAV per share on the
date of the high and low sales prices. The NAVs shown are based
on outstanding shares at the end of each period. |
|
(2) |
|
Calculated as of the respective high or low closing sales price
divided by the quarter end NAV. |
|
(3) |
|
From October 29, 2010 (initial public offering) to
December 31, 2010. |
The last reported price for our common stock on March 1,
2011 was $15.79 per share. As of March 1, 2011 we had two
stockholders of record, which did not include stockholders for
whom shares are held in nominee or street name. We
believe the number of beneficial owners of our common stock is
over 1,600.
Sales
of Unregistered Securities
While we did not engage in any sales of unregistered securities
during the year ended December 31, 2010, we issued a total
of 38,298 shares of common stock under our dividend
reinvestment plan, which we refer to as our DRIP.
The issuances under our DRIP are not subject to the registration
requirements of the Securities Act of 1933, as amended. The
aggregate value of the shares of our common stock issued under
our DRIP was approximately $565,000.
Distributions
We intend to continue making quarterly distributions to our
stockholders. The timing and amount of our quarterly
distributions, if any, is determined by our board of directors.
Any distributions to our stockholders are declared out of assets
legally available for distribution. We monitor available net
investment income to determine if a tax return of capital may
occur for the fiscal year. To the extent our taxable earnings
fall below the total amount of our distributions for any given
fiscal year, a portion of those distributions may be deemed to
be a return of capital to our common stockholders.
To maintain RIC status, we must, among other things, meet the
Annual Distribution Requirement. Depending on the level of
taxable income earned in a tax year, we may choose to carry
forward taxable income in excess of current year distributions
into the next tax year and pay a 4% excise tax on such income.
Distributions of any such carryover taxable income must be made
through a dividend declared prior to filing the final tax return
related to the year in which such taxable income was generated
in order to count towards the satisfaction of the Annual
Distribution Requirement in the year in which such income was
generated. We may, in the future, make actual distributions to
our stockholders of our net capital gains. We can offer no
assurance that we will achieve results that will permit the
payment of any cash distributions and, if we issue senior
securities, we may be prohibited from making distributions if
doing so causes us to fail to maintain the asset coverage ratios
stipulated by the 1940 Act or if
44
distributions are limited by the terms of any of our borrowings.
See Item 1. Business
Regulation Taxation as a RIC.
We maintain an opt out DRIP for our common
stockholders. As a result, if we declare a dividend or other
distribution, the stockholders cash distributions will be
automatically reinvested in additional shares of our common
stock, unless they specifically opt out of the
dividend reinvestment plan so as to receive cash distributions.
In January 2010, the Internal Revenue Service extended a revenue
procedure that temporarily allows a RIC to distribute its own
stock as a dividend for the purpose of fulfilling its
distribution requirements. Pursuant to this revenue procedure, a
RIC may treat a distribution of its own stock as a dividend if
(1) the stock is publicly traded on an established
securities market, (2) the distribution is declared on or
before December 31, 2012 with respect to a taxable year
ending on or before December 31, 2011 and (3) each
stockholder may elect to receive his or her entire distribution
in either cash or stock of the RIC subject to a limitation on
the aggregate amount of cash to be distributed to all
stockholders, which must be at least 10% of the aggregate
declared distribution. If too many stockholders elect to receive
cash, each stockholder electing to receive cash will receive a
pro rata amount of cash (with the balance of the distribution
paid in stock). In no event will any stockholder electing to
receive cash receive less than 10% of his or her entire
distribution in cash. We have not elected to distribute stock as
a dividend pursuant to this procedure, but reserve the right to
do so.
The following table reflects the cash distributions, including
dividends and returns of capital per share that our board of
directors has declared and we have paid, including shares issued
under our DRIP, on our common stock since our inception.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dividends
|
|
Record Date
|
|
Payment Date
|
|
|
Declared
|
|
|
Year ended December 31, 2010
|
|
|
|
|
|
|
|
|
December 28, 2010
|
|
|
December 31, 2010
|
|
|
$
|
0.22
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
|
|
|
$
|
0.22
|
|
|
|
|
|
|
|
|
|
|
45
Stock
Performance Graph
The following graph compares the return on our common stock with
that of the Standard & Poors 500 Stock Index and
the NASDAQ Financial Services Index, for the period from
October 28, 2010 (the date of the initial public offering)
through December 31, 2010. The graph assumes that, on
October 29, 2010, a person invested $100 in each of our
common stock, the S&P 500 Index, and the NASDAQ Financial
Services Index. The graph measures total stockholder return,
which takes into account both changes in stock price and
dividends. It assumes that dividends paid are invested in like
securities.
The graph and other information furnished under this
Part II Item 5 of
Form 10-K
shall not be deemed to be soliciting material or to
be filed with the SEC or subject to
Regulation 14A or 14C, or to the liabilities of
Section 18 of the Exchange Act. The stock price performance
included in the above graph is not necessarily indicative of
future stock price performance.
46
|
|
Item 6.
|
Selected
Financial Data
|
We have derived the selected historical consolidated balance
sheet information as of December 31, 2009 and 2008 and the
selected historical consolidated statement of operations
information for the year ended December 31, 2009 and for
the period from March 4, 2008 (inception) through
December 31, 2008 from Compass Horizons financial
statements, which were audited by McGladrey & Pullen
LLP, an independent registered public accounting firm. We have
derived the selected historical consolidated financial data as
of December 31, 2010 and for the year ended
December 31, 2010 from the audited consolidated financial
statements of Horizon Technology Finance Corporation and
Subsidiaries. This selected financial data should be read in
conjunction with our financial statements and related notes
thereto and Managements Discussion and Analysis of
Financial Condition and Results of Operations.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Post-IPO as a
|
|
Pre-IPO Prior to becoming a Business
|
|
|
Business
|
|
Development Company
|
|
|
Development
|
|
|
|
|
|
March 4,
|
|
|
Company
|
|
|
|
|
|
2008
|
|
|
October 29,
|
|
January 1,
|
|
|
|
(Inception)
|
|
|
2010 to
|
|
2010 to
|
|
Year Ended
|
|
through
|
|
|
December 31,
|
|
October 28,
|
|
December 31,
|
|
December 31,
|
|
|
2010
|
|
2010
|
|
2009
|
|
2008
|
|
|
(In thousands, except per share data)
|
|
Statement of Operations Data:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total investment income
|
|
$
|
3,251
|
|
|
$
|
14,956
|
|
|
$
|
15,326
|
|
|
$
|
7,021
|
|
Base management fee
|
|
|
668
|
|
|
|
2,019
|
|
|
|
2,202
|
|
|
|
1,073
|
|
Performance based incentive fee
|
|
|
414
|
|
|
|
|
|
|
|
|
|
|
|
|
|
All other expenses
|
|
|
810
|
|
|
|
3,912
|
|
|
|
4,567
|
|
|
|
2,958
|
|
Net investment income
|
|
|
1,359
|
|
|
|
9,025
|
|
|
|
8,557
|
|
|
|
2,990
|
|
Net realized gain on investments
|
|
|
611
|
|
|
|
69
|
|
|
|
138
|
|
|
|
22
|
|
Net unrealized appreciation (depreciation) on investments
|
|
|
1,449
|
|
|
|
1,481
|
|
|
|
892
|
|
|
|
(73
|
)
|
Credit (provision) for loan losses
|
|
|
|
|
|
|
739
|
|
|
|
(274
|
)
|
|
|
(1,650
|
)
|
Net increase in net assets resulting from operations
|
|
|
3,419
|
|
|
|
11,314
|
|
|
|
9,313
|
|
|
|
1,289
|
|
Per share data:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net asset value
|
|
$
|
16.75
|
|
|
|
N/A
|
|
|
|
N/A
|
|
|
|
N/A
|
|
Net investment income
|
|
|
0.18
|
|
|
|
N/A
|
|
|
|
N/A
|
|
|
|
N/A
|
|
Net realized gain on investments
|
|
|
0.08
|
|
|
|
N/A
|
|
|
|
N/A
|
|
|
|
N/A
|
|
Net change in unrealized appreciation (depreciation) on
investments
|
|
|
0.19
|
|
|
|
N/A
|
|
|
|
N/A
|
|
|
|
N/A
|
|
Net increase/(decrease) in net assets resulting from operations
|
|
|
0.45
|
|
|
|
N/A
|
|
|
|
N/A
|
|
|
|
N/A
|
|
Per share dividends declared
|
|
|
0.22
|
|
|
|
N/A
|
|
|
|
N/A
|
|
|
|
N/A
|
|
Dollar amount of dividends declared
|
|
|
1,662
|
|
|
|
N/A
|
|
|
|
N/A
|
|
|
|
N/A
|
|
Balance Sheet data at period end:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investments, at fair value/book value
|
|
$
|
136,810
|
|
|
|
N/A
|
|
|
$
|
111,954
|
|
|
$
|
92,174
|
|
Cash and cash equivalents
|
|
|
76,793
|
|
|
|
N/A
|
|
|
|
9,892
|
|
|
|
20,024
|
|
Other assets
|
|
|
2,602
|
|
|
|
N/A
|
|
|
|
3,022
|
|
|
|
3,017
|
|
Total assets
|
|
|
216,205
|
|
|
|
N/A
|
|
|
|
124,868
|
|
|
|
115,215
|
|
Total liabilities
|
|
|
89,010
|
|
|
|
N/A
|
|
|
|
65,375
|
|
|
|
65,430
|
|
Total net assets/members capital
|
|
|
127,195
|
|
|
|
N/A
|
|
|
|
59,493
|
|
|
|
49,784
|
|
Other data:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average annualized yield on income producing
investments at fair value
|
|
|
14.6
|
%
|
|
|
N/A
|
|
|
|
13.9
|
%
|
|
|
12.7
|
%
|
Number of portfolio companies at period end
|
|
|
32
|
|
|
|
N/A
|
|
|
|
32
|
|
|
|
26
|
|
47
|
|
Item 7.
|
Managements
Discussion and Analysis of Financial Condition and Results of
Operations
|
The information contained in this section should be read in
conjunction with our audited consolidated financial statements
and related notes thereto appearing elsewhere in this annual
report on
Form 10-K.
For periods prior to October 28, 2010, the consolidated
financial statements and related footnotes reflect the
performance of our predecessor, Compass Horizon Funding Company
LLC, and its wholly owned subsidiary, Horizon Credit I LLC, both
of which were formed in January 2008 and commenced operations in
March 2008.
Overview
We are a specialty finance company that lends to and invests in
development-stage companies in the technology, life science,
healthcare information and services, and cleantech industries,
which we refer to as our Target Industries. Our
investment objective is to generate current income from the
loans we make and capital appreciation from the warrants we
receive when making such loans. We make secured loans, which we
refer to as Technology Loans, to companies backed by
established venture capital and private equity firms in our
Target Industries, which we refer to as Technology
Lending. We also selectively lend to publicly traded
companies in our Target Industries.
We are an externally managed, closed-end, non-diversified
management investment company that has elected to be regulated
as a business development company under the Investment Company
Act of 1940, or the 1940 Act. As a business development company,
we are required to comply with regulatory requirements,
including limitations on our use of debt. We are permitted to,
and expect to, finance our investments through borrowings.
However, as a business development company, we are only
generally allowed to borrow amounts such that our asset
coverage, as defined in the 1940 Act, equals at least 200% after
such borrowing. The amount of leverage that we employ will
depend on our assessment of market conditions and other factors
at the time of any proposed borrowing.
Compass Horizon Funding Company LLC, which we refer to as
Compass Horizon, our predecessor company, commenced
operations in March 2008. We were formed in 2010 for the purpose
of acquiring Compass Horizon and continuing its business as a
public entity. On October 28, 2010, we and certain selling
stockholders completed an initial public offering and sold
6,250,000 shares of our common stock at a public offering
price of $16.00 per share. Our shares are listed on The NASDAQ
Global Market under the symbol HRZN.
Current
Market Conditions
Current
Market Overview
Venture Capital financing and mergers and acquisitions
(M&A) activity in our Target Markets improved significantly
in 2010. According to VentureSource, venture capital investment
of $26.2 billion in 2010 represented an 11% increase over
venture capital investment in 2009. In addition, according to
VentureDeal forty-four (44) venture capital backed
companies completed IPOs in 2010 raising approximately
$4.5 billion, which compares favorably to 2009 when twelve
(12) venture capital backed companies completed IPOs and
raised less than $2 billion. According to VentureSource,
there were 404 M&A exits totaling approximately
$21.9 billion in 2009, compared to 468 M&A exits
totaling approximately $35.8 billion in 2010. This
represents a 16% increase in the number of transactions and a
63% increase in the amount of dollars. The average M&A
price increased from $54 million in 2009 to
$76 million in 2010.
With increased access to capital and the potential for better
exits, we believe venture capital backed companies and their
investors are becoming increasingly focused on product
development and revenue growth. We believe this focus on growth
will further increase the need for capital and create greater
demand for our debt products in our Target Markets in 2011 and
2012.
We see increased investment opportunities in drug development
and healthcare information and services companies which provide
new technology services and products designed to bring down the
cost of healthcare and make the healthcare system more
efficient. We believe the cleantech market is maturing, which
makes it a more attractive market for venture capital investors.
As venture capital investment in cleantech increases, it will
become a greater growth market opportunity for us in 2011 and
2012.
48
As market conditions for venture lending continue to trend
positive, we believe competition from other venture lenders will
increase in 2011. We believe our marketing strategy, experience,
relationships and strong balance sheet will allow us to continue
to be a leader in the venture lending market in 2011.
Portfolio
Composition and Investment Activity
As of December 31, 2010 and 2009, our loan portfolio
consisted of 32 loans, which had an aggregate fair value of
$130.2 million at December 31, 2010 and an aggregate
book value of $111.4 million at December 31, 2009, and
our warrant portfolio had an aggregate fair value of
$6.2 million and $2.5 million at December 31,
2010 and 2009, respectively.
The following table shows our portfolio by asset class as of
December 31, 2010 and 2009. Please note for all tables
included in this section the loans at December 31, 2010 are
presented at fair value and the loans at December 31, 2009
are presented at book value as we did not record our loans at
fair value prior to going public.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2010
|
|
|
December 31, 2009
|
|
|
|
|
|
|
|
|
|
% of
|
|
|
|
|
|
|
|
|
% of
|
|
|
|
# of
|
|
|
Fair
|
|
|
Total
|
|
|
# of
|
|
|
Book
|
|
|
Total
|
|
|
|
Investments
|
|
|
Value
|
|
|
Portfolio
|
|
|
Investments
|
|
|
Value
|
|
|
Portfolio
|
|
|
|
($ in thousands)
|
|
|
Secured term loans
|
|
|
31
|
|
|
$
|
127,949
|
|
|
|
93.5
|
%
|
|
|
29
|
|
|
$
|
104,295
|
|
|
|
91.6
|
%
|
Secured revolving loans
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2
|
|
|
|
3,665
|
|
|
|
3.2
|
%
|
Equipment loans
|
|
|
1
|
|
|
|
2,285
|
|
|
|
1.6
|
%
|
|
|
1
|
|
|
|
3,460
|
|
|
|
3.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total loans
|
|
|
32
|
|
|
|
130,234
|
|
|
|
95.1
|
%
|
|
|
32
|
|
|
|
111,420
|
|
|
|
97.8
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants to purchase stock
|
|
|
43
|
|
|
|
6,225
|
|
|
|
4.6
|
%
|
|
|
37
|
|
|
|
2,458
|
|
|
|
2.2
|
%
|
Equity
|
|
|
2
|
|
|
|
351
|
|
|
|
0.3
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
|
|
|
$
|
136,810
|
|
|
|
100.0
|
%
|
|
|
|
|
|
$
|
113,878
|
|
|
|
100.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total portfolio investment activity as of and for the years
ended December 31, 2010 and 2009 was as follows:
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
|
($ in thousands)
|
|
|
Beginning portfolio
|
|
$
|
113,878
|
|
|
$
|
93,824
|
|
New loan funding
|
|
|
98,267
|
|
|
|
49,934
|
|
Less refinanced balances
|
|
|
(13,593
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net new loan funding
|
|
|
84,674
|
|
|
|
49,934
|
|
|
|
|
|
|
|
|
|
|
Principal and stock payments received on investments
|
|
|
(33,149
|
)
|
|
|
(16,805
|
)
|
Early pay-offs
|
|
|
(31,709
|
)
|
|
|
(14,582
|
)
|
Accretion of loan fees
|
|
|
1,399
|
|
|
|
1,068
|
|
New loan fees
|
|
|
(836
|
)
|
|
|
(449
|
)
|
New equity
|
|
|
350
|
|
|
|
|
|
Net appreciation on investments
|
|
|
2,203
|
|
|
|
888
|
|
|
|
|
|
|
|
|
|
|
Ending Portfolio
|
|
$
|
136,810
|
|
|
$
|
113,878
|
|
|
|
|
|
|
|
|
|
|
We receive payments in our loan portfolio based on scheduled
amortization of the outstanding balances. In addition, we
receive repayments of some of our loans prior to their scheduled
maturity date. The frequency or volume of these repayments may
fluctuate significantly from period to period.
49
The following table shows our loan portfolio by industry sector
as of December 31, 2010, and 2009:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2010
|
|
|
December 31, 2009
|
|
|
|
Loans at
|
|
|
Percentage
|
|
|
Loans at
|
|
|
Percentage
|
|
|
|
Fair
|
|
|
of Total
|
|
|
Book
|
|
|
of Total
|
|
|
|
Value
|
|
|
Portfolio
|
|
|
Value
|
|
|
Portfolio
|
|
|
|
($ in thousands)
|
|
|
Life Science
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Biotechnology
|
|
$
|
30,470
|
|
|
|
23.4
|
%
|
|
$
|
21,761
|
|
|
|
19.5
|
%
|
Medical Device
|
|
|
19,572
|
|
|
|
15.0
|
%
|
|
|
16,033
|
|
|
|
14.4
|
%
|
Technology
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Consumer-related Technologies
|
|
|
4,460
|
|
|
|
3.4
|
%
|
|
|
15,180
|
|
|
|
13.6
|
%
|
Networking
|
|
|
2,285
|
|
|
|
1.8
|
%
|
|
|
14,562
|
|
|
|
13.1
|
%
|
Software
|
|
|
8,745
|
|
|
|
6.7
|
%
|
|
|
12,887
|
|
|
|
11.6
|
%
|
Data Storage
|
|
|
7,912
|
|
|
|
6.1
|
%
|
|
|
9,024
|
|
|
|
8.1
|
%
|
Internet and Media
|
|
|
|
|
|
|
|
|
|
|
2,483
|
|
|
|
2.2
|
%
|
Communications
|
|
|
7,591
|
|
|
|
5.9
|
%
|
|
|
2,457
|
|
|
|
2.2
|
%
|
Semiconductors
|
|
|
|
|
|
|
|
|
|
|
866
|
|
|
|
0.8
|
%
|
Cleantech
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Energy Efficiency
|
|
|
16,570
|
|
|
|
12.7
|
%
|
|
|
|
|
|
|
|
|
Waste Recycling
|
|
|
2,363
|
|
|
|
1.8
|
%
|
|
|
|
|
|
|
|
|
Healthcare Information and Services
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diagnostics
|
|
|
20,472
|
|
|
|
15.7
|
%
|
|
|
16,167
|
|
|
|
14.5
|
%
|
Other Healthcare Related Services and Technologies
|
|
|
9,794
|
|
|
|
7.5
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
130,234
|
|
|
|
100.0
|
%
|
|
$
|
111,420
|
|
|
|
100.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The largest loans may vary from year to year as new loans are
recorded and repaid. Our five largest loans represented
approximately 31% and 28% of total loans outstanding as of
December 31, 2010 and 2009, respectively. No single loan
represented more than 10% of our total loans as of
December 31, 2010 or 2009.
As of December 31, 2010 and 2009, interest receivable was
$1.9 million and $1.5 million, respectively, which
represents one month of accrued interest income on our loans.
The increase in 2010 was due to a larger loan portfolio relative
to 2009.
Loan
Portfolio Asset Quality
We use a credit rating system which rates each loan on a scale
of 4 to 1, with 4 being the highest credit quality rating and 3
being the rating for a standard level of risk. A rating of 2 or
1 represents a deteriorating credit quality and increased risk.
See Business for more detailed descriptions. The
following table shows the classification of our loan portfolio
by credit rating as of December 31, 2010 and 2009:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2010
|
|
|
December 31, 2009
|
|
|
|
Loans at
|
|
|
Percentage
|
|
|
Loans at
|
|
|
Percentage
|
|
|
|
Fair
|
|
|
of Loan
|
|
|
Book
|
|
|
of Loan
|
|
|
|
Value
|
|
|
Portfolio
|
|
|
Value
|
|
|
Portfolio
|
|
|
|
($ in thousands)
|
|
|
($ in thousands)
|
|
|
Credit Rating
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4
|
|
$
|
29,054
|
|
|
|
22.3
|
%
|
|
$
|
19,113
|
|
|
|
17.2
|
%
|
3
|
|
|
94,200
|
|
|
|
72.3
|
%
|
|
$
|
64,224
|
|
|
|
57.6
|
%
|
2
|
|
|
6,980
|
|
|
|
5.4
|
%
|
|
$
|
28,083
|
|
|
|
25.2
|
%
|
1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
130,234
|
|
|
|
100.0
|
%
|
|
$
|
111,420
|
|
|
|
100.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
50
As of December 31, 2010 and 2009 our loan portfolio had a
weighted average credit rating of 3.2 and 2.9, respectively. As
of December 31, 2010 and 2009 no investments were on
non-accrual status.
Consolidated
Results of Operations
The consolidated results of operations set forth below include
historical financial information of our predecessor, Compass
Horizon, prior to our election to become a business development
company and our intended election to be treated as a RIC. As a
business development company and a RIC for U.S. federal
income tax purposes, we are also subject to certain constraints
on our operations, including limitations imposed by the 1940 Act
and the Code. Also, the management fee that we pay to our
Advisor under the Investment Management Agreement is determined
by reference to a formula that differs materially from the
management fee paid by Compass Horizon in prior periods. For
these and other reasons, the results of operations described
below may not be indicative of the results we report in future
periods.
Compass Horizon, our predecessor for accounting purposes, was
formed as a Delaware limited liability company in January 2008
and had limited operations through March 3, 2008. As a
result, there is no period with which to compare our results of
operations for the period from January 1, 2008 through
March 3, 2008 or for the period from March 4, 2008
through December 31, 2008.
Consolidated operating results for the years ended
December 31, 2010 and 2009, and the period from
March 4, 2008 (inception) to December 31, 2008 are as
follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2010
|
|
|
2009
|
|
|
2008
|
|
|
|
($ in thousands)
|
|
|
Total investment income
|
|
$
|
18,207
|
|
|
$
|
15,326
|
|
|
$
|
7,021
|
|
Total expenses
|
|
|
7,823
|
|
|
|
6,769
|
|
|
|
4,031
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net investment income
|
|
|
10,384
|
|
|
|
8,557
|
|
|
|
2,990
|
|
Net realized gains
|
|
|
680
|
|
|
|
138
|
|
|
|
22
|
|
Net unrealized appreciation (depreciation)
|
|
|
2,930
|
|
|
|
892
|
|
|
|
(73
|
)
|
Credit (provision) for loan losses
|
|
|
739
|
|
|
|
(274
|
)
|
|
|
(1,650
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
14,733
|
|
|
$
|
9,313
|
|
|
$
|
1,289
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Average investments, at fair value
|
|
$
|
124,027
|
|
|
$
|
109,561
|
|
|
$
|
63,111
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Average debt outstanding
|
|
$
|
77,174
|
|
|
$
|
70,582
|
|
|
$
|
37,010
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income can vary substantially from period to period for
various reasons, including the recognition of realized gains and
losses and unrealized appreciation and depreciation. As a
result, annual comparisons of net income may not be meaningful.
Investment
Income
Investment income increased by $2.9 million, or 19.0%, for
the year ended December 31, 2010 as compared to the year
ended December 31, 2009. For the year ended
December 31, 2010, total investment income consisted
primarily of $17.4 million in interest income from
investments, which included $1.4 million in income from the
amortization of discounts and origination fees on investments.
Interest income on investments and other investment income
increased primarily due to the increased average size of the
loan portfolio. Other investment income was primarily comprised
of loan prepayment fees collected from our portfolio companies
and increased primarily due to a higher number of prepayments in
2010.
Investment income increased by $8.3 million, or 118.3%, for
the year ended December 31, 2009 as compared to the period
from March 4, 2008 (inception) to December 31, 2009.
For the year ended December 31, 2009, total investment
income consisted primarily of $14.9 million in interest
income from investments, which included $1.0 million in
income from the amortization of discounts and origination fees
on investments. Interest income on investments and other
investment income increased primarily due to (i) the
increased average size of the loan portfolio and (ii) there
being a full 12 months of income in 2009 compared to only
10 months in 2008 in light of
51
when we commenced operations. Other investment income was
primarily comprised of loan prepayment fees collected from our
portfolio companies.
For the years ended December 31, 2010, December 31,
2009 and the ten month period ended December 31, 2008, our
dollar-weighted average annualized yield on average loans was
approximately 14.6%, 13.9% and 12.7%, respectively. We compute
the yield on average loans as (i) total investment interest
and other investment income divided by (b) average gross
loans receivable. We used month end loan balances during the
period to compute average loans receivable. Since we commenced
operations in March 2008, the results for the period ended
December 31, 2008 were annualized.
Investment income, consisting of interest income and fees on
loans, can fluctuate significantly upon repayment of large
loans. Interest income from the five largest loans accounted for
approximately 22%, 23% and 21% of investment income for the
years ended December 31, 2010, December 31, 2009 and
the period from March 4, 2008 (inception) to
December 31, 2008, respectively.
Expenses
Total expenses increased by $1.1 million, or 15.6%, to
$7.8 million for the year ended December 31, 2010 as
compared to the year ended December 31, 2009. Total
expenses increased by $2.7 million, or 67.9%, to
$6.8 million for the year ended December 31, 2009 as
compared to the period March 4, 2008 to December 31,
2008.
Total operating expenses for each period consisted principally
of management fees and interest expense and, to a lesser degree,
professional fees and general and administrative expenses.
Interest expense, which includes the amortization of debt
issuance costs, increased in 2010 from 2009 primarily from
higher average outstanding debt balances on the Credit Facility.
Interest expense increased in 2009 from 2008 primarily due to
higher average outstanding debt balances on the Credit Facility,
partially offset by lower rates charged on the Credit Facility
due to lower level of the Credit Facilitys index rate,
one-month LIBOR.
Effective with the completion of our initial public offering in
October 2010, we now pay management and incentive fees under the
Investment Management Agreement which provides a higher
management fee base as compared to amounts previously paid by
Compass Horizon. Management fee expense in 2010 increased
compared to 2009 primarily due to an increase in the average
loan portfolio in 2010 from 2009 and increased in 2009 compared
to 2008 due to a full 12 months of expense in 2009 compared
to only 10 months in 2008. Incentive fees for the period
since our initial public offering totaled approximately $414,000
compared to no incentives fees prior to the IPO.
In connection with the Administrative Agreement, we have
incurred $88,000 for the period since our initial public
offering through December 31, 2010. We did not pay an
administrative servicing fee prior to our IPO.
Professional fees and general and administrative expenses
include legal, accounting fees, insurance premiums, and
miscellaneous other expenses. These expenses increased in 2010
from 2009 primarily from the increased cost as a public company.
These expenses increased in 2009 from 2008 primarily because of
the longer period in 2009.
Net
Realized Gains and Net Unrealized Appreciation and
Depreciation
During the years ended December 31, 2010 and 2009, we had
$0.7 million and $0.1 million in net realized gains on
investments, respectively. During the same periods, we had
$2.9 million and $0.9 million in unrealized
appreciation on investments, respectively. Net realized gain on
warrants resulted from the sale of stock through the exercise of
warrants in portfolio companies. For these periods the net
increase in unrealized appreciation on investments was primarily
from our warrant investments. Net unrealized appreciation on
warrants is the difference between the net changes in warrant
fair values from the prior determination date and the reversal
of previously recorded unrealized appreciation or depreciation
when gains or losses are realized. The increase in net
unrealized appreciation on warrants in 2010 and 2009 is
primarily due to an increase in the enterprise value of a number
of private companies for which we hold warrants. In addition,
the increased net appreciation on warrants is due to the
increase in the share value of the public company warrants held.
52
Credit
or Provision for Loan Losses
For the period from January 1, 2010 through
October 28, 2010 the credit for loan losses was
$0.7 million and for the year ended December 31, 2009
and the period ended December 31, 2008 the provision for
loan losses was $0.3 million and $1.6 million,
respectively. The credit arose from December 31, 2009
through October 28, 2010 primarily due to improved
portfolio asset quality during 2010 across all Credit Ratings
within the loan portfolio. The loan portfolio had a weighted
average credit rating of 3.1 and 2.9 as of October 28, 2010
and December 31, 2009, respectively. See Loan
Portfolio Asset Quality. The decrease in the provision for
loan losses in 2009 compared to 2008 was due to less significant
loan growth in 2009. As of our election to be treated as a
business development company, we no longer record a credit or
provision for loan losses. We record each individual loan and
investment on a quarterly basis at fair value. Changes in fair
value are recorded through our statement of operations.
Liquidity
and Capital Resources
As of December 31, 2010 and 2009, we had cash and cash
equivalents of $76.8 million and $9.9 million,
respectively. Cash and cash equivalents are available to fund
new investments, pay operating expenses and pay dividends. To
date, our primary sources of capital have been from our IPO, use
of our Credit Facility and from the private placement for
$50 million of equity capital we completed on March 4,
2008.
As of December 31, 2010, we had available borrowing
capacity of approximately $37.5 million under our
$125 million Credit Facility, subject to existing terms and
advance rates.
Our operating activities used cash of $8 million for the
year ended December 31, 2010 and our financing activities
provided net cash proceeds of $75 million for the same
period. Our operating activities used cash primarily for
investing in portfolio companies. Such cash was provided
primarily from proceeds from our initial public offering and
draws under the Credit Facility.
Our operating activities used cash of $11 million for the
year ended December 31, 2009 and our financing activities
provided net cash proceeds of $0.5 million for the same
period. Our operating activities used cash primarily for
investing in portfolio companies that was provided primarily
from our availability on our Credit Facility.
Our operating activities used cash of $90 million for the
10 month period ended December 31, 2008 and our
financing activities provided net cash proceeds of
$110 million for the same period. Our operating activities
used cash primarily for investing in portfolio companies that
was provided primarily from proceeds from an equity private
placement and draws under the Credit Facility.
Our primary use of available funds will be investments in
portfolio companies and cash distributions to holders of our
common stock. After we have used our current capital resources,
including the net proceeds from our initial public offering, we
expect to opportunistically raise additional capital as needed
and subject to market conditions to support our future growth
through future equity offerings, issuances of senior securities
and/or
future borrowings, to the extent permitted by the 1940 Act. To
the extent we determine to raise additional equity through an
offering of our common stock at a price below net asset value,
existing investors will experience dilution.
In order to satisfy the Code requirements applicable to a RIC,
we intend to distribute to our stockholders all or substantially
all of our income except for certain net capital gains. In
addition, as a business development company, we generally will
be required to meet a coverage ratio of 200%. This requirement
will limit the amount that we may borrow.
If we receive approval to license an SBIC, we will have the
ability to issue debentures guaranteed by the SBA at favorable
interest rates. Under the Small Business Investment Act and the
SBA rules applicable to SBICs, an SBIC can have outstanding at
any time debentures guaranteed by the SBA generally in an amount
up to twice its regulatory capital, which generally is the
amount raised from private investors. The maximum statutory
limit on the dollar amount of outstanding debentures guaranteed
by the SBA issued by a single SBIC or group of SBICs under
common control as of December 31, 2009, was
$150 million (which amount is subject to increase on an
annual basis based on cost of living index increases).
53
Current
Borrowings
We, through our wholly owned subsidiary, Credit I, entered
into a revolving credit facility (the Credit
Facility) with WestLB AG, New York Branch as Lender
(WestLB) effective March 4, 2008. Per this
agreement, base rate borrowings bear interest at one-month LIBOR
plus 2.50%. The rates were 2.76% and 2.73% as of
December 31, 2010 and 2009, respectively. The facility size
is currently $125 million.
We were able to request advances under the Credit Facility
through March 4, 2011. We may not request new advances and
we must repay the outstanding advances under the Credit Facility
as of such date at such times and in such amounts as are
necessary to maintain compliance with the terms and conditions
of the Credit Facility, particularly the condition that the
principal balance of the Credit Facility does not exceed
seventy-five percent (75%) of the aggregate principal balance of
our eligible loans to our portfolio companies. All outstanding
advances under the Credit Facility are due and payable on
March 4, 2015 (Maturity Date), unless such date
is extended upon Credit Is request and upon mutual
agreement of WestLB and Credit I.
The Credit Facility is collateralized by loans held by Credit I
and permitted an advance rate of up to 75% of eligible loans.
The Credit Facility contains certain customary affirmative and
negative covenants, including covenants that restrict certain of
our subsidiaries ability to make loans to, or investments
in, third parties (other than technology loans and warrants or
other equity participation rights), pay dividends and
distributions, incur additional indebtedness and engage in
mergers or consolidations. The Credit Facility also restricts
certain of our subsidiaries and our Advisors ability
to create liens on the collateral securing the Credit Facility,
permit additional negative pledges on such collateral and change
the business currently conducted by them. The Credit Facility
contains events of default, including upon the occurrence of a
change of control, and contains certain financial covenants that
among other things, require Compass Horizon to maintain a
minimum net worth, for fiscal year 2010 and after, equal to the
minimum net worth amount for 2009 plus 50% of Compass
Horizons cumulative positive net income for fiscal year
2010 on and after December 31, 2010, and require our
Advisor to maintain a minimum net worth, for fiscal year 2010
and after, equal to the greater of (i) $1 million or
(ii) the 2009 minimum net worth amount plus 50% of the
cumulative positive net income for each fiscal year. The Credit
Facility also includes borrower concentration limits which
include limitations on the amount of loans to companies in
particular industries sectors and also restrict certain terms of
the loans.
Future
Borrowings
Our ability to make loans in the future is dependent upon our
SBIC qualification, or if such approval is not granted in due
course, our ability to arrange for a credit facility in the
lending markets. While we are confident in both our prospects of
receiving SBA approval and also our prospects of sourcing a
replacement credit facility, we can give no assurances of either
such event.
Interest
Rate Swaps and Hedging Activities
In 2008, we entered into two interest rate swap agreements with
WestLB, fixing the rate of $10 million at 3.58% and
$15 million at 3.2% on the first advances of a like amount
of variable rate Credit Facility borrowings. As of
December 31, 2010 only the $10 million interest rate
swap is still outstanding and expires in October 2011.
Off-Balance
Sheet Arrangements
In the normal course of business, we are party to financial
instruments with off-balance sheet risk. These consist primarily
of unfunded commitments to extend credit, in the form of loans,
to our portfolio companies. Unfunded commitments to provide
funds to portfolio companies are not reflected on our balance
sheet. Our unfunded commitments may be significant from time to
time. As of December 31, 2010, we had unfunded commitments
of approximately $26.5 million. These commitments will be
subject to the same underwriting and ongoing portfolio
maintenance as are the on balance sheet financial instruments
that we hold. Since these commitments may expire without being
drawn upon, the total commitment amount does not necessarily
represent future cash requirements. We intend to use primarily
cash flows from operations and our Credit Facility to fund these
commitments. However, there can be no assurance that we will
have sufficient capital available to fund these commitments as
they come due.
54
Contractual
Obligations
In addition to the Credit Facility, we have certain commitments
pursuant to our Investment Management Agreement entered into
with Horizon Technology Finance Management LLC, our Advisor. We
have agreed to pay a fee for investment advisory and management
services consisting of two components a base
management fee and an incentive fee. Payments under the
Investment Management Agreement are equal to (1) a base
management fee equal to a percentage of the value of our average
gross assets and (2) a two-part incentive fee. See
Investment Management and Administration Agreements.
We have also entered into a contract with our Advisor to serve
as our administrator. Payments under the Administration
Agreement are equal to an amount based upon our allocable
portion of our Advisors overhead in performing its
obligation under the agreement, including rent, fees, and other
expenses inclusive of our allocable portion of the compensation
of our chief financial officer and any administrative staff. See
Administration Agreement.
Distributions
In order to qualify as a RIC and to avoid corporate level tax on
the income we distribute to our stockholders, we are required
under the Code to distribute at least 90% of our net ordinary
income and net short-term capital gains in excess of net
long-term capital losses, if any, to our net stockholders on an
annual basis. Additionally, we must distribute at least 98% of
our ordinary income and 98% (or, for our taxable years beginning
in 2011, 98.2%) of our capital gain net income on an annual
basis and any net ordinary income and net capital gains for
preceding years that were not distributed during such years and
on which we previously paid no U.S. federal income tax to
avoid a U.S. federal excise tax. We intend to distribute
quarterly dividends to our stockholders as determined by our
Board.
We may not be able to achieve operating results that will allow
us to make distributions at a specific level or to increase the
amount of our distributions from time to time. In addition, we
may be limited in our ability to make distributions due to the
asset coverage requirements applicable to us as a business
development company under the 1940 Act. If we do not distribute
a certain percentage of our income annually, we will suffer
adverse tax consequences, including the possible loss of our
qualification as a RIC. We cannot assure stockholders that they
will receive any distributions.
To the extent our taxable earnings fall below the total amount
of our distributions for that fiscal year, a portion of those
distributions may be deemed a return of capital to our
stockholders for U.S. federal income tax purposes. Thus,
the source of a distribution to our stockholders may be the
original capital invested by the stockholder rather than our
income or gains. Stockholders should read any written disclosure
accompanying a dividend payment carefully and should not assume
that the source of any distribution is our ordinary income or
gains.
We have adopted an opt out dividend reinvestment
plan for our common stockholders. As a result, if we declare a
distribution, then stockholders cash distributions will be
automatically reinvested in additional shares of our common
stock unless a stockholder specifically opts out of
our dividend reinvestment plan. If a stockholder opts out, that
stockholder will receive cash distributions. Although
distributions paid in the form of additional shares of our
common stock will generally be subject to U.S. federal,
state and local taxes in the same manner as cash distributions,
stockholders participating in our dividend reinvestment plan
will not receive any corresponding cash distributions with which
to pay any such applicable taxes.
Critical
Accounting Policies
The discussion of our financial condition and results of
operation is based upon our financial statements, which have
been prepared in accordance with U.S. generally accepted
accounting principles, or GAAP. The preparation of
these consolidated financial statements requires management to
make estimates and assumptions that affect the reported amounts
of assets, liabilities, revenues and expenses. Changes in the
economic environment, financial markets and any other parameters
used in determining such estimates could cause actual results to
differ. In addition to the discussion below, we describe our
significant accounting policies in the notes to our consolidated
financial statements.
We have identified the following items as critical accounting
policies.
55
Valuation
of Investments
Investments are recorded at fair value. Our board of directors
(Board) determines the fair value of its portfolio
investments. Prior to our election to become a BDC, loan
investments were stated at current unpaid principal balances
adjusted for the allowance for loan losses, unearned income and
any unamortized deferred fees or costs.
We apply fair value to substantially all of its investments in
accordance with relevant GAAP, which establishes a framework
used to measure fair value and requires disclosures for fair
value measurements. We have categorized its investments carried
at fair value, based on the priority of the valuation technique,
into a three-level fair value hierarchy. Fair value is a
market-based measure considered from the perspective of the
market participant who holds the financial instrument rather
than an entity specific measure. Therefore, when market
assumptions are not readily available, our own assumptions are
set to reflect those that management believes market
participants would use in pricing the financial instrument at
the measurement date.
The availability of observable inputs can vary depending on the
financial instrument and is affected by a wide variety of
factors, including, for example, the type of product, whether
the product is new, whether the product is traded on an active
exchange or in the secondary market and the current market
conditions. To the extent that the valuation is based on models
or inputs that are less observable or unobservable in the
market, the determination of fair value requires more judgment.
The three categories within the hierarchy are as follows:
|
|
|
|
Level 1
|
Quoted prices in active markets for identical assets and
liabilities.
|
|
|
Level 2
|
Observable inputs other than Level 1 prices such as quoted
prices for similar assets or liabilities in active markets,
quoted prices in markets that are not active, and model-based
valuation techniques for which all significant inputs are
observable or can be corroborated by observable market data for
substantially the full term of the assets or liabilities.
|
|
|
Level 3
|
Unobservable inputs that are supported by little or no market
activity and that are significant to the fair value of the
assets or liabilities. Level 3 assets and liabilities
include financial instruments whose value is determined using
pricing models, discounted cash flow methodologies, or similar
techniques, as well as instruments for which the determination
of fair value requires significant management judgment or
estimation.
|
See Note 5 Fair Value to the Consolidated Financial
Statements for further information regarding fair value.
Income
Recognition
Interest on loan investments is accrued and included in income
based on contractual rates applied to principal amounts
outstanding. Interest income is determined using a method that
results in a level rate of return on principal amounts
outstanding. When a loan becomes 90 days or more past due,
or if we otherwise do not expect to receive interest and
principal repayments, the loan is placed on non-accrual status
and the recognition of interest income is discontinued. Interest
payments received on loans that are on non-accrual status are
treated as reductions of principal until the principal is
repaid. No loans were on non-accrual status as of
December 31, 2010 and 2009.
We receive a variety of fees from borrowers in the ordinary
course of conducting our business, including advisory fees,
commitment fees, amendment fees, non-utilization fees and
prepayment fees (collectively, the Fees). In a
limited number of cases, we may also receive a non-refundable
deposit earned upon the termination of a transaction. Loan
origination fees, net of certain direct origination costs, are
deferred, and along with unearned income, are amortized as a
level yield adjustment over the respective term of the loan.
Fees for counterparty loan commitments with multiple loans are
allocated to each loan based upon each loans relative fair
value. When a loan is placed on non-accrual status, the
amortization of the related fees and unearned income is
discontinued until the loan is returned to accrual status.
Certain loan agreements also require the borrower to make an
end-of-term
payment that is accrued into income over the life of the loan to
the extent such amounts are expected to be collected. We will
generally cease accruing the income if there is insufficient
value to support the accrual or if we do not expect the borrower
to be able to pay all principal and interest due.
56
In connection with substantially all lending arrangements, we
receive warrants to purchase shares of stock from the borrower.
The warrants are recorded as assets at estimated fair value on
the grant date using the Black-Scholes valuation model. The
warrants are considered loan fees and are also recorded as
unearned loan income on the grant date. The unearned income is
recognized as interest income over the contractual life of the
related loan in accordance with our income recognition policy.
Subsequent to loan origination, the warrants are also measured
at fair value using the Black-Scholes valuation model. Any
adjustment to fair value is recorded through earnings as net
unrealized gain or loss on warrants. Gains from the disposition
of the warrants or stock acquired from the exercise of warrants
are recognized as realized gains on warrants.
Allowance
for Loan Losses
Prior to our election to become a BDC, the allowance for loan
losses represented managements estimate of probable loan
losses inherent in the loan portfolio as of the balance sheet
date. The estimation of the allowance was based on a variety of
factors, including past loan loss experience, the current credit
profile of our borrowers, adverse situations that had occurred
that may affect individual borrowers ability to repay, the
estimated value of underlying collateral and general economic
conditions. The loan portfolio is comprised of large balance
loans that are evaluated individually for impairment and are
risk-rated based upon a borrowers individual situation,
current economic conditions, collateral and industry-specific
information that management believes is relevant in determining
the potential occurrence of a loss event and in measuring
impairment. The allowance for loan losses was sensitive to the
risk rating assigned to each of the loans and to corresponding
qualitative loss factors that we used to estimate the allowance.
Those factors were applied to the outstanding loan balances in
estimating the allowance for loan losses. If necessary, based on
performance factors related to specific loans, specific
allowances for loan losses were established for individual
impaired loans. Increases or decreases to the allowance for loan
losses were charged or credited to current period earnings
through the provision (credit) for loan losses. Amounts
determined to be uncollectible were charged against the
allowance for loan losses, while amounts recovered on previously
charged-off loans increased the allowance for loan losses.
A loan was considered impaired when, based on current
information and events, it was probable that we were unable to
collect the scheduled payments of principal or interest when due
according to the contractual terms of the loan agreement.
Factors considered by management in determining impairment
included payment status, collateral value, and the probability
of collecting scheduled principal and interest payments when
due. Loans that experienced insignificant payment delays and
payment shortfalls generally were not classified as impaired.
Management determined the significance of payment delays and
payment shortfalls on a
case-by-case
basis, taking into consideration all of the circumstances
surrounding the loan and the borrower, including the length of
the delay, the reasons for the delay, the borrowers prior
payment record, and the amount of the shortfall in relation to
the principal and interest owed. Impairment was measured on a
loan by loan basis by either the present value of expected
future cash flows discounted at the loans effective
interest rate, the loans observable market price, or the
fair value of the collateral, if the loan was collateral
dependent.
Impaired loans also included loans modified in troubled debt
restructurings where concessions had been granted to borrowers
experiencing financial difficulties. These concessions could
include a reduction in the interest rate on the loan, payment
extensions, forgiveness of principal, forbearance or other
actions intended to maximize collection. There were no impaired
loans or troubled debt restructured loans at December 31,
2009.
Income
taxes
We will elect to be treated as a RIC under subchapter M of the
Code and operates in a manner so as to qualify for the tax
treatment applicable to RICs. In order to qualify as a RIC,
among other things, we are required to meet certain source of
income and asset diversification requirements and we must timely
distribute to our stockholders at least 90% of investment
company taxable income, as defined by the Code, for each year.
We, among other things, have made and intend to continue to make
the requisite distributions to our stockholders, which will
generally relieve us from U.S. federal income taxes.
Depending on the level of taxable income earned in a tax year,
we may choose to carry forward taxable income in excess of
current year dividend distributions into the next tax year and
pay a 4% excise tax on such income, as
57
required. To the extent that we determine that our estimated
current year annual taxable income will be in excess of
estimated current year dividend distributions, we will accrue
excise tax, if any, on estimated excess taxable income as
taxable income is earned. For the period from October 29,
2010 to December 31, 2010 no amount was recorded for
U.S. federal excise tax.
We evaluate tax positions taken in the course of preparing our
tax returns to determine whether the tax positions are
more-likely-than-not to be sustained by the
applicable tax authority. Tax benefits of positions not deemed
to meet the more-likely-than-not threshold, or uncertain tax
positions, would be recorded as a tax expense in the current
year. It is our policy to recognize accrued interest and
penalties related to uncertain tax benefits in income tax
expense. There were no material uncertain tax positions at
December 31, 2010 and 2009.
Prior to our election to become a BDC, we were a limited
liability company treated as a partnership for U.S. federal
income tax purposes and, as a result, all items of income and
expense were passed through to, and are generally reportable on,
the tax returns of the respective members of the limited
liability company. Therefore, no federal or state income tax
provision has been recorded for the period from January 1,
2010 to October 28, 2010 and the years ended
December 31, 2009 and 2008.
Recently
Issued Accounting Standards
In January 2010, the FASB issued Accounting Standards Update
2010-06,
Fair Value Measurements and Disclosure Improving
Disclosures about Fair Value Measurements, which amends the
existing guidance related to fair value measurements and
disclosures. The amendments require the following new fair value
disclosures:
|
|
|
|
|
Separate disclosure of the significant transfers in and out of
Level 1 and Level 2 fair value measurements, and a
description of the reasons for the transfers.
|
|
|
|
In the roll forward of activity for Level 3 fair value
measurements (significant unobservable inputs), purchases,
sales, issuances, and settlements should be presented separately
(on a gross basis rather than as one net number).
|
In addition, the amendments clarify existing disclosure
requirements, as follows:
|
|
|
|
|
Fair value measurements and disclosures should be presented for
each class of assets and liabilities within a line item in the
balance sheet.
|
|
|
|
Reporting entities should provide disclosures about the
valuation techniques and inputs used to measure fair value for
both recurring and nonrecurring fair value measurements that
fall in either Level 2 or Level 3.
|
The new disclosures and clarifications of existing disclosures
were effective for our interim and annual reporting periods
beginning after December 15, 2009, except for the
disclosures included in the roll forward of activity for
Level 3 fair value measurements, for which the effective
date is for fiscal years beginning after December 15, 2010,
and for interim periods within those fiscal years.
|
|
Item 7A.
|
Quantitative
And Qualitative Disclosures About Market Risk
|
We are subject to financial market risks, including changes in
interest rates. During the periods covered by our financial
statements, the interest rates on the loans within our portfolio
were all at fixed rates and we expect that our loans in the
future will also have primarily fixed interest rates. The
initial commitments to lend to our portfolio companies are
usually based on a floating LIBOR index and typically have
interest rates that are fixed at the time of the loan funding
and remain fixed for the term of the loan.
Assuming that the balance sheet as of December 31, 2010 was
to remain constant and no actions were taken to alter the
existing interest rate sensitivity, a hypothetical immediate 1%
change in interest rates may affect net income by more than 1%
over a one-year horizon. Although management believes that this
measure is indicative of our sensitivity to interest rate
changes, it does not adjust for potential changes in the credit
market, credit quality, size and composition of the assets on
the balance sheet and other business developments that could
affect net increase in net assets resulting from operations, or
net income. Accordingly, no assurances can be given that actual
results would not differ materially from the statement above.
58
Our Credit Facility has a floating interest rate provision based
on a LIBOR index which resets daily, and we expect that, other
than any SBIC debenture program debt, any other credit
facilities into which we enter in the future may have floating
interest rate provisions. We have used hedging instruments in
the past to protect us against interest rate fluctuations and we
may use them in the future. Such instruments may include swaps,
futures, options and forward contracts. While hedging activities
may insulate us against adverse changes in interest rates, they
may also limit our ability to participate in the benefits of
lower interest rates with respect to the investments in our
portfolio with fixed interest rates.
Because we currently fund, and will continue to fund, our
investments with borrowings, our net income is dependent upon
the difference between the rate at which we borrow funds and the
rate at which we invest the funds borrowed. Accordingly, there
can be no assurance that a significant change in market interest
rates will not have a material adverse effect on our net income.
In periods of rising interest rates, our cost of funds would
increase, which could reduce our net investment income if there
is not a corresponding increase in interest income generated by
floating rate assets in our investment portfolio.
59
|
|
Item 8.
|
Consolidated
Financial Statements and Supplementary Data
|
Index to
Consolidated Financial Statements
|
|
|
|
|
|
|
Page
|
|
|
|
|
61
|
|
|
|
|
62
|
|
Consolidated Statements of Operations for the
Period from October 29, 2010 to December 31, 2010, the
Period from January 1, 2010 to October 28, 2010, the
Year Ended December 30, 2009, and the Period March 4,
2008 (Inception) to December 31, 2008
|
|
|
63
|
|
|
|
|
64
|
|
Consolidated Statements of Cash Flows for the
Period from October 29, 2010 to December 31, 2010, the
Period from January 1, 2010 to October 28, 2010, the
Year Ended December 31, 2009, and the Period March 4,
2008 (Inception) to December 31, 2008
|
|
|
65
|
|
|
|
|
66
|
|
|
|
|
72
|
|
60
Report of
Independent Registered Public Accounting Firm
To the Board of Directors and Stockholders
Horizon Technology Finance Corporation
We have audited the accompanying consolidated statements of
assets and liabilities, including the consolidated schedules of
investments, of Horizon Technology Finance Corporation and
Subsidiary (the Company) as of December 31,
2010 and 2009, and the related consolidated statements of
operations, changes in net assets, and cash flows for the period
from October 29, 2010 to December 31, 2010, the period
from January 1, 2010 to October 28, 2010, the year
ended December 31, 2009, and the period from March 4,
2008 (inception) to December 31, 2008. These financial
statements are the responsibility of the Companys
management. Our responsibility is to express an opinion on these
financial statements based on our audits.
We conducted our audits in accordance with the standards of the
Public Company Accounting Oversight Board (United States). Those
standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are
free of material misstatement. The Company is not required to
have, nor were we engaged to perform an audit of its internal
control over financial reporting. Our audit included
consideration of internal control over financial reporting as a
basis for designing audit procedures that are appropriate in the
circumstances, but not for the purpose of expressing an opinion
on the effectiveness of the Companys internal control over
financial reporting. Accordingly, we express no such opinion. An
audit also includes examining, on a test basis, evidence
supporting the amounts and disclosures in the financial
statements, assessing the accounting principles used and
significant estimates made by management, as well as evaluating
the overall financial statement presentation. We believe that
our audits provide a reasonable basis for our opinion.
In our opinion, the consolidated financial statements referred
to above present fairly, in all material respects, the financial
position of Horizon Technology Finance Corporation and
Subsidiary as of December 31, 2010 and 2009, and the
results of their operations and their cash flows for the period
from October 29, 2010 to December 31, 2010, the period
from January 1, 2010 to October 28, 2010, the year
ended December 31, 2009, and for the period from
March 4, 2008 (inception) to December 31, 2008, in
conformity with U.S. generally accepted accounting
principles.
/s/ McGladrey &
Pullen, LLP
New Haven, Connecticut
March 16, 2011
61
Horizon
Technology Finance Corporation and Subsidiaries
(In thousands, except share data)
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
ASSETS
|
Non-affiliate investments at fair value at December 31,
2010 (cost of $133,494), at cost net of allowance for loan
losses of $1,924 at December 31, 2009 (Note 4)
|
|
$
|
136,810
|
|
|
$
|
111,954
|
|
Cash and cash equivalents
|
|
|
76,793
|
|
|
|
9,892
|
|
Interest receivable
|
|
|
1,938
|
|
|
|
1,452
|
|
Debt issuance costs (net of accumulated amortization of:
|
|
|
|
|
|
|
|
|
December 31, 2010 $3,292 and December 31, 2009 $2,130)
|
|
|
194
|
|
|
|
1,355
|
|
Other assets
|
|
|
470
|
|
|
|
215
|
|
|
|
|
|
|
|
|
|
|
Total assets
|
|
$
|
216,205
|
|
|
$
|
124,868
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITIES
|
Borrowings (Note 6)
|
|
$
|
87,425
|
|
|
$
|
64,166
|
|
Base management fee payable (Note 3)
|
|
|
360
|
|
|
|
182
|
|
Incentive fee payable (Note 3)
|
|
|
414
|
|
|
|
|
|
Interest rate swap liability (Note 10)
|
|
|
258
|
|
|
|
768
|
|
Other accrued expenses
|
|
|
553
|
|
|
|
259
|
|
|
|
|
|
|
|
|
|
|
Total liabilities
|
|
|
89,010
|
|
|
|
65,375
|
|
|
|
|
|
|
|
|
|
|
Net assets/members capital
|
|
|
|
|
|
|
|
|
Members capital
|
|
$
|
|
|
|
$
|
60,261
|
|
Accumulated other comprehensive loss Unrealized loss
on interest rate swaps
|
|
|
|
|
|
|
(768
|
)
|
Common Stock, par value $0.001 per share,
100,000,000 shares authorized, 7,593,422 shares
outstanding as of December 31, 2010
|
|
|
8
|
|
|
|
|
|
Paid-in capital in excess of par
|
|
|
123,836
|
|
|
|
|
|
Distributions in excess of net investment income
|
|
|
(143
|
)
|
|
|
|
|
Net unrealized appreciation on investments
|
|
|
3,043
|
|
|
|
|
|
Net realized gains on investments
|
|
|
451
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total net assets/members capital
|
|
|
127,195
|
|
|
|
59,493
|
|
|
|
|
|
|
|
|
|
|
Total liabilities and net assets/members capital
|
|
$
|
216,205
|
|
|
$
|
124,868
|
|
|
|
|
|
|
|
|
|
|
Net asset value per common share
|
|
$
|
16.75
|
|
|
|
N/A
|
|
|
|
|
|
|
|
|
|
|
See Notes to Consolidated Financial Statements
62
Horizon
Technology Finance Corporation and Subsidiaries
(In thousands, except share data)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Post-IPO as a
|
|
|
Pre-IPO Prior to becoming a
|
|
|
|
Business
|
|
|
Business Development Company
|
|
|
|
Development
|
|
|
|
|
|
|
|
|
March 4, 2008
|
|
|
|
Company
|
|
|
January 1,
|
|
|
|
|
|
(Inception)
|
|
|
|
October 29, 2010
|
|
|
2010 to
|
|
|
Year Ended
|
|
|
through
|
|
|
|
to December 31,
|
|
|
October 28,
|
|
|
December 31,
|
|
|
December 31,
|
|
|
|
2010
|
|
|
2010
|
|
|
2009
|
|
|
2008
|
|
|
Investment income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest income on non-affiliate investments
|
|
$
|
2,993
|
|
|
$
|
14,373
|
|
|
$
|
14,987
|
|
|
$
|
6,530
|
|
Interest income on cash and cash equivalents
|
|
|
10
|
|
|
|
60
|
|
|
|
67
|
|
|
|
359
|
|
Fee income on non-affiliate investments
|
|
|
248
|
|
|
|
523
|
|
|
|
272
|
|
|
|
132
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total investment income
|
|
|
3,251
|
|
|
|
14,956
|
|
|
|
15,326
|
|
|
|
7,021
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expenses
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest expense
|
|
|
508
|
|
|
|
3,622
|
|
|
|
4,246
|
|
|
|
2,748
|
|
Base management fee (Note 3)
|
|
|
668
|
|
|
|
2,019
|
|
|
|
2,202
|
|
|
|
1,073
|
|
Performance based incentive fee (Note 3)
|
|
|
414
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Administrative fee (Note 3)
|
|
|
88
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Professional fees
|
|
|
92
|
|
|
|
112
|
|
|
|
131
|
|
|
|
60
|
|
General and administrative
|
|
|
122
|
|
|
|
178
|
|
|
|
190
|
|
|
|
150
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total expenses
|
|
|
1,892
|
|
|
|
5,931
|
|
|
|
6,769
|
|
|
|
4,031
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net investment income
|
|
|
1,359
|
|
|
|
9,025
|
|
|
|
8,557
|
|
|
|
2,990
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Credit (provision) for loan losses
|
|
|
|
|
|
|
739
|
|
|
|
(274
|
)
|
|
|
(1,650
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net realized and unrealized gain (loss) on investments
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net realized gain on investments
|
|
|
611
|
|
|
|
69
|
|
|
|
138
|
|
|
|
22
|
|
Net unrealized appreciation (depreciation) on investments
|
|
|
1,449
|
|
|
|
1,481
|
|
|
|
892
|
|
|
|
(73
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net realized and unrealized gain (loss) on investments
|
|
|
2,060
|
|
|
|
1,550
|
|
|
|
1,030
|
|
|
|
(51
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net increase in net assets resulting from operations
|
|
$
|
3,419
|
|
|
$
|
11,314
|
|
|
$
|
9,313
|
|
|
$
|
1,289
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net investment income per common share
|
|
$
|
0.18
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in net assets per common share
|
|
$
|
0.45
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average shares outstanding
|
|
|
7,555,722
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
See Notes to Consolidated Financial Statements
63
Horizon
Technology Finance Corporation and Subsidiaries
(In thousands, except share data)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Distributions
|
|
|
Net
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated
|
|
|
|
|
|
|
|
|
|
|
|
in Excess of
|
|
|
Unrealized
|
|
|
Net
|
|
|
|
|
|
|
|
|
|
Other
|
|
|
|
|
|
|
|
|
Paid-In
|
|
|
Net
|
|
|
Appreciation
|
|
|
Realized
|
|
|
|
|
|
|
Members
|
|
|
Comprehensive
|
|
|
Common Stock
|
|
|
Capital in
|
|
|
Investment
|
|
|
on
|
|
|
Gains on
|
|
|
Total
|
|
|
|
Capital
|
|
|
Loss
|
|
|
Shares
|
|
|
Amount
|
|
|
Excess of Par
|
|
|
Income
|
|
|
Investments
|
|
|
Investments
|
|
|
Net Assets
|
|
|
March 4, 2008
|
|
$
|
|
|
|
$
|
|
|
|
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
Comprehensive income:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
|
1,289
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,289
|
|
Unrealized loss on interest rate swaps
|
|
|
|
|
|
|
(1,163
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1,163
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total comprehensive income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
126
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Capital contribution, net of costs
|
|
|
49,659
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
49,659
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 31, 2008
|
|
|
50,948
|
|
|
|
(1,163
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
49,785
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Comprehensive income:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
|
9,313
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
9,313
|
|
Unrealized gain on interest rate swaps
|
|
|
|
|
|
|
395
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
395
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total comprehensive income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
9,708
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 31, 2009
|
|
|
60,261
|
|
|
|
(768
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
59,493
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Comprehensive income:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
|
11,314
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
11,314
|
|
Unrealized gain on interest rate swaps
|
|
|
|
|
|
|
409
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
409
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total comprehensive income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
11,723
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash distribution
|
|
|
(18,000
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(18,000
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at October 28, 2010
|
|
|
53,575
|
|
|
|
(359
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
53,216
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Election to business development company(1)
|
|
|
(53,575
|
)
|
|
|
359
|
|
|
|
2,645,124
|
|
|
|
3
|
|
|
|
52,456
|
|
|
|
|
|
|
|
1,594
|
|
|
|
|
|
|
|
837
|
|
Issuance of common stock, net of offering costs(2)
|
|
|
|
|
|
|
|
|
|
|
4,910,000
|
|
|
|
5
|
|
|
|
70,815
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
70,820
|
|
Net increase in net assets from operations
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,359
|
|
|
|
1,449
|
|
|
|
611
|
|
|
|
3,419
|
|
Issuance of common stock as stock dividend(3)
|
|
|
|
|
|
|
|
|
|
|
38,298
|
|
|
|
|
|
|
|
565
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
565
|
|
Dividends declared
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1,502
|
)
|
|
|
|
|
|
|
(160
|
)
|
|
|
(1,662
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 31, 2010
|
|
$
|
|
|
|
$
|
|
|
|
|
7,593,422
|
|
|
$
|
8
|
|
|
$
|
123,836
|
|
|
$
|
(143
|
)
|
|
$
|
3,043
|
|
|
$
|
451
|
|
|
$
|
127,195
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Reclassification from members capital to net assets and
net unrealized appreciation on investments upon election.
Immediately prior to the initial public offering
(IPO), the members of Compass Horizon Funding
Company LLC (CHF) exchanged their membership
interests for 2,645,124 shares of common stock of the
Company and CHF became a wholly owned subsidiary of the Company.
Concurrent with the IPO Compass Horizon Partners, LP, one of
CHFs owners, sold 1,340,000 shares. |
|
(2) |
|
On October 28, 2010, the Company priced its IPO, offering
6,250,000 shares of its common stock at a public offering
price of $16.00 per share. Of the 6,250,000 shares offered,
4,910,000 shares were sold by the Company and
1,340,000 shares were sold by Compass Horizon Partners, LP,
one of CHFs owners. Total offering costs were $7,740. |
|
(3) |
|
The Company declared a fourth quarter dividend of $0.22 per
share, payable on December 31, 2010 to stockholders of
record on December 28, 2010. The Companys dividend
reinvestment plan provides for reinvestment of dividends, unless
a shareholder elects to receive cash. Dividends were reinvested
at $14.75 per share resulting in 38,298 additional shares. |
See Notes to Consolidated Financial Statements
64
Horizon
Technology Finance Corporation and Subsidiaries
(In thousands)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Post-IPO as a
|
|
|
Pre-IPO Prior to becoming a
|
|
|
|
Business
|
|
|
Business Development Company
|
|
|
|
Development
|
|
|
|
|
|
|
|
|
March 4,
|
|
|
|
Company
|
|
|
|
|
|
|
|
|
2008
|
|
|
|
October 29,
|
|
|
January 1,
|
|
|
|
|
|
(Inception)
|
|
|
|
2010 to
|
|
|
2010 to
|
|
|
Year Ended
|
|
|
through
|
|
|
|
December 31,
|
|
|
October 28,
|
|
|
December 31,
|
|
|
December 31,
|
|
|
|
2010
|
|
|
2010
|
|
|
2009
|
|
|
2008
|
|
|
Cash flows from operating activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net increase in net assets resulting from operations
|
|
$
|
3,419
|
|
|
$
|
11,314
|
|
|
$
|
9,313
|
|
|
$
|
1,289
|
|
Adjustments to reconcile net increase in net assets resulting
from operations:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Credit) provision for loan losses
|
|
|
|
|
|
|
(739
|
)
|
|
|
274
|
|
|
|
1,650
|
|
Amortization of debt issuance costs
|
|
|
200
|
|
|
|
962
|
|
|
|
1,123
|
|
|
|
953
|
|
Net realized gain on investments
|
|
|
(611
|
)
|
|
|
(69
|
)
|
|
|
(138
|
)
|
|
|
(22
|
)
|
Net unrealized (appreciation) depreciation on investments
|
|
|
(1,449
|
)
|
|
|
(1,481
|
)
|
|
|
(892
|
)
|
|
|
73
|
|
Purchase of investments
|
|
|
(19,316
|
)
|
|
|
(65,357
|
)
|
|
|
(49,936
|
)
|
|
|
(112,178
|
)
|
Principal payments received on investments
|
|
|
14,273
|
|
|
|
50,325
|
|
|
|
31,190
|
|
|
|
18,154
|
|
Proceeds from sale of investments
|
|
|
874
|
|
|
|
135
|
|
|
|
142
|
|
|
|
32
|
|
Changes in assets and liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Decrease (increase) in interest receivable
|
|
|
675
|
|
|
|
(1,162
|
)
|
|
|
(949
|
)
|
|
|
(503
|
)
|
(Decrease) increase in unearned loan income
|
|
|
(63
|
)
|
|
|
(500
|
)
|
|
|
(618
|
)
|
|
|
117
|
|
(Increase) decrease in other assets
|
|
|
(151
|
)
|
|
|
(246
|
)
|
|
|
19
|
|
|
|
(35
|
)
|
Increase (decrease) in other accrued expenses
|
|
|
220
|
|
|
|
74
|
|
|
|
(175
|
)
|
|
|
435
|
|
Increase in base management fee payable
|
|
|
157
|
|
|
|
21
|
|
|
|
22
|
|
|
|
159
|
|
Increase in incentive fee payable
|
|
|
414
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash used in operating activities
|
|
|
(1,358
|
)
|
|
|
(6,723
|
)
|
|
|
(10,625
|
)
|
|
|
(89,876
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from financing activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from shares sold, net of offering costs
|
|
|
70,820
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Capital contributions, net of offering costs
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
49,659
|
|
Dividends and distributions paid
|
|
|
(1,097
|
)
|
|
|
(18,000
|
)
|
|
|
|
|
|
|
|
|
Net (decrease) increase in revolving borrowings
|
|
|
(3,748
|
)
|
|
|
27,007
|
|
|
|
493
|
|
|
|
63,673
|
|
Debt issuance costs
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(3,432
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by financing activities
|
|
|
65,975
|
|
|
|
9,007
|
|
|
|
493
|
|
|
|
109,900
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net increase (decrease) in cash and cash equivalents
|
|
|
64,617
|
|
|
|
2,284
|
|
|
|
(10,132
|
)
|
|
|
20,024
|
|
Cash and cash equivalents:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Beginning of period
|
|
|
12,176
|
|
|
|
9,892
|
|
|
|
20,024
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
End of period
|
|
$
|
76,793
|
|
|
$
|
12,176
|
|
|
$
|
9,892
|
|
|
$
|
20,024
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash paid for interest
|
|
$
|
393
|
|
|
$
|
2,655
|
|
|
$
|
3,096
|
|
|
$
|
1,535
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Supplemental non-cash investing and financing activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant investments received & recorded as unearned
loan income
|
|
$
|
304
|
|
|
$
|
1,212
|
|
|
$
|
876
|
|
|
$
|
776
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock received in settlement of investments
|
|
$
|
209
|
|
|
$
|
|
|
|
$
|
198
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Decrease) increase in interest rate swap liability
|
|
$
|
|
|
|
$
|
(409
|
)
|
|
$
|
(395
|
)
|
|
$
|
1,163
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
See Notes to Consolidated Financial Statements
65
Horizon
Technology Finance Corporation and Subsidiaries
December 31,
2010
(In thousands)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Type of
|
|
Interest
|
|
|
|
|
|
Cost of
|
|
|
|
|
Portfolio Company
|
|
Sector
|
|
Investment(2)
|
|
Rate(3)
|
|
|
Maturity
|
|
|
Investment(5)
|
|
|
Fair Value
|
|
|
Debt Investments(1)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt Investments Life Science
39.3%
|
|
|
|
|
|
|
|
|
ACT Biotech, Inc.
|
|
Biotechnology
|
|
Term Loan
|
|
|
12.10
|
%
|
|
|
6/1/2013
|
|
|
$
|
958
|
|
|
$
|
958
|
|
|
|
|
|
Term Loan
|
|
|
12.01
|
%
|
|
|
6/1/2013
|
|
|
|
957
|
|
|
|
957
|
|
|
|
|
|
Term Loan
|
|
|
12.01
|
%
|
|
|
6/1/2013
|
|
|
|
1,478
|
|
|
|
1,478
|
|
Ambit Biosciences, Inc.
|
|
Biotechnology
|
|
Term Loan
|
|
|
12.25
|
%
|
|
|
10/1/2013
|
|
|
|
5,898
|
|
|
|
5,898
|
|
Concentric Medical, Inc.
|
|
Medical Device
|
|
Term Loan
|
|
|
12.04
|
%
|
|
|
9/1/2013
|
|
|
|
6,887
|
|
|
|
6,887
|
|
GenturaDX, Inc.
|
|
Biotechnology
|
|
Term Loan
|
|
|
11.25
|
%
|
|
|
4/1/2014
|
|
|
|
1,917
|
|
|
|
1,917
|
|
Novalar Pharmaceuticals, Inc.
|
|
Biotechnology
|
|
Term Loan
|
|
|
12.00
|
%
|
|
|
6/1/2012
|
|
|
|
3,146
|
|
|
|
3,146
|
|
OraMetrix, Inc.
|
|
Medical Device
|
|
Term Loan
|
|
|
11.50
|
%
|
|
|
4/1/2014
|
|
|
|
4,887
|
|
|
|
4,887
|
|
Pharmasset, Inc.(4)
|
|
Biotechnology
|
|
Term Loan
|
|
|
12.00
|
%
|
|
|
8/1/2011
|
|
|
|
868
|
|
|
|
868
|
|
|
|
|
|
Term Loan
|
|
|
12.00
|
%
|
|
|
1/1/2012
|
|
|
|
1,448
|
|
|
|
1,448
|
|
|
|
|
|
Term Loan
|
|
|
12.50
|
%
|
|
|
10/1/2012
|
|
|
|
2,422
|
|
|
|
2,422
|
|
PixelOptics, Inc.
|
|
Medical Device
|
|
Term Loan
|
|
|
13.00
|
%
|
|
|
1/1/2013
|
|
|
|
4,221
|
|
|
|
4,221
|
|
Revance Therapeutics, Inc.
|
|
Biotechnology
|
|
Term Loan
|
|
|
10.50
|
%
|
|
|
12/1/2011
|
|
|
|
1,445
|
|
|
|
1,445
|
|
|
|
|
|
Term Loan
|
|
|
10.50
|
%
|
|
|
3/1/2013
|
|
|
|
3,478
|
|
|
|
3,478
|
|
Tengion, Inc.(4)
|
|
Medical Device
|
|
Term Loan
|
|
|
12.26
|
%
|
|
|
9/1/2011
|
|
|
|
2,740
|
|
|
|
2,740
|
|
Tranzyme, Inc.
|
|
Biotechnology
|
|
Term Loan
|
|
|
10.75
|
%
|
|
|
1/1/2014
|
|
|
|
4,966
|
|
|
|
4,966
|
|
ViOptix, Inc.
|
|
Medical Device
|
|
Term Loan
|
|
|
13.55
|
%
|
|
|
11/1/2011
|
|
|
|
885
|
|
|
|
837
|
|
Xcovery Holding Company, LLC
|
|
Biotechnology
|
|
Term Loan
|
|
|
12.00
|
%
|
|
|
10/1/2013
|
|
|
|
1,490
|
|
|
|
1,490
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Debt Investments Life Science
|
|
|
50,091
|
|
|
|
50,043
|
|
|
|
|
|
|
|
|
|
|
Debt Investments Technology 24.4%
|
|
|
|
|
|
|
|
|
Clarabridge, Inc.
|
|
Software
|
|
Term Loan
|
|
|
12.50
|
%
|
|
|
1/1/2013
|
|
|
|
1,166
|
|
|
|
1,166
|
|
|
|
|
|
Term Loan
|
|
|
12.50
|
%
|
|
|
6/1/2013
|
|
|
|
688
|
|
|
|
688
|
|
|
|
|
|
Term Loan
|
|
|
12.50
|
%
|
|
|
5/1/2014
|
|
|
|
743
|
|
|
|
743
|
|
Courion Corporation
|
|
Software
|
|
Term Loan
|
|
|
11.45
|
%
|
|
|
12/1/2011
|
|
|
|
1,083
|
|
|
|
1,083
|
|
Hatteras Networks, Inc.
|
|
Communications
|
|
Term Loan
|
|
|
12.40
|
%
|
|
|
2/1/2011
|
|
|
|
1,042
|
|
|
|
1,042
|
|
IntelePeer, Inc.
|
|
Networking
|
|
Term Loan
|
|
|
12.43
|
%
|
|
|
4/1/2012
|
|
|
|
515
|
|
|
|
515
|
|
|
|
|
|
Term Loan
|
|
|
12.33
|
%
|
|
|
6/1/2012
|
|
|
|
598
|
|
|
|
598
|
|
|
|
|
|
Term Loan
|
|
|
12.33
|
%
|
|
|
10/1/2012
|
|
|
|
1,171
|
|
|
|
1,171
|
|
Netuitive, Inc.
|
|
Software
|
|
Term Loan
|
|
|
12.90
|
%
|
|
|
4/1/2011
|
|
|
|
152
|
|
|
|
152
|
|
OpenPeak, Inc.
|
|
Communications
|
|
Term Loan
|
|
|
11.86
|
%
|
|
|
12/1/2013
|
|
|
|
6,549
|
|
|
|
6,549
|
|
Starcite, Inc.
|
|
Consumer-related technologies
|
|
Term Loan
|
|
|
12.05
|
%
|
|
|
9/1/2012
|
|
|
|
2,679
|
|
|
|
2,679
|
|
StreamBase Systems, Inc.
|
|
Software
|
|
Term Loan
|
|
|
12.51
|
%
|
|
|
11/1/2013
|
|
|
|
3,934
|
|
|
|
3,934
|
|
|
|
|
|
Term Loan
|
|
|
12.50
|
%
|
|
|
6/1/2014
|
|
|
|
977
|
|
|
|
977
|
|
Tagged, Inc.
|
|
Consumer-related technologies
|
|
Term Loan
|
|
|
12.78
|
%
|
|
|
5/1/2012
|
|
|
|
1,284
|
|
|
|
1,284
|
|
|
|
|
|
Term Loan
|
|
|
11.46
|
%
|
|
|
8/1/2012
|
|
|
|
498
|
|
|
|
498
|
|
Vette Corp.
|
|
Data Storage
|
|
Term Loan
|
|
|
11.75
|
%
|
|
|
7/1/2014
|
|
|
|
4,916
|
|
|
|
4,916
|
|
XIOtech, Inc.
|
|
Data Storage
|
|
Term Loan
|
|
|
14.00
|
%
|
|
|
5/1/2012
|
|
|
|
2,997
|
|
|
|
2,997
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Debt Investments Technology
|
|
|
30,992
|
|
|
|
30,992
|
|
|
|
|
|
|
|
|
|
|
Debt Investments Cleantech 14.9%
|
|
|
|
|
|
|
|
|
Cereplast, Inc.(4)
|
|
Waste Removal
|
|
Term Loan
|
|
|
12.00
|
%
|
|
|
4/1/2014
|
|
|
|
2,363
|
|
|
|
2,363
|
|
Enphase Energy, Inc.
|
|
Energy Efficiency
|
|
Term Loan
|
|
|
12.60
|
%
|
|
|
10/1/2013
|
|
|
|
6,869
|
|
|
|
6,869
|
|
Satcon Technology Corporation(4)
|
|
Energy Efficiency
|
|
Term Loan
|
|
|
12.58
|
%
|
|
|
1/1/2014
|
|
|
|
9,701
|
|
|
|
9,701
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Debt Investments Cleantech
|
|
|
18,933
|
|
|
|
18,933
|
|
|
|
|
|
|
|
|
|
|
Debt Investments Healthcare information and
services 23.8%
|
|
|
|
|
|
|
|
|
BioScale, Inc.
|
|
Diagnostics
|
|
Term Loan
|
|
|
12.00
|
%
|
|
|
8/1/2012
|
|
|
|
2,454
|
|
|
|
2,454
|
|
|
|
|
|
Term Loan
|
|
|
11.51
|
%
|
|
|
1/1/2014
|
|
|
|
4,908
|
|
|
|
4,908
|
|
Precision Therapeutics, Inc.
|
|
Diagnostics
|
|
Term Loan
|
|
|
13.00
|
%
|
|
|
3/1/2012
|
|
|
|
3,255
|
|
|
|
3,255
|
|
See Notes to Consolidated Financial Statements
66
Horizon
Technology Finance Corporation and Subsidiaries
Consolidated
Schedule of Investments
December 31,
2010 (Continued)
(In thousands)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Type of
|
|
Interest
|
|
|
|
|
|
Cost of
|
|
|
|
|
Portfolio Company
|
|
Sector
|
|
Investment(2)
|
|
Rate(3)
|
|
|
Maturity
|
|
|
Investment(5)
|
|
|
Fair Value
|
|
|
Radisphere National Radiology Group, Inc.
|
|
Diagnostics
|
|
Term Loan
|
|
|
12.75
|
%
|
|
|
1/1/2014
|
|
|
|
9,855
|
|
|
|
9,855
|
|
Singulex, Inc.
|
|
Other Healthcare
|
|
Term Loan
|
|
|
11.00
|
%
|
|
|
3/1/2014
|
|
|
|
2,949
|
|
|
|
2,949
|
|
|
|
|
|
Term Loan
|
|
|
11.00
|
%
|
|
|
3/1/2014
|
|
|
|
1,964
|
|
|
|
1,964
|
|
Talyst, Inc.
|
|
Other Healthcare
|
|
Term Loan
|
|
|
12.10
|
%
|
|
|
12/1/2013
|
|
|
|
2,443
|
|
|
|
2,443
|
|
|
|
|
|
Term Loan
|
|
|
12.05
|
%
|
|
|
12/1/2013
|
|
|
|
2,438
|
|
|
|
2,438
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Debt Investment Healthcare information and
services
|
|
|
30,266
|
|
|
|
30,266
|
|
|
|
|
|
|
|
|
|
|
Total Debt Investments
|
|
|
130,282
|
|
|
|
130,234
|
|
|
|
|
|
|
|
|
|
|
Warrant Investments(1)
|
|
|
|
|
|
|
|
|
Warrants Life Science 2.1%
|
|
|
|
|
|
|
|
|
ACT Biotech, Inc.
|
|
Biotechnology
|
|
Preferred Stock Warrants
|
|
|
|
|
|
|
|
|
|
|
23
|
|
|
|
23
|
|
Advanced BioHealing, Inc.
|
|
Biotechnology
|
|
Preferred Stock Warrants
|
|
|
|
|
|
|
|
|
|
|
9
|
|
|
|
1,209
|
|
Ambit Biosciences, Inc.
|
|
Biotechnology
|
|
Preferred Stock Warrants
|
|
|
|
|
|
|
|
|
|
|
143
|
|
|
|
147
|
|
Anesiva, Inc.(4)
|
|
Biotechnology
|
|
Common Stock Warrants
|
|
|
|
|
|
|
|
|
|
|
18
|
|
|
|
|
|
Calypso Medical Technologies, Inc.
|
|
Medical Device
|
|
Preferred Stock Warrants
|
|
|
|
|
|
|
|
|
|
|
17
|
|
|
|
76
|
|
Concentric Medical, Inc.
|
|
Medical Device
|
|
Preferred Stock Warrants
|
|
|
|
|
|
|
|
|
|
|
85
|
|
|
|
89
|
|
EnteroMedics, Inc.(4)
|
|
Medical Device
|
|
Common Stock Warrants
|
|
|
|
|
|
|
|
|
|
|
347
|
|
|
|
18
|
|
GenturaDX, Inc.
|
|
Biotechnology
|
|
Preferred Stock Warrants
|
|
|
|
|
|
|
|
|
|
|
63
|
|
|
|
63
|
|
Novalar Pharmaceuticals, Inc.
|
|
Biotechnology
|
|
Preferred Stock Warrants
|
|
|
|
|
|
|
|
|
|
|
69
|
|
|
|
|
|
OraMetrix, Inc.
|
|
Medical Device
|
|
Preferred Stock Warrants
|
|
|
|
|
|
|
|
|
|
|
78
|
|
|
|
83
|
|
Pharmasset, Inc.(4)
|
|
Biotechnology
|
|
Common Stock Warrants
|
|
|
|
|
|
|
|
|
|
|
126
|
|
|
|
789
|
|
PixelOptics, Inc.
|
|
Medical Device
|
|
Preferred Stock Warrants
|
|
|
|
|
|
|
|
|
|
|
61
|
|
|
|
61
|
|
Revance Therapeutics, Inc.
|
|
Biotechnology
|
|
Preferred Stock Warrants
|
|
|
|
|
|
|
|
|
|
|
224
|
|
|
|
121
|
|
Tengion, Inc.(4)
|
|
Medical Device
|
|
Common Stock Warrants
|
|
|
|
|
|
|
|
|
|
|
15
|
|
|
|
|
|
Tranzyme, Inc.
|
|
Biotechnology
|
|
Preferred Stock Warrants
|
|
|
|
|
|
|
|
|
|
|
1
|
|
|
|
1
|
|
ViOptix, Inc.
|
|
Medical Device
|
|
Preferred Stock Warrants
|
|
|
|
|
|
|
|
|
|
|
13
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Warrants Life Science
|
|
|
1,292
|
|
|
|
2,680
|
|
|
|
|
|
|
|
|
|
|
Warrants Technology 1.2%
|
|
|
|
|
|
|
|
|
Cartera Commerce, Inc.
|
|
Internet and media
|
|
Preferred Stock Warrants
|
|
|
|
|
|
|
|
|
|
|
16
|
|
|
|
38
|
|
Clarabridge, Inc.
|
|
Software
|
|
Preferred Stock Warrants
|
|
|
|
|
|
|
|
|
|
|
28
|
|
|
|
25
|
|
Courion Corporation
|
|
Software
|
|
Preferred Stock Warrants
|
|
|
|
|
|
|
|
|
|
|
7
|
|
|
|
17
|
|
DriveCam, Inc.
|
|
Software
|
|
Preferred Stock Warrants
|
|
|
|
|
|
|
|
|
|
|
20
|
|
|
|
8
|
|
Everyday Health, Inc.
|
|
Consumer related technologies
|
|
Preferred Stock Warrants
|
|
|
|
|
|
|
|
|
|
|
69
|
|
|
|
137
|
|
Grab Networks, Inc.
|
|
Networking
|
|
Preferred Stock Warrants
|
|
|
|
|
|
|
|
|
|
|
74
|
|
|
|
|
|
Hatteras Networks, Inc.
|
|
Communications
|
|
Preferred Stock Warrants
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
35
|
|
Impinj, Inc.
|
|
Semi-conductor
|
|
Preferred Stock Warrants
|
|
|
|
|
|
|
|
|
|
|
7
|
|
|
|
|
|
IntelePeer, Inc.
|
|
Networking
|
|
Preferred Stock Warrants
|
|
|
|
|
|
|
|
|
|
|
39
|
|
|
|
544
|
|
Motion Computing, Inc.
|
|
Networking
|
|
Preferred Stock Warrants
|
|
|
|
|
|
|
|
|
|
|
7
|
|
|
|
292
|
|
Netuitive, Inc.
|
|
Software
|
|
Preferred Stock Warrants
|
|
|
|
|
|
|
|
|
|
|
27
|
|
|
|
22
|
|
OpenPeak, Inc.
|
|
Communications
|
|
Preferred Stock Warrants
|
|
|
|
|
|
|
|
|
|
|
89
|
|
|
|
92
|
|
Plateau Systems, Ltd.
|
|
Software
|
|
Preferred Stock Warrants
|
|
|
|
|
|
|
|
|
|
|
7
|
|
|
|
35
|
|
SnagAJob.com, Inc.
|
|
Consumer-related technologies
|
|
Preferred Stock Warrants
|
|
|
|
|
|
|
|
|
|
|
23
|
|
|
|
39
|
|
Starcite, Inc.
|
|
Consumer-related technologies
|
|
Preferred Stock Warrants
|
|
|
|
|
|
|
|
|
|
|
24
|
|
|
|
28
|
|
StreamBase Systems, Inc.
|
|
Technology-Software
|
|
Preferred Stock Warrants
|
|
|
|
|
|
|
|
|
|
|
67
|
|
|
|
69
|
|
Tagged, Inc.
|
|
Consumer-related technologies
|
|
Preferred Stock Warrants
|
|
|
|
|
|
|
|
|
|
|
17
|
|
|
|
27
|
|
Vette Corp.
|
|
Data Storage
|
|
Preferred Stock Warrants
|
|
|
|
|
|
|
|
|
|
|
75
|
|
|
|
49
|
|
XIOtech, Inc.
|
|
Data Storage
|
|
Preferred Stock Warrants
|
|
|
|
|
|
|
|
|
|
|
22
|
|
|
|
81
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Warrants Technology
|
|
|
618
|
|
|
|
1,538
|
|
|
|
|
|
|
|
|
|
|
See Notes to Consolidated Financial Statements
67
Horizon
Technology Finance Corporation and Subsidiaries
Consolidated
Schedule of Investments
December 31,
2010 (Continued)
(In thousands)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Type of
|
|
Interest
|
|
|
|
|
|
Cost of
|
|
|
|
|
Portfolio Company
|
|
Sector
|
|
Investment(2)
|
|
Rate(3)
|
|
|
Maturity
|
|
|
Investment(5)
|
|
|
Fair Value
|
|
|
Warrants Cleantech 1.0%
|
|
|
|
|
|
|
|
|
Cereplast, Inc.(4)
|
|
Waste Removal
|
|
Common Stock Warrants
|
|
|
|
|
|
|
|
|
|
|
112
|
|
|
|
112
|
|
Enphase Energy, Inc.
|
|
Energy Efficiency
|
|
Preferred Stock Warrants
|
|
|
|
|
|
|
|
|
|
|
122
|
|
|
|
122
|
|
Satcon Technology Corporation(4)
|
|
Energy Efficiency
|
|
Common Stock Warrants
|
|
|
|
|
|
|
|
|
|
|
286
|
|
|
|
1,057
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Warrants Cleantech
|
|
|
520
|
|
|
|
1,291
|
|
|
|
|
|
|
|
|
|
|
Warrants Healthcare information and
services 0.6%
|
|
|
|
|
|
|
|
|
BioScale, Inc.
|
|
Diagnostics
|
|
Preferred Stock Warrants
|
|
|
|
|
|
|
|
|
|
|
55
|
|
|
|
49
|
|
Precision Therapeutics, Inc.
|
|
Diagnostics
|
|
Preferred Stock Warrants
|
|
|
|
|
|
|
|
|
|
|
52
|
|
|
|
139
|
|
Radisphere National Radiology Group, Inc.
|
|
Diagnostics
|
|
Preferred Stock Warrants
|
|
|
|
|
|
|
|
|
|
|
167
|
|
|
|
384
|
|
Singulex, Inc.
|
|
Other Healthcare
|
|
Preferred Stock Warrants
|
|
|
|
|
|
|
|
|
|
|
39
|
|
|
|
39
|
|
Talyst, Inc.
|
|
Other Healthcare
|
|
Preferred Stock Warrants
|
|
|
|
|
|
|
|
|
|
|
100
|
|
|
|
105
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Warrants Healthcare information and services
|
|
|
413
|
|
|
|
716
|
|
|
|
|
|
|
|
|
|
|
Total Warrants
|
|
|
2,843
|
|
|
|
6,225
|
|
|
|
|
|
|
|
|
|
|
Equity 0.3%
|
|
|
|
|
|
|
|
|
AFS Technologies, Inc.
|
|
|
|
Common Stock
|
|
|
|
|
|
|
|
|
|
|
142
|
|
|
|
142
|
|
Insmed Incorporated(4)
|
|
|
|
Common Stock and
Convertible Preferred Stock
|
|
|
|
|
|
|
|
|
|
|
227
|
|
|
|
209
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total equity
|
|
|
369
|
|
|
|
351
|
|
|
|
|
|
|
|
|
|
|
Total investments assets
|
|
$
|
133,494
|
|
|
$
|
136,810
|
|
|
|
|
|
|
|
|
|
|
Investment Liabilities
|
|
|
|
|
|
|
|
|
Derivative Agreement
|
|
|
|
|
|
|
|
|
WestLB, AG
|
|
Interest rate swap pay fixed/receive floating,
Notional Amount $10 million
|
|
3.58%
|
|
|
10/14/2011
|
|
|
|
|
|
|
|
|
|
|
|
258
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total investment liabilities
|
|
$
|
|
|
|
|
258
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Substantially all debt and warrant investments have been pledged
as collateral under the Credit Facility. |
|
(2) |
|
All investments are less than 5% ownership of the class and
ownership of the portfolio company. |
|
(3) |
|
All interest is payable in cash due monthly in arrears, unless
otherwise indicated and applies only to the Companys debt
investments. Amount is the annual interest rate on the debt
investment and does not include any additional fees related to
the investment such as commitment fees or prepayment fees. The
majority of the debt investments are at fixed rates for the term
of the loan. For each debt investment we have provided the
current interest rate in effect as of December 31, 2010. |
|
(4) |
|
Portfolio company is a public company. |
|
(5) |
|
For debt investments, represents principal balance. |
See Notes to Consolidated Financial Statements
68
Horizon
Technology Finance Corporation and Subsidiaries
Consolidated
Schedule of Investments
December 31,
2009
(In thousands)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest
|
|
|
|
|
|
Cost of
|
|
|
|
|
Portfolio Company
|
|
Sector
|
|
Type of Investment(2)
|
|
Rate(3)
|
|
|
Maturity
|
|
|
Investment(5)
|
|
|
Fair Value
|
|
|
Debt Investments(1)
|
|
|
|
|
|
|
|
|
Debt Investments Life Science
29.6%
|
|
|
|
|
|
|
|
|
Ambit Biosciences, Inc.
|
|
Biotechnology
|
|
Term Loan
|
|
|
12.15
|
%
|
|
|
6/1/2011
|
|
|
$
|
1,272
|
|
|
$
|
1,272
|
|
Concentric Medical, Inc.
|
|
Medical Device
|
|
Revolving Loan
|
|
|
Prime + 3.25
|
%
|
|
|
7/1/2010
|
|
|
|
3,333
|
|
|
|
3,333
|
|
Novalar Pharmaceuticals, Inc.
|
|
Biotechnology
|
|
Term Loan
|
|
|
12.00
|
%
|
|
|
6/1/2012
|
|
|
|
4,770
|
|
|
|
4,770
|
|
Pharmasset, Inc.(4)
|
|
Biotechnology
|
|
Term Loan
|
|
|
12.00
|
%
|
|
|
8/1/2011
|
|
|
|
2,201
|
|
|
|
2,201
|
|
|
|
|
|
Term Loan
|
|
|
12.00
|
%
|
|
|
1/1/2012
|
|
|
|
2,704
|
|
|
|
2,704
|
|
|
|
|
|
Term Loan
|
|
|
12.50
|
%
|
|
|
10/1/2012
|
|
|
|
3,284
|
|
|
|
3,284
|
|
PixelOptics, Inc.
|
|
Medical Device
|
|
Term Loan
|
|
|
13.00
|
%
|
|
|
1/1/2013
|
|
|
|
4,889
|
|
|
|
4,889
|
|
Revance Therapeutics, Inc.
|
|
Biotechnology
|
|
Term Loan
|
|
|
10.50
|
%
|
|
|
12/1/2011
|
|
|
|
2,705
|
|
|
|
2,705
|
|
Tengion, Inc.
|
|
Medical Device
|
|
Term Loan
|
|
|
12.26
|
%
|
|
|
9/1/2011
|
|
|
|
5,753
|
|
|
|
5,753
|
|
Transave, Inc.
|
|
Biotechnology
|
|
Term Loan
|
|
|
11.75
|
%
|
|
|
2/29/2012
|
|
|
|
2,730
|
|
|
|
2,730
|
|
|
|
|
|
Term Loan
|
|
|
11.75
|
%
|
|
|
7/1/2012
|
|
|
|
1,992
|
|
|
|
1,992
|
|
|
|
|
|
Convertible Note
|
|
|
10.00
|
%
|
|
|
6/30/2010
|
|
|
|
102
|
|
|
|
102
|
|
ViOptix, Inc.
|
|
Medical Device
|
|
Term Loan
|
|
|
13.55
|
%
|
|
|
11/1/2011
|
|
|
|
1,727
|
|
|
|
1,626
|
|
Xoft, Inc.
|
|
Medical Device
|
|
Revolving Loan
|
|
|
Prime + 4.25
|
%
|
|
|
11/15/2010
|
|
|
|
331
|
|
|
|
331
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total debt investments Life Science
|
|
|
37,793
|
|
|
|
37,692
|
|
|
|
|
|
|
|
|
|
|
Debt Investments Technology 44.9%
|
|
|
|
|
|
|
|
|
Cartera Commerce, Inc.
|
|
Internet and media
|
|
Term Loan
|
|
|
11.75
|
%
|
|
|
6/1/2012
|
|
|
|
2,483
|
|
|
|
2,483
|
|
Clarabridge, Inc.
|
|
Software
|
|
Term Loan
|
|
|
12.50
|
%
|
|
|
1/1/2013
|
|
|
|
1,467
|
|
|
|
1,467
|
|
|
|
|
|
Term Loan
|
|
|
12.50
|
%
|
|
|
6/1/2013
|
|
|
|
743
|
|
|
|
743
|
|
Courion Corporation
|
|
Software
|
|
Term Loan
|
|
|
11.45
|
%
|
|
|
12/1/2011
|
|
|
|
2,044
|
|
|
|
2,044
|
|
Genesis Networks, Inc.
|
|
Networking
|
|
Term Loan
|
|
|
11.80
|
%
|
|
|
8/1/2012
|
|
|
|
3,955
|
|
|
|
3,555
|
|
Grab Networks, Inc.
|
|
Networking
|
|
Term Loan
|
|
|
13.00
|
%
|
|
|
4/1/2012
|
|
|
|
3,579
|
|
|
|
3,579
|
|
Hatteras Networks, Inc.
|
|
Communications
|
|
Term Loan
|
|
|
12.40
|
%
|
|
|
2/1/2011
|
|
|
|
2,457
|
|
|
|
2,457
|
|
Impinj, Inc.
|
|
Semi-conductor
|
|
Term Loan
|
|
|
Prime + 4.25
|
%
|
|
|
1/1/2011
|
|
|
|
866
|
|
|
|
866
|
|
IntelePeer, Inc.
|
|
Networking
|
|
Term Loan
|
|
|
12.43
|
%
|
|
|
4/1/2012
|
|
|
|
836
|
|
|
|
836
|
|
|
|
|
|
Term Loan
|
|
|
12.33
|
%
|
|
|
6/1/2012
|
|
|
|
933
|
|
|
|
933
|
|
|
|
|
|
Term Loan
|
|
|
12.33
|
%
|
|
|
10/1/2012
|
|
|
|
1,692
|
|
|
|
1,692
|
|
iSkoot, Inc.
|
|
Software
|
|
Term Loan
|
|
|
12.75
|
%
|
|
|
5/1/2013
|
|
|
|
3,917
|
|
|
|
3,917
|
|
Motion Computing, Inc.
|
|
Networking
|
|
Term Loan
|
|
|
12.25
|
%
|
|
|
4/1/2011
|
|
|
|
1,431
|
|
|
|
1,431
|
|
|
|
|
|
Term Loan
|
|
|
12.25
|
%
|
|
|
1/1/2012
|
|
|
|
2,136
|
|
|
|
2,136
|
|
Netuitive, Inc.
|
|
Software
|
|
Term Loan
|
|
|
12.90
|
%
|
|
|
4/1/2011
|
|
|
|
569
|
|
|
|
569
|
|
NewRiver, Inc.
|
|
Software
|
|
Term Loan
|
|
|
11.60
|
%
|
|
|
1/1/2012
|
|
|
|
3,403
|
|
|
|
3,403
|
|
Plateau Systems, Ltd.
|
|
Software
|
|
Term Loan
|
|
|
12.40
|
%
|
|
|
9/1/2010
|
|
|
|
744
|
|
|
|
744
|
|
SnagAJob.com, Inc.
|
|
Consumer-related technologies
|
|
Term Loan
|
|
|
11.50
|
%
|
|
|
6/1/2012
|
|
|
|
3,477
|
|
|
|
3,477
|
|
Starcite, Inc.
|
|
Consumer-related technologies
|
|
Term Loan
|
|
|
12.05
|
%
|
|
|
9/1/2012
|
|
|
|
3,960
|
|
|
|
3,960
|
|
Tagged, Inc.
|
|
Consumer-related technologies
|
|
Term Loan
|
|
|
12.78
|
%
|
|
|
5/1/2012
|
|
|
|
2,108
|
|
|
|
2,108
|
|
|
|
|
|
Term Loan
|
|
|
11.46
|
%
|
|
|
8/1/2012
|
|
|
|
746
|
|
|
|
746
|
|
Vette Corp.
|
|
Data Storage
|
|
Term Loan
|
|
|
11.85
|
%
|
|
|
3/1/2012
|
|
|
|
4,530
|
|
|
|
4,530
|
|
Waterfront Media, Inc.
|
|
Consumer-related technologies
|
|
Term Loan
|
|
|
13.00
|
%
|
|
|
5/1/2013
|
|
|
|
4,890
|
|
|
|
4,890
|
|
XIOtech, Inc.
|
|
Data Storage
|
|
Term Loan
|
|
|
14.00
|
%
|
|
|
5/1/2012
|
|
|
|
4,494
|
|
|
|
4,494
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total debt investment Technology
|
|
|
57,460
|
|
|
|
57,060
|
|
|
|
|
|
|
|
|
|
|
Healthcare information and services 12.5%
|
|
|
|
|
|
|
|
|
BioScale, Inc.
|
|
Diagnostics
|
|
Term Loan
|
|
|
12.00
|
%
|
|
|
8/1/2012
|
|
|
|
3,774
|
|
|
|
3,509
|
|
F & S Health Care Services, Inc.
|
|
Diagnostics
|
|
Term Loan
|
|
|
11.80
|
%
|
|
|
12/1/2012
|
|
|
|
7,457
|
|
|
|
7,457
|
|
Precision Therapeutics, Inc.
|
|
Diagnostics
|
|
Term Loan
|
|
|
13.00
|
%
|
|
|
3/1/2012
|
|
|
|
4,936
|
|
|
|
4,936
|
|
See Notes to Consolidated Financial Statements
69
Horizon
Technology Finance Corporation and Subsidiaries
Consolidated
Schedule of Investments
December 31,
2009 (Continued)
(In thousands)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest
|
|
|
|
|
|
Cost of
|
|
|
|
|
Portfolio Company
|
|
Sector
|
|
Type of Investment(2)
|
|
Rate(3)
|
|
|
Maturity
|
|
|
Investment(5)
|
|
|
Fair Value
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Debt Investments Healthcare information and
services
|
|
|
16,167
|
|
|
|
15,902
|
|
|
|
|
|
|
|
|
|
|
Total Debt Investments
|
|
|
111,420
|
|
|
|
110,654
|
|
|
|
|
|
|
|
|
|
|
Warrant Investments(1)
|
|
|
|
|
|
|
|
|
Warrants Life Science 0.8%
|
|
|
|
|
|
|
|
|
Advanced BioHealing, Inc.
|
|
Biotechnology
|
|
Preferred Stock Warrants
|
|
|
|
|
|
|
|
|
|
|
9
|
|
|
|
42
|
|
Ambit Biosciences, Inc.
|
|
Biotechnology
|
|
Preferred Stock Warrants
|
|
|
|
|
|
|
|
|
|
|
18
|
|
|
|
55
|
|
Anesiva, Inc.(4)
|
|
Biotechnology
|
|
Common Stock Warrants
|
|
|
|
|
|
|
|
|
|
|
18
|
|
|
|
|
|
Calypso Medical Technologies, Inc.
|
|
Medical Device
|
|
Preferred Stock Warrants
|
|
|
|
|
|
|
|
|
|
|
17
|
|
|
|
75
|
|
Concentric Medical, Inc.
|
|
Medical Device
|
|
Preferred Stock Warrants
|
|
|
|
|
|
|
|
|
|
|
9
|
|
|
|
11
|
|
EnteroMedics, Inc.(4)
|
|
Medical Device
|
|
Common Stock Warrants
|
|
|
|
|
|
|
|
|
|
|
347
|
|
|
|
10
|
|
Novalar Pharmaceuticals, Inc.
|
|
Biotechnology
|
|
Preferred Stock Warrants
|
|
|
|
|
|
|
|
|
|
|
69
|
|
|
|
79
|
|
Pharmasset, Inc.(4)
|
|
Biotechnology
|
|
Common Stock Warrants
|
|
|
|
|
|
|
|
|
|
|
251
|
|
|
|
437
|
|
PixelOptics, Inc.
|
|
Medical Device
|
|
Preferred Stock Warrants
|
|
|
|
|
|
|
|
|
|
|
61
|
|
|
|
61
|
|
Revance Therapeutics, Inc.
|
|
Biotechnology
|
|
Preferred Stock Warrants
|
|
|
|
|
|
|
|
|
|
|
156
|
|
|
|
49
|
|
Tengion, Inc.
|
|
Medical Device
|
|
Preferred Stock Warrants
|
|
|
|
|
|
|
|
|
|
|
15
|
|
|
|
50
|
|
Transave, Inc.
|
|
Biotechnology
|
|
Preferred Stock Warrants
|
|
|
|
|
|
|
|
|
|
|
12
|
|
|
|
45
|
|
ViOptix, Inc.
|
|
Medical Device
|
|
Preferred Stock Warrants
|
|
|
|
|
|
|
|
|
|
|
13
|
|
|
|
21
|
|
Xoft, Inc.
|
|
Medical Device
|
|
Preferred Stock Warrants
|
|
|
|
|
|
|
|
|
|
|
13
|
|
|
|
51
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Warrants Life Science
|
|
|
1,008
|
|
|
|
986
|
|
|
|
|
|
|
|
|
|
|
Warrants Technology 1.0%
|
|
|
|
|
|
|
|
|
Arcot Systems, Inc.
|
|
Software
|
|
Preferred Stock Warrants
|
|
|
|
|
|
|
|
|
|
|
5
|
|
|
|
57
|
|
Cartera Commerce, Inc.
|
|
Internet and media
|
|
Preferred Stock Warrants
|
|
|
|
|
|
|
|
|
|
|
16
|
|
|
|
35
|
|
Clarabridge, Inc.
|
|
Software
|
|
Preferred Stock Warrants
|
|
|
|
|
|
|
|
|
|
|
28
|
|
|
|
31
|
|
Courion Corporation
|
|
Software
|
|
Preferred Stock Warrants
|
|
|
|
|
|
|
|
|
|
|
7
|
|
|
|
16
|
|
DriveCam, Inc.
|
|
Software
|
|
Preferred Stock Warrants
|
|
|
|
|
|
|
|
|
|
|
20
|
|
|
|
15
|
|
Genesis Networks, Inc.
|
|
Networking
|
|
Preferred Stock Warrants
|
|
|
|
|
|
|
|
|
|
|
53
|
|
|
|
|
|
Grab Networks, Inc.
|
|
Networking
|
|
Preferred Stock Warrants
|
|
|
|
|
|
|
|
|
|
|
74
|
|
|
|
84
|
|
Hatteras Networks, Inc.
|
|
Communications
|
|
Preferred Stock Warrants
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
35
|
|
Impinj, Inc.
|
|
Semi-conductor
|
|
Preferred Stock Warrants
|
|
|
|
|
|
|
|
|
|
|
7
|
|
|
|
34
|
|
IntelePeer, Inc.
|
|
Networking
|
|
Preferred Stock Warrants
|
|
|
|
|
|
|
|
|
|
|
39
|
|
|
|
52
|
|
iSkoot, Inc.
|
|
Software
|
|
Preferred Stock Warrants
|
|
|
|
|
|
|
|
|
|
|
59
|
|
|
|
59
|
|
Motion Computing, Inc.
|
|
Networking
|
|
Preferred Stock Warrants
|
|
|
|
|
|
|
|
|
|
|
9
|
|
|
|
465
|
|
Netuitive, Inc.
|
|
Software
|
|
Preferred Stock Warrants
|
|
|
|
|
|
|
|
|
|
|
27
|
|
|
|
43
|
|
Plateau Systems, Ltd.
|
|
Software
|
|
Preferred Stock Warrants
|
|
|
|
|
|
|
|
|
|
|
7
|
|
|
|
34
|
|
SnagAJob.com, Inc.
|
|
Consumer-related technologies
|
|
Preferred Stock Warrants
|
|
|
|
|
|
|
|
|
|
|
23
|
|
|
|
38
|
|
Starcite, Inc.
|
|
Consumer-related technologies
|
|
Preferred Stock Warrants
|
|
|
|
|
|
|
|
|
|
|
24
|
|
|
|
28
|
|
Tagged, Inc.
|
|
Consumer-related technologies
|
|
Preferred Stock Warrants
|
|
|
|
|
|
|
|
|
|
|
17
|
|
|
|
28
|
|
Vette Corp.
|
|
Data Storage
|
|
Preferred Stock Warrants
|
|
|
|
|
|
|
|
|
|
|
27
|
|
|
|
69
|
|
Waterfront Media, Inc.
|
|
Consumer-related technologies
|
|
Preferred Stock Warrants
|
|
|
|
|
|
|
|
|
|
|
69
|
|
|
|
69
|
|
XIOtech, Inc.
|
|
Data Storage
|
|
Preferred Stock Warrants
|
|
|
|
|
|
|
|
|
|
|
22
|
|
|
|
81
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Warrants Technology
|
|
|
533
|
|
|
|
1,273
|
|
|
|
|
|
|
|
|
|
|
Warrants Healthcare information and
services 0.2%
|
|
|
|
|
|
|
|
|
BioScale, Inc.
|
|
Diagnostics
|
|
Preferred Stock Warrants
|
|
|
|
|
|
|
|
|
|
|
13
|
|
|
|
33
|
|
F & S Health Care Services, Inc.
|
|
Diagnostics
|
|
Preferred Stock Warrants
|
|
|
|
|
|
|
|
|
|
|
32
|
|
|
|
105
|
|
See Notes to Consolidated Financial Statements
70
Horizon
Technology Finance Corporation and Subsidiaries
Consolidated
Schedule of Investments
December 31,
2009 (Continued)
(In thousands)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest
|
|
|
|
|
|
Cost of
|
|
|
|
|
Portfolio Company
|
|
Sector
|
|
Type of Investment(2)
|
|
Rate(3)
|
|
|
Maturity
|
|
|
Investment(5)
|
|
|
Fair Value
|
|
|
Precision Therapeutics, Inc.
|
|
Diagnostics
|
|
Preferred Stock Warrants
|
|
|
|
|
|
|
|
|
|
|
52
|
|
|
|
61
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants Healthcare information and services
|
|
|
97
|
|
|
|
199
|
|
|
|
|
|
|
|
|
|
|
Total Warrants
|
|
|
1,638
|
|
|
|
2,458
|
|
|
|
|
|
|
|
|
|
|
Total investment assets(6)
|
|
$
|
113,058
|
|
|
$
|
113,112
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Substantially all debt and warrant investments have been pledged
as collateral under the Credit Facility. |
|
(2) |
|
All investments are less than 5% ownership of the class and
ownership of the portfolio company. |
|
(3) |
|
All interest is payable in cash due monthly in arrears, unless
otherwise indicated and applies only to the Companys debt
investments. Amount is the annual interest rate on the debt
investment and does not include any additional fees related to
the investment such as commitment fees or prepayment fees. The
majority of the debt investments are at fixed rates for the term
of the loan. For each debt investment we have provided the
current interest rate in effect as of December 31, 2009.
For variable rate debt investments we have also provided the
reference index plus the applicable spread which resets monthly. |
|
(4) |
|
Portfolio company is a public company. |
|
(5) |
|
For debt investments, represents principal balance. |
|
(6) |
|
Total investment assets in 2009 were recorded at book value net
of allowance for loan losses as follows: |
|
|
|
|
|
Book value of debt investments (at cost)
|
|
$
|
112,572
|
|
Book value of warrants investments (at fair value)
|
|
|
2,458
|
|
Unearned income
|
|
|
(1,152
|
)
|
Allowance for loan losses
|
|
|
(1,924
|
)
|
|
|
|
|
|
Net investments at book value
|
|
$
|
111,954
|
|
|
|
|
|
|
See Notes to Consolidated Financial Statements
71
Horizon
Technology Finance Corporation and Subsidiaries
Notes to
Consolidated Financial Statements
(In
thousands, except shares and per share data)
Horizon Technology Finance Corporation (the Company)
was organized as a Delaware corporation on March 16, 2010
and is an externally managed non-diversified closed end
investment company. The Company has elected to be regulated as a
business development company (BDC) under the
Investment Company Act of 1940, as amended (1940
Act). In addition, for tax purposes, the Company will
elect to be treated as a regulated investment company
(RIC) as defined in Subtitle A, Chapter 1,
under Subchapter M of the Internal Revenue Code of 1986, as
amended (the Code). As a RIC, the Company will not
be subject to federal income tax on the portion of its taxable
income and capital gains the Company distributes to the
shareholders. The Company primarily makes secured loans to
development-stage companies in the technology, life science,
healthcare information and services and cleantech industries.
On October 28, 2010 the Company completed an initial public
offering (IPO) and its common stock trades on the
NASDAQ Global Market under the symbol HRZN. The
Company was formed to continue and expand the business of
Compass Horizon Funding Company LLC (CHF), a
Delaware limited liability company, which commenced operations
in March 2008 and became the Companys wholly owned
subsidiary with the completion of the IPO.
Horizon Credit I LLC (Credit I) was formed as a
Delaware limited liability company on January 23, 2008,
with CHF as the sole equity member. Credit I is a special
purpose bankruptcy remote entity and is reported herein as a
wholly owned subsidiary of the Company. CHF sells certain
portfolio transactions to Credit I (Purchased
Assets). Credit I is a separate legal entity from CHF and
the Purchased Assets have been conveyed to Credit I and are not
available for creditors of CHF or any other entity other than
its lenders.
The Companys investment strategy is to maximize the
investment portfolios return by generating current income
from the loans made and the capital appreciation from the
warrants received when making such loans. The Company has
entered into an investment management agreement (the
Investment Management Agreement) with Horizon
Technology Finance Management LLC (HTFM or the
Advisor), under which the Advisor will manage the
day-to-day
operations of, and provide investment advisory services to the
Company.
|
|
Note 2.
|
Basis of
Presentation and Significant Accounting Policies
|
Election
to become a Business Development Company and Basis of Financial
Statement Presentation
The results of operations for 2010 are divided into two periods.
The period from January 1, 2010 through October 28,
2010, reflects the Companys results prior to operating as
a BDC under the 1940 Act. The period from October 29, 2010
through December 31, 2010, reflects the Companys
results as a BDC under the 1940 Act. Accounting principles used
in the preparation of the consolidated financial statements
beginning October 29, 2010 are different than those of
prior periods and, therefore, the financial position and results
of operations of these periods are not directly comparable. The
primary differences in accounting principles relate to the
carrying value of loan investments and classification of hedging
activity see corresponding sections below for
further discussion.
Cumulative
Effect of Business Development Company Election
|
|
|
|
|
Effect of recording loans at fair value
|
|
$
|
(348
|
)
|
Elimination of allowance for loan losses
|
|
|
1,185
|
|
|
|
|
|
|
Total cumulative effect of BDC election
|
|
$
|
837
|
|
|
|
|
|
|
In addition, the balance of the unrealized loss on interest rate
swaps included in accumulated other comprehensive loss at
October 28, 2010 of $359 was reclassified to Paid-In
Capital in Excess of Par and subsequent to October 28,
2010, changes in the fair value of the interest rate swaps are
recorded in operations.
72
Horizon
Technology Finance Corporation and Subsidiaries
Notes to
Consolidated Financial
Statements (Continued)
(In thousands, except shares and per share data)
The consolidated financial statements of the Company have been
prepared in accordance with U.S. generally accepted
accounting principles (GAAP) and pursuant to the
requirements for reporting on
Form 10-K
and Article 6 or 10 of
Regulation S-X.
In the opinion of management, the consolidated financial
statements reflect all adjustments and reclassifications that
are necessary for the fair presentation of financial results as
of and for the periods presented. All intercompany balances and
transactions have been eliminated. Certain prior period amounts
have been reclassified to conform to the current period
presentation.
Principles
of Consolidation
As permitted under
Regulation S-X
and the AICPA Audit and Accounting Guide for Investment
Companies, the Company will generally not consolidate its
investment in a company other than an investment company
subsidiary or a controlled operating company whose business
consists of providing services to the Company. Accordingly, the
Company consolidated the results of the Companys
subsidiaries in its consolidated financial statements.
Use of
Estimates
In preparing the consolidated financial statements in accordance
with GAAP, management is required to make estimates and
assumptions that affect the reported amounts of assets and
liabilities, and disclosures of contingent assets and
liabilities, as of the date of the balance sheet and income and
expenses for the period. Actual results could differ from those
estimates. Material estimates that are particularly susceptible
to significant change in the near term relate to the valuation
of loans and warrants.
Fair
Value
The Company applies fair value to substantially all of its
investments in accordance with relevant GAAP, which establishes
a framework used to measure fair value and requires disclosures
for fair value measurements. The Company has categorized its
investments carried at fair value, based on the priority of the
valuation technique, into a three-level fair value hierarchy.
Fair value is a market-based measure considered from the
perspective of the market participant who holds the financial
instrument rather than an entity specific measure. Therefore,
when market assumptions are not readily available, the
Companys own assumptions are set to reflect those that
management believes market participants would use in pricing the
financial instrument at the measurement date.
The availability of observable inputs can vary depending on the
financial instrument and is affected by a wide variety of
factors, including, for example, the type of product, whether
the product is new, whether the product is traded on an active
exchange or in the secondary market and the current market
conditions. To the extent that the valuation is based on models
or inputs that are less observable or unobservable in the
market, the determination of fair value requires more judgment.
Accordingly, the degree of judgment exercised by the Company in
determining fair value is greatest for financial instruments
classified as Level 3.
In January 2010, the FASB issued Accounting Standards Update
2010-06,
Fair Value Measurements and Disclosure Improving
Disclosures about Fair Value Measurements, which amends the
existing guidance related to fair value measurements and
disclosures. The amendments require the following new fair value
disclosures:
|
|
|
|
|
Separate disclosure of the significant transfers in and out of
Level 1 and Level 2 fair value measurements, and a
description of the reasons for the transfers.
|
|
|
|
In the roll forward of activity for Level 3 fair value
measurements (significant unobservable inputs), purchases,
sales, issuances, and settlements should be presented separately
(on a gross basis rather than as one net number).
|
73
Horizon
Technology Finance Corporation and Subsidiaries
Notes to
Consolidated Financial
Statements (Continued)
(In thousands, except shares and per share data)
In addition, the amendments clarify existing disclosure
requirements, as follows:
|
|
|
|
|
Fair value measurements and disclosures should be presented for
each class of assets and liabilities within a line item in the
balance sheet.
|
|
|
|
Reporting entities should provide disclosures about the
valuation techniques and inputs used to measure fair value for
both recurring and nonrecurring fair value measurements that
fall in either Level 2 or Level 3.
|
The new disclosures and clarifications of existing disclosures
were effective for the Companys interim and annual
reporting periods beginning after December 15, 2009, except
for the disclosures included in the roll forward of activity for
Level 3 fair value measurements, for which the effective
date is for fiscal years beginning after December 15, 2010,
and for interim periods within those fiscal years.
See Note 5 for additional information regarding fair value.
Segments
The Company has determined that it has a single reporting
segment and operating unit structure. The Company lends to and
invests in portfolio companies in various technology, life
science, healthcare information and services and cleantech
industries. The Company separately evaluates the performance of
each of its lending and investment relationships. However,
because each of these loan and investment relationships has
similar business and economic characteristics, they have been
aggregated into a single lending and investment segment.
Cash
and Cash Equivalents
Cash and cash equivalents as presented in the consolidated
balance sheets and the consolidated statements of cash flows
include bank checking accounts and money market funds with an
original maturity of less than 90 days.
Investments
Investments are recorded at fair value. The Companys board
of directors (Board) determines the fair value of
its portfolio investments. Prior to the Companys election
to become a BDC, loan investments were stated at current unpaid
principal balances adjusted for the allowance for loan losses,
unearned income and any unamortized deferred fees or costs.
The Company has the intent to hold its loans for the foreseeable
future or until maturity or payoff.
Interest on loan investments is accrued and included in income
based on contractual rates applied to principal amounts
outstanding. Interest income is determined using a method that
results in a level rate of return on principal amounts
outstanding. When a loan becomes 90 days or more past due,
or if the Company otherwise does not expect to receive interest
and principal repayments, the loan is placed on non-accrual
status and the recognition of interest income is discontinued.
Interest payments received on loans that are on non-accrual
status are treated as reductions of principal until the
principal is repaid. No loans were on non-accrual status as of
December 31, 2010 and 2009.
The Company receives a variety of fees from borrowers in the
ordinary course of conducting its business, including advisory
fees, commitment fees, amendment fees, non-utilization fees and
prepayment fees (collectively, the Fees). In a
limited number of cases, the Company may also receive a
non-refundable deposit earned upon the termination of a
transaction. Loan origination fees, net of certain direct
origination costs, are deferred, and along with unearned income,
are amortized as a level yield adjustment over the respective
term of the loan. Fees for counterparty loan commitments with
multiple loans are allocated to each loan based upon each
loans relative fair value. When a loan is placed on
non-accrual status, the amortization of the related fees and
unearned income is discontinued until the loan is returned to
accrual status.
74
Horizon
Technology Finance Corporation and Subsidiaries
Notes to
Consolidated Financial
Statements (Continued)
(In thousands, except shares and per share data)
Certain loan agreements also require the borrower to make an
end-of-term
payment that is accrued into income over the life of the loan to
the extent such amounts are expected to be collected. The
Company will generally cease accruing the income if there is
insufficient value to support the accrual or the Company does
not expect the borrower to be able to pay all principal and
interest due.
In connection with substantially all lending arrangements, the
Company receives warrants to purchase shares of stock from the
borrower. The warrants are recorded as assets at estimated fair
value on the grant date using the Black-Scholes valuation model.
The warrants are considered loan fees and are also recorded as
unearned loan income on the grant date. The unearned income is
recognized as interest income over the contractual life of the
related loan in accordance with the Companys income
recognition policy. Subsequent to loan origination, the warrants
are also measured at fair value using the Black-Scholes
valuation model. Any adjustment to fair value is recorded
through earnings as net unrealized gain or loss on investments.
Gains from the disposition of the warrants or stock acquired
from the exercise of warrants are recognized as realized gains
on investments.
See Note 5 for additional information regarding fair value.
Allowance
for Loan Losses
Prior to the Companys election to become a BDC, the
allowance for loan losses represented managements estimate
of probable loan losses inherent in the loan portfolio as of the
balance sheet date. The estimation of the allowance was based on
a variety of factors, including past loan loss experience, the
current credit profile of the Companys borrowers, adverse
situations that had occurred that may affect individual
borrowers ability to repay, the estimated value of
underlying collateral and general economic conditions. The loan
portfolio is comprised of large balance loans that are evaluated
individually for impairment and are risk-rated based upon a
borrowers individual situation, current economic
conditions, collateral and industry-specific information that
management believes is relevant in determining the potential
occurrence of a loss event and in measuring impairment. The
allowance for loan losses was sensitive to the risk rating
assigned to each of the loans and to corresponding qualitative
loss factors that the Company used to estimate the allowance.
Those factors were applied to the outstanding loan balances in
estimating the allowance for loan losses. If necessary, based on
performance factors related to specific loans, specific
allowances for loan losses were established for individual
impaired loans. Increases or decreases to the allowance for loan
losses were charged or credited to current period earnings
through the provision (credit) for loan losses. Amounts
determined to be uncollectible were charged against the
allowance for loan losses, while amounts recovered on previously
charged-off loans increased the allowance for loan losses.
A loan was considered impaired when, based on current
information and events, it was probable that the Company was
unable to collect the scheduled payments of principal or
interest when due according to the contractual terms of the loan
agreement. Factors considered by management in determining
impairment included payment status, collateral value, and the
probability of collecting scheduled principal and interest
payments when due. Loans that experienced insignificant payment
delays and payment shortfalls generally were not classified as
impaired. Management determined the significance of payment
delays and payment shortfalls on a
case-by-case
basis, taking into consideration all of the circumstances
surrounding the loan and the borrower, including the length of
the delay, the reasons for the delay, the borrowers prior
payment record, and the amount of the shortfall in relation to
the principal and interest owed. Impairment was measured on a
loan by loan basis by either the present value of expected
future cash flows discounted at the loans effective
interest rate, the loans observable market price, or the
fair value of the collateral, if the loan was collateral
dependent.
Impaired loans also included loans modified in troubled debt
restructurings where concessions had been granted to borrowers
experiencing financial difficulties. These concessions could
include a reduction in the interest rate on the loan, payment
extensions, forgiveness of principal, forbearance or other
actions intended to maximize collection. There were no impaired
loans or troubled debt restructured loans at December 31,
2009.
75
Horizon
Technology Finance Corporation and Subsidiaries
Notes to
Consolidated Financial
Statements (Continued)
(In thousands, except shares and per share data)
Debt
Issuance Costs
Debt issuance costs are fees and other direct incremental costs
incurred by the Company in obtaining debt financing from its
lender and are recognized as assets and are amortized as
interest expense over the term of the related Credit Facility.
The unamortized balance of debt issuance costs as of
December 31, 2010 and 2009 was $194 and $1,355,
respectively. The amortization expense for the period from
October 29, 2010 to December 31, 2010, the period from
January 1, 2010 to October 28, 2010 and the years
ended December 31, 2009 and 2008 relating to debt issuance
costs was $200, $962, $1,123 and $953, respectively.
Income
Taxes
The Company intends to elect to be treated as a RIC under
subchapter M of the Code and operates in a manner so as to
qualify for the tax treatment applicable to RICs. In order to
qualify as a RIC, among other things, the Company is required to
meet certain source of income and asset diversification
requirements and timely distribute to its stockholders at least
90% of investment company taxable income, as defined by the
Code, for each year. The Company, among other things, has made
and intends to continue to make the requisite distributions to
its stockholders, which will generally relieve the Company from
U.S. federal income taxes.
Depending on the level of taxable income earned in a tax year,
the Company may choose to carry forward taxable income in excess
of current year dividend distributions into the next tax year
and pay a 4% excise tax on such income, as required. To the
extent that the Company determines that its estimated current
year annual taxable income will be in excess of estimated
current year dividend distributions, the Company accrues excise
tax, if any, on estimated excess taxable income as taxable
income is earned. For the period from October 29, 2010 to
December 31, 2010 no amount was recorded for
U.S. federal excise tax.
The Company evaluates tax positions taken in the course of
preparing the Companys tax returns to determine whether
the tax positions are more-likely-than-not to be
sustained by the applicable tax authority. Tax benefits of
positions not deemed to meet the more-likely-than-not threshold,
or uncertain tax positions, would be recorded as a tax expense
in the current year. It is the Companys policy to
recognize accrued interest and penalties related to uncertain
tax benefits in income tax expense. There were no material
uncertain tax positions at December 31, 2010 and 2009. The
2008 and 2009 tax years remain subject to examination by
U.S. federal and state tax authorities.
Prior to the Companys election to become a BDC, the
Company was a limited liability company treated as a partnership
for U.S. federal income tax purposes and, as a result, all
items of income and expense were passed through to, and are
generally reportable on, the tax returns of the respective
members of the limited liability company. Therefore, no federal
or state income tax provision has been recorded for the period
from January 1, 2010 to October 28, 2010 and the years
ended December 31, 2009 and 2008.
Dividends
Dividends and distributions to common stockholders are recorded
on the declaration date. The amount to be paid out as a dividend
is determined by the Board each. Net realized capital gains, if
any, are distributed at least annually, although the Company may
decide to retain such capital gains for investment.
The Company has adopted a dividend reinvestment plan that
provides for reinvestment of cash distributions and other
distributions on behalf of its stockholders, unless a
stockholder elects to receive cash. As a result, if the Board
authorizes, and the Company declares, a cash dividend, then
stockholders who have not opted out of the dividend
reinvestment plan will have their cash dividends automatically
reinvested in additional shares of the Companys common
stock, rather than receiving the cash dividend. The Company may
use newly issued shares to implement the plan (especially if the
Companys shares are trading at a premium to net asset
value), or the Company may purchase shares in the open market in
connection with the obligations under the plan.
76
Horizon
Technology Finance Corporation and Subsidiaries
Notes to
Consolidated Financial
Statements (Continued)
(In thousands, except shares and per share data)
Interest
Rate Swaps and Hedging Activities
The Company entered into interest rate swap agreements to manage
interest rate risk. The Company does not hold or issue interest
rate swap agreements or other derivative financial instruments
for speculative purposes.
Subsequent to the Companys election to become a BDC, the
interest rate swaps are recorded at fair value with changes in
fair value reflected in net unrealized appreciation or
depreciation of investments during the reporting period. The
Company records the accrual of periodic interest settlements of
interest rate swap agreements in net unrealized appreciation or
depreciation of investments and subsequently records the amount
as a net realized gain or loss on investments on the interest
settlement date. Cash payments received or paid for the
termination of an interest rate swap agreement would be recorded
as a realized gain or loss upon termination in the consolidated
statements of operations.
Prior to the Companys election to become a BDC, the
Company recognized its interest rate swap derivatives on the
balance sheet as either an asset or liability measured at fair
value. Changes in the derivatives fair value were
recognized in income unless specific hedge accounting criteria
were met. Special accounting for qualifying hedges allows a
derivatives gains and losses to offset related results on
the hedged item in the statement of operations and required the
Company to formally document, designate and assess effectiveness
of transactions that receive hedge accounting. Derivatives that
are not hedges are adjusted to fair value through earnings. If
the derivative qualifies as a hedge, depending on the nature of
the hedge, changes in the fair value of derivatives are either
offset against the change in fair value of hedged assets,
liabilities, or firm commitments through earnings, or recognized
in other comprehensive income until the hedged item is
recognized in earnings. The ineffective portion of a
derivatives change in fair value, if any, would have been
recognized as interest expense.
Transfers
of Financial Assets
Transfers of financial assets are accounted for as sales, when
control over the assets has been surrendered. Control over
transferred assets is deemed to be surrendered when (1) the
assets have been isolated from the Company put
presumptively beyond the reach of the transferor and its
creditors, even in bankruptcy or other receivership,
(2) the transferee obtains the right (free of conditions
that constrain it from taking advantage of that right) to pledge
or exchange the transferred assets, and (3) the transferor
does not maintain effective control over the transferred assets
through either (a) an agreement that both entitles and
obligates the transferor to repurchase or redeem the assets
before maturity or (b) the ability to unilaterally cause
the holder to return specific assets, other than through a
cleanup call.
In June 2009, the Financial Accounting Standards Board (the
FASB) issued guidance which modified certain
guidance relating to transfers and servicing of financial
assets. This guidance eliminates the concept of qualifying
special purpose entities, provides guidance as to when a portion
of a transferred financial asset can be evaluated for sale
accounting, provides additional guidance with regard to
accounting for transfers of financial assets and requires
additional disclosures. This guidance was effective for the
Company as of January 1, 2010, with adoption applied
prospectively for transfers that occurred on and after the
effective date. The adoption of this guidance did not have an
impact on the Companys financial statements.
|
|
Note 3.
|
Related
Party Transactions
|
Investment
Management Agreement
On October 28, 2010 the Company entered into the Investment
Management Agreement with the Advisor, under which the Advisor
manages the
day-to-day
operations of, and provides investment advisory services to the
Company. Under the terms of the Investment Management Agreement,
the Advisor determines the composition of the Companys
investment portfolio, the nature and timing of the changes to
the investment portfolio and the manner of implementing such
changes; identifies, evaluates and negotiates the structure of
the investments the
77
Horizon
Technology Finance Corporation and Subsidiaries
Notes to
Consolidated Financial
Statements (Continued)
(In thousands, except shares and per share data)
Company makes (including performing due diligence on the
Companys prospective portfolio companies); and closes,
monitors and administers the investments the Company makes,
including the exercise of any voting or consent rights.
The Advisors services under the Investment Management
Agreement are not exclusive to the Company, and the Advisor is
free to furnish similar services to other entities so long as
its services to the Company are not impaired. The Advisor is a
registered investment advisor with the SEC. The Advisor receives
fees for providing services, consisting of two components, a
base management fee and an incentive fee.
The base management fee is calculated at an annual rate of 2.00%
of the Companys gross assets, payable monthly in arrears.
For purposes of calculating the base management fee, the term
gross assets includes any assets acquired with the
proceeds of leverage.
The incentive fee has two parts, as follows:
The first part is calculated and payable quarterly in arrears
based on the Companys pre-incentive fee net investment
income for the immediately preceding calendar quarter. For this
purpose, pre-incentive fee net investment income means interest
income, dividend income and any other income (including any
other fees (other than fees for providing managerial
assistance), such as commitment, origination, structuring,
diligence and consulting fees or other fees received from
portfolio companies) accrued during the calendar quarter, minus
operating expenses for the quarter (including the base
management fee, expenses payable under the administration
agreement (as defined below), and any interest expense and any
dividends paid on any issued and outstanding preferred stock,
but excluding the incentive fee). Pre-incentive fee net
investment income includes, in the case of investments with a
deferred interest feature (such as original issue discount, debt
instruments with
payment-in-kind
interest and zero coupon securities), accrued income that we
have not yet received in cash. The incentive fee with respect to
the pre-incentive fee net income is 20.00% of the amount, if
any, by which the pre-incentive fee net investment income for
the immediately preceding calendar quarter exceeds a 1.75%
(which is 7.00% annualized) hurdle rate and a
catch-up
provision measured as of the end of each calendar quarter. Under
this provision, in any calendar quarter, the Advisor receives no
incentive fee until the net investment income equals the hurdle
rate of 1.75%, but then receives, as a
catch-up,
100.00% of the pre-incentive fee net investment income with
respect to that portion of such pre-incentive fee net investment
income, if any, that exceeds the hurdle rate but is less than
2.1875%. The effect of this provision is that, if pre-incentive
fee net investment income exceeds 2.1875% in any calendar
quarter, the Advisor will receive 20.00% of the pre-incentive
fee net investment income as if a hurdle rate did not apply.
Pre-incentive fee net investment income does not include any
realized capital gains, realized capital losses or unrealized
capital appreciation or depreciation. Because of the structure
of the incentive fee, it is possible that the Company may pay an
incentive fee in a quarter in which the Company incurs a loss.
For example, if the Company receives pre-incentive fee net
investment income in excess of the quarterly minimum hurdle
rate, the Company will pay the applicable incentive fee even if
the Company has incurred a loss in that quarter due to realized
and unrealized capital losses. The Companys net investment
income used to calculate this part of the incentive fee is also
included in the amount of the Companys gross assets used
to calculate the 2.00% base management fee. These calculations
are appropriately prorated for any period of less than three
months and adjusted for any share issuances or repurchases
during the current quarter. The base management fee expense was
$668 for the period from October 29, 2010 through
December 31, 2010 and the accrued management fee was $360
as of December 31, 2010.
The second part of the incentive fee is determined and payable
in arrears as of the end of each calendar year (or upon
termination of the investment management agreement, as of the
termination date), commencing on December 31, 2010, and
equals 20% of the Companys aggregate realized capital
gains, if any, on a cumulative basis from the date of the
election to be a BDC through the end of each calendar year,
computed net
78
Horizon
Technology Finance Corporation and Subsidiaries
Notes to
Consolidated Financial
Statements (Continued)
(In thousands, except shares and per share data)
of all realized capital losses and unrealized capital
depreciation through the end of such year, less all previous
amounts paid in respect of the capital gain incentive fee;
provided that the incentive fee determined as of
December 31, 2010 is calculated for a period of shorter
than twelve calendar months to take into account any realized
capital gains computed net of all realized capital losses and
unrealized capital depreciation for the period beginning on the
date of the Companys election to be a BDC and ending
December 31, 2010. The incentive fee expense was $414 for
the period from October 29, 2010 through December 31,
2010 and the incentive fee payable was $414 as of
December 31, 2010.
Prior to the Companys election to become a BDC, the
Advisor served as the Advisor for CHF under a Management and
Services Agreement which provided for management fees to be paid
monthly at a rate of 2.0% per annum of the gross investment
assets of CHF. Total management fee expense was $2,019 for the
period from January 1, 2010 to October 28, 2010, and
$2,202 and $1,073 for the years ended December 31, 2009 and
2008, respectively.
Administration
Agreement
The Company entered into an administration agreement with the
Advisor to provide administrative services to the Company. For
providing these services, facilities and personnel, the Company
will reimburse the Advisor for the Companys allocable
portion of overhead and other expenses incurred by the Advisor
in performing its obligations under the administration
agreement, including rent, the fees and expenses associated with
performing compliance functions, and the Companys
allocable portion of the costs of compensation and related
expenses of the Companys chief compliance officer and
chief financial officer and their respective staffs. During the
period from October 29, 2010 to December 31, 2010, $88
was charged to operations under this agreement.
From time to time, the Advisor may pay amounts owed by the
Company to third-party providers of goods or services. The
Company will subsequently reimburse the Advisor for such amounts
paid on the Companys behalf.
Investments, all of which are with portfolio companies in the
United States, consisted of the following:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2010
|
|
|
December 31, 2009
|
|
|
|
Cost
|
|
|
Fair Value
|
|
|
Book Value
|
|
|
Fair Value
|
|
|
Debt
|
|
$
|
130,282
|
|
|
$
|
130,234
|
|
|
$
|
109,496
|
|
|
$
|
110,654
|
|
Warrants
|
|
|
2,843
|
|
|
|
6,225
|
|
|
|
2,458
|
|
|
|
2,458
|
|
Equity
|
|
|
369
|
|
|
|
351
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
133,494
|
|
|
$
|
136,810
|
|
|
$
|
111,954
|
|
|
$
|
113,112
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
79
Horizon
Technology Finance Corporation and Subsidiaries
Notes to
Consolidated Financial
Statements (Continued)
(In thousands, except shares and per share data)
The following table shows the Companys investments by
industry sector. The book value as of December 31, 2009
excludes the effect of the allowance for loan loss of $1,924.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2010
|
|
|
December 31, 2009
|
|
|
|
Cost
|
|
|
Fair Value
|
|
|
Book Value
|
|
|
Fair Value
|
|
|
Life Science
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Biotechnology
|
|
$
|
31,138
|
|
|
$
|
31,614
|
|
|
$
|
22,426
|
|
|
$
|
22,426
|
|
Medical Device
|
|
|
20,472
|
|
|
|
21,317
|
|
|
|
16,355
|
|
|
|
16,255
|
|
Technology
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Consumer-related Technologies
|
|
|
4,592
|
|
|
|
4,692
|
|
|
|
15,342
|
|
|
|
15,342
|
|
Networking
|
|
|
2,405
|
|
|
|
3,120
|
|
|
|
15,162
|
|
|
|
14,762
|
|
Software
|
|
|
9,042
|
|
|
|
9,062
|
|
|
|
13,143
|
|
|
|
13,143
|
|
Data Storage
|
|
|
8,010
|
|
|
|
8,042
|
|
|
|
9,174
|
|
|
|
9,174
|
|
Internet and Media
|
|
|
16
|
|
|
|
38
|
|
|
|
2,518
|
|
|
|
2,518
|
|
Communications
|
|
|
7,681
|
|
|
|
7,719
|
|
|
|
2,492
|
|
|
|
2,492
|
|
Semiconductors
|
|
|
7
|
|
|
|
|
|
|
|
900
|
|
|
|
900
|
|
Healthcare Information and Services
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diagnostics
|
|
|
20,745
|
|
|
|
21,044
|
|
|
|
16,366
|
|
|
|
16,100
|
|
Other healthcare related services
|
|
|
9,934
|
|
|
|
9,938
|
|
|
|
|
|
|
|
|
|
Cleantech
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Energy efficiency
|
|
|
16,977
|
|
|
|
17,749
|
|
|
|
|
|
|
|
|
|
Waste recycling
|
|
|
2, 475
|
|
|
|
2,475
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
133,494
|
|
|
$
|
136,810
|
|
|
$
|
113,878
|
|
|
$
|
113,112
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The Company uses fair value measurements to record fair value
adjustments to certain assets and liabilities and to determine
fair value disclosures. Fair value is the price that would be
received to sell an asset or paid to transfer a liability in an
orderly transaction between market participants at the
measurement date. Fair value is best determined based upon
quoted market prices. However, in certain instances, there are
no quoted market prices for certain assets or liabilities. In
cases where quoted market prices are not available, fair values
are based on estimates using present value or other valuation
techniques. Those techniques are significantly affected by the
assumptions used, including the discount rate and estimates of
future cash flows. Accordingly, the fair value estimates may not
be realized in an immediate settlement of the asset or liability.
Fair value measurements focus on exit prices in an orderly
transaction (that is, not a forced liquidation or distressed
sale) between market participants at the measurement date under
current market conditions. If there has been a significant
decrease in the volume and level of activity for the asset or
liability, a change in valuation technique or the use of
multiple valuation techniques may be appropriate. In such
instances, determining the price at which willing market
participants would transact at the measurement date under
current market conditions depends on the facts and circumstances
and requires the use of significant judgment.
The Companys fair value measurements are classified into a
fair value hierarchy based on the markets in which the assets
and liabilities are traded and the reliability of the
assumptions used to determine fair value. The three categories
within the hierarchy are as follows:
|
|
|
|
Level 1
|
Quoted prices in active markets for identical assets and
liabilities.
|
80
Horizon
Technology Finance Corporation and Subsidiaries
Notes to
Consolidated Financial
Statements (Continued)
(In thousands, except shares and per share data)
|
|
|
|
Level 2
|
Observable inputs other than Level 1 prices such as quoted
prices for similar assets or liabilities in active markets,
quoted prices in markets that are not active, and model-based
valuation techniques for which all significant inputs are
observable or can be corroborated by observable market data for
substantially the full term of the assets or liabilities.
|
|
|
Level 3
|
Unobservable inputs that are supported by little or no market
activity and that are significant to the fair value of the
assets or liabilities. Level 3 assets and liabilities
include financial instruments whose value is determined using
pricing models, discounted cash flow methodologies, or similar
techniques, as well as instruments for which the determination
of fair value requires significant management judgment or
estimation.
|
Cash and cash equivalents and interest
receivable: The carrying amount is a reasonable
estimate of fair value. These financial instruments are not
recorded at fair value on a recurring basis.
Loans: For variable rate loans which re-price
frequently and have no significant change in credit risk,
carrying values are a reasonable estimate of fair values,
adjusted for credit losses inherent in the portfolio. The fair
value of fixed rate loans is estimated by discounting the future
cash flows using the year end rates at which similar loans would
be made to borrowers with similar credit ratings and for the
same remaining maturities, adjusted for credit losses inherent
in the portfolio. Therefore, the Company has categorized loan
investments as Level 3 within the fair value hierarchy
described above. Upon the Companys election to become a
BDC, these financial instruments are recorded at fair value on a
recurring basis.
Warrants: The Company values its warrants
using the Black-Scholes valuation model incorporating the
following material assumptions:
|
|
|
|
|
Underlying asset value of the issuer is estimated based on
information available, including any information regarding the
most recent rounds of borrower funding.
|
|
|
|
Volatility, or the amount of uncertainty or risk about the size
of the changes in the warrant price, is based on guideline
publicly traded companies within indices similar in nature to
the underlying company issuing the warrant. A total of seven
such indices were used. The weighted average volatility
assumptions used for the warrant valuation at December 31,
2010, 2009 and 2008 were 30%, 29% and 25%, respectively.
|
|
|
|
The risk-free interest rates are derived from the
U.S. Treasury yield curve. The risk-free interest rates are
calculated based on a weighted average of the risk-free interest
rates that correspond closest to the expected remaining life of
the warrant.
|
|
|
|
Other adjustments, including a marketability discount on private
company warrants, are estimated based on managements
judgment about the general industry environment. The
marketability discount used for the warrant valuation at
December 31, 2010, 2009 and 2008 was 20%.
|
The fair value of the Companys warrants held in publicly
traded companies is determined based on inputs that are readily
available in public markets or can be derived from information
available in public markets. Therefore, the Company has
categorized these warrants as Level 2 within the fair value
hierarchy described in Note 2. The fair value of the
Companys warrants held in private companies is determined
using both observable and unobservable inputs and represents
managements best estimate of what market participants
would use in pricing the warrants at the measurement date.
Therefore, the Company has categorized these warrants as
Level 3 within the fair value hierarchy described above.
These financial instruments are recorded at fair value on a
recurring basis.
Borrowings: The carrying amount of borrowings
under the revolving credit facility approximates its fair value
due to the short duration and variable interest rate of this
debt. Additionally, the Company considers its creditworthiness
in determining the fair value of such borrowings. These
financial instruments are not recorded at fair value on a
recurring basis.
81
Horizon
Technology Finance Corporation and Subsidiaries
Notes to
Consolidated Financial
Statements (Continued)
(In thousands, except shares and per share data)
Interest rate swap derivatives: The fair value
of the Companys interest rate swap derivative instruments
is estimated as the amount the Company would pay to terminate
its swaps at the balance sheet date, taking into account current
interest rates and the creditworthiness of the counterparty for
assets and the creditworthiness of the Company for liabilities.
The Company has categorized these derivative instruments as
Level 2 within the fair value hierarchy described above.
These financial instruments are recorded at fair value on a
recurring basis.
Off-balance-sheet instruments: Fair values for
off-balance-sheet lending commitments are based on fees
currently charged to enter into similar agreements, taking into
account the remaining terms of the agreements and the
counterparties credit standings. Off-balance-sheet
instruments are not recorded at fair value on a recurring basis.
The following tables detail the financial instruments that are
carried at fair value and measured at fair value on a recurring
basis as of December 31, 2010 and 2009, and indicate the
fair value hierarchy of the valuation techniques utilized by the
Company to determine the fair value:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2010
|
|
|
|
Total
|
|
|
Level 1
|
|
|
Level 2
|
|
|
Level 3
|
|
|
Loan investments
|
|
$
|
130,234
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
130,234
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity investments
|
|
$
|
351
|
|
|
$
|
209
|
|
|
$
|
|
|
|
$
|
142
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant investments
|
|
$
|
6,225
|
|
|
$
|
|
|
|
$
|
1,976
|
|
|
$
|
4,249
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rate swap liability
|
|
$
|
258
|
|
|
$
|
|
|
|
$
|
258
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2009
|
|
|
|
Total
|
|
|
Level 1
|
|
|
Level 2
|
|
|
Level 3
|
|
|
Warrant Assets
|
|
$
|
2,458
|
|
|
$
|
|
|
|
$
|
448
|
|
|
$
|
2,010
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest Rate Swap Liability
|
|
$
|
768
|
|
|
$
|
|
|
|
$
|
768
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The following table shows a reconciliation of the beginning and
ending balances for Level 3 assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Post-IPO as a BDC
|
|
|
|
October 29, 2010 to December 31, 2010
|
|
|
|
Loan
|
|
|
Warrant
|
|
|
Equity
|
|
|
|
|
|
|
Investments
|
|
|
Investments
|
|
|
Investments
|
|
|
Total
|
|
|
Level 3 assets, beginning of period
|
|
$
|
|
|
|
$
|
3,715
|
|
|
$
|
|
|
|
$
|
3,715
|
|
Transfers into Level 3 upon election to BDC
|
|
|
125,741
|
|
|
|
|
|
|
|
142
|
|
|
|
125,883
|
|
Purchase of investments
|
|
|
19,316
|
|
|
|
|
|
|
|
|
|
|
|
19,316
|
|
Warrants received and classified as Level 3
|
|
|
|
|
|
|
192
|
|
|
|
|
|
|
|
192
|
|
Principal payments received on investments
|
|
|
(14,273
|
)
|
|
|
|
|
|
|
|
|
|
|
(14,273
|
)
|
Unrealized (depreciation)/ appreciation included in earnings
|
|
|
(48
|
)
|
|
|
528
|
|
|
|
|
|
|
|
480
|
|
Other
|
|
|
(502
|
)
|
|
|
(186
|
)
|
|
|
|
|
|
|
(688
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Level 3 assets, end of period
|
|
$
|
130,234
|
|
|
$
|
4,249
|
|
|
$
|
142
|
|
|
$
|
134,625
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
82
Horizon
Technology Finance Corporation and Subsidiaries
Notes to
Consolidated Financial
Statements (Continued)
(In thousands, except shares and per share data)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pre-IPO Prior to becoming a BDC
|
|
|
|
January 1,
|
|
|
|
|
|
March 4,
|
|
|
|
2010
|
|
|
|
|
|
2008
|
|
|
|
through
|
|
|
Year Ended
|
|
|
through
|
|
|
|
October 28,
|
|
|
December 31,
|
|
|
December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
2008
|
|
|
Warrants
|
|
|
|
|
|
|
|
|
|
|
|
|
Level 3 assets, beginning of period
|
|
$
|
2,010
|
|
|
$
|
557
|
|
|
$
|
|
|
Warrants received and classified as Level 3
|
|
|
927
|
|
|
|
535
|
|
|
|
515
|
|
Unrealized appreciation included in earnings
|
|
|
780
|
|
|
|
918
|
|
|
|
42
|
|
Other
|
|
|
(2
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Level 3 assets, end of period
|
|
$
|
3,715
|
|
|
$
|
2,010
|
|
|
$
|
557
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The total change in unrealized appreciation
(depreciation)included in the statement of operations
attributable to Level 3 investments still held at
December 31, 2010 includes $48 depreciation on loans and
$1,505 appreciation on warrants.
The Company discloses fair value information about financial
instruments, whether or not recognized in the statement of
assets and liabilities, for which it is practicable to estimate
that value. Certain financial instruments are excluded from the
disclosure requirements. Accordingly, the aggregate fair value
amounts presented do not represent the underlying value of the
Company.
The fair value amounts for 2010 and 2009 have been measured as
of the year-end date, and have not been reevaluated or updated
for purposes of these financial statements subsequent to that
date. As such, the fair values of these financial instruments
subsequent to the reporting date may be different than amounts
reported at year-end.
As of December 31, 2010 and 2009, the recorded book
balances and fair values of the Companys financial
instruments were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2010
|
|
December 31, 2009
|
|
|
Recorded
|
|
|
|
Recorded
|
|
|
|
|
Book
|
|
|
|
Book
|
|
|
|
|
Balance
|
|
Fair Value
|
|
Balance
|
|
Fair Value
|
|
Financial Assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash & cash equivalents
|
|
$
|
76,793
|
|
|
$
|
76,793
|
|
|
$
|
9,892
|
|
|
$
|
9,892
|
|
Investments:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt
|
|
$
|
130,234
|
|
|
$
|
130,234
|
|
|
$
|
109,496
|
|
|
$
|
110,654
|
|
Warrants
|
|
$
|
6,225
|
|
|
$
|
6,225
|
|
|
$
|
2,458
|
|
|
$
|
2,458
|
|
Equity
|
|
$
|
351
|
|
|
$
|
351
|
|
|
$
|
|
|
|
$
|
|
|
Interest receivable
|
|
$
|
1,938
|
|
|
$
|
1,938
|
|
|
$
|
1,452
|
|
|
$
|
1,452
|
|
Financial Liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Borrowings
|
|
$
|
87,425
|
|
|
$
|
87,425
|
|
|
$
|
64,166
|
|
|
$
|
64,166
|
|
Interest rate swap liability
|
|
$
|
258
|
|
|
$
|
258
|
|
|
$
|
768
|
|
|
$
|
768
|
|
Off-balance-sheet
instruments
The Company assumes interest rate risk (the risk that general
interest rate levels will change) as a result of its normal
operations. As a result, the fair values of the Companys
financial instruments will change when interest rate levels
change and that change may be either favorable or unfavorable to
the Company. Management attempts to match maturities of assets
and liabilities to the extent believed necessary to minimize
interest rate risk. Management
83
Horizon
Technology Finance Corporation and Subsidiaries
Notes to
Consolidated Financial
Statements (Continued)
(In thousands, except shares and per share data)
monitors rates and maturities of assets and liabilities and
attempts to minimize interest rate risk by adjusting terms of
new loans and by investing in securities with terms that
mitigate the Companys overall interest rate risk.
In accordance with the 1940 Act, with certain limited
exceptions, the Company is only allowed to borrow amounts such
that the asset coverage, as defined in the 1940 Act, is at least
200% after such borrowings. As of December 31, 2010, the
asset coverage for borrowed amounts was 243%.
The Company entered into a Revolving Credit Facility (the
Credit Facility) with WestLB, AG, New York Branch
(WestLB) effective March 4, 2008. The facility
limit is $125 million at December 31, 2010.
The Credit Facility has a three year initial revolving term and
on March 3, 2011 the revolving term ended. The balance at
that time of $92,712 will be amortized based on loan investment
payments received over four years. The interest rate is based
upon the one-month LIBOR plus a spread of 2.50%. The rates at
December 31, 2010 and 2009 were 2.76% and 2.73%,
respectively, and the average rates for the years ending
December 31, 2010, 2009 and 2008 were 2.78%, 2.85%, and
5.00%, respectively.
The Credit Facility is collateralized by all loans and warrants
held by the Companys subsidiary, Credit I and permits an
advance rate of up to 75% of eligible loans held by the Credit
I. The Credit Facility contains covenants that, among other
things, require the Company to maintain a minimum net worth and
to restrict the loans securing the Credit Facility to certain
criteria for qualified loans, and includes portfolio company
concentration limits as defined in the related loan agreement.
The average amounts of borrowings were approximately $77,000 and
$71,000 for the years ended December 31, 2010 and 2009,
respectively. At December 31, 2010 the Company had
available borrowing capacity of approximately $37,500 and had
actual borrowings outstanding of $87,425 on the Credit Facility.
|
|
Note 7.
|
Federal
Income Tax
|
The Company intends to elect to be treated as a RIC under
Subchapter M of the Code, and to distribute substantially all of
its respective net taxable income. Accordingly, no provision for
federal income tax has been recorded in the financial
statements. Taxable income differs from net increase in net
assets resulting from operations primarily due to unrealized
appreciation on investments as investment gains and losses are
not included in taxable income until they are realized.
The following reconciles net increase in net assets resulting
from operations to taxable income for the period from
October 29, 2010 to December 31, 2010:
|
|
|
|
|
Net increase in net assets resulting from operations
|
|
$
|
3,419
|
|
Net unrealized appreciation on investments
|
|
|
(1,449
|
)
|
Other temporary differences
|
|
|
143
|
|
|
|
|
|
|
Taxable income before deductions for distributions
|
|
$
|
2,113
|
|
|
|
|
|
|
The tax character of distributions paid during the period from
October 29, 2010 to December 31, 2010 was as follows:
|
|
|
|
|
Ordinary income
|
|
$
|
1,502
|
|
Long-term capital gains
|
|
|
160
|
|
|
|
|
|
|
Total
|
|
$
|
1,662
|
|
|
|
|
|
|
84
Horizon
Technology Finance Corporation and Subsidiaries
Notes to
Consolidated Financial
Statements (Continued)
(In thousands, except shares and per share data)
As of December 31, 2010 the components of undistributed
ordinary income earnings on a tax basis were as follows:
|
|
|
|
|
Undistributed long-term gain
|
|
|
451
|
|
Unrealized appreciation
|
|
|
1,449
|
|
|
|
|
|
|
Total
|
|
$
|
1,900
|
|
|
|
|
|
|
|
|
Note 8.
|
Financial
Instruments with Off-Balance-Sheet Risk
|
In the normal course of business, the Company is party to
financial instruments with off-balance-sheet risk to meet the
financing needs of its borrowers. These financial instruments
include commitments to extend credit and involve, to varying
degrees, elements of credit risk in excess of the amount
recognized in the consolidated balance sheet. The Company
attempts to limit its credit risk by conducting extensive due
diligence and obtaining collateral where appropriate.
The balance of unfunded commitments to extend credit was
approximately $26,500 and $5,400 as of December 31, 2010
and 2009, respectively. Commitments to extend credit consist
principally of the unused portions of commitments that obligate
the Company to extend credit, such as revolving credit
arrangements or similar transactions. Commitments may also
include a financial or non-financial milestone that has to be
achieved before the commitment can be drawn. Commitments
generally have fixed expiration dates or other termination
clauses. Since commitments may expire without being drawn upon,
the total commitment amounts do not necessarily represent future
cash requirements.
|
|
Note 9.
|
Concentrations
of Credit Risk
|
The Companys loan portfolio consists primarily of loans to
development-stage companies at various stages of development in
the technology, life science, healthcare information and
services and cleantech industries. Many of these companies may
have relatively limited operating histories and also may
experience variation in operating results. Many of these
companies conduct business in regulated industries and could be
affected by changes in government regulations. Most of the
Companys borrowers will need additional capital to satisfy
their continuing working capital needs and other requirements,
and in many instances, to service the interest and principal
payments on the loans.
The largest loans may vary from year to year as new loans are
recorded and repaid. The Companys five largest loans
represented approximately 31% and 28% of total loans outstanding
as of December 31, 2010 and 2009, respectively. No single
loan represents more than 10% of the total loans as of
December 31, 2010 and 2009. Loan income, consisting of
interest and fees, can fluctuate significantly upon repayment of
large loans. Interest income from the five largest loans
accounted for approximately 22%, 23% and 21% of total loan
interest and fee income for the years ended December 31,
2010, 2009 and 2008, respectively.
|
|
Note 10:
|
Interest
Rate Swaps and Hedging Activities
|
On October 14, 2008, the Company entered into two interest
rate swap agreements (collectively, the Swap) with
WestLB, fixing the rate of $10 million at 3.58% and
$15 million at 3.20% on the first advances of a like amount
of variable rate Credit Facility borrowings. The
$15 million interest rate swap expired in October 2010 and
the $10 million will expire in October 2011. The objective
of the Swap was to hedge the risk of changes in cash flows
associated with the future interest payments on the first
$25 million of the variable rate Credit Facility debt with
a combined notional amount of $25 million.
During the period from October 29, 2010 to
December 31, 2010, approximately $85 of net unrealized
appreciation from the Swap was recorded in the statement of
operations, and approximately $42 of net realized losses from
the Swap was recorded in the statement of operations.
85
Horizon
Technology Finance Corporation and Subsidiaries
Notes to
Consolidated Financial
Statements (Continued)
(In thousands, except shares and per share data)
Prior to the Companys election to become a BDC, the Swap
was designated as a hedging instrument and the Company applied
cash flow hedge accounting. The Swap was recorded in the
statement of assets and liabilities at fair value, and any
related increases or decreases in the fair value were recognized
within accumulated other comprehensive income.
The Company assessed the effectiveness of the Swap on a
quarterly basis. The Company had considered the impact of the
current credit crisis in the United States in assessing the risk
of counterparty default. As most of the critical terms of the
hedging instruments and hedged items matched, the hedging
relationship was considered to be highly effective. No
ineffectiveness on the Swap was recognized during the period
from January 1, 2010 to October 28, 2010, and the
years ended December 31, 2009 and 2008, respectively.
|
|
Note 11:
|
Subsequent
Events
|
On February 11, 2011, the Company formed, as wholly owned
subsidiaries, Longview SBIC GP LLC and Longview SBIC LP
(collectively, Horizon SBIC) in anticipation of
receiving a license to operate a small business investment
company (SBIC) from the Small Business
Administration (SBA). When licensed, Longview SBIC
LP will issue SBA-guaranteed debentures at long-term fixed
rates. On March 1, 2011, the Company applied for exemptive
relief from the Securities and Exchange Commission to permit the
Company to exclude the debt of the Longview SBIC LP from the
consolidated asset coverage ratio.
|
|
Note 12:
|
Financial
Highlights
|
The financial highlights for the Company are as follows:(1)
|
|
|
|
|
|
|
Post-IPO as a
|
|
|
Business
|
|
|
Development
|
|
|
Company
|
|
|
October 29, 2010 to
|
|
|
December 31, 2010
|
|
Per share data:
|
|
|
|
|
Net Asset value at beginning of period
|
|
|
N/A
|
(2)
|
Issuance of common stock and capital contributions
|
|
|
N/A
|
(2)
|
Dividend declared and distributions to members
|
|
|
N/A
|
(2)
|
Offering costs
|
|
|
N/A
|
(2)
|
Net investment income
|
|
|
N/A
|
(2)
|
Realized gain (loss) on investments
|
|
|
N/A
|
(2)
|
Unrealized appreciation (depreciation) on investments
|
|
|
N/A
|
(2)
|
Net asset value at end of period
|
|
$
|
16.75
|
|
Per share market value, end of period
|
|
$
|
14.44
|
|
Total return based on a market value
|
|
|
22.7
|
%(3)
|
Shares outstanding at end of period
|
|
|
7,593,422
|
|
Ratios to average net assets:
|
|
|
|
|
Expenses without incentive fees
|
|
|
9.8
|
%(3)
|
Incentive fees
|
|
|
2.8
|
%(3)
|
Total expenses
|
|
|
12.6
|
%(3)
|
Net investment income without incentive fees
|
|
|
11.8
|
%(3)
|
Average net asset value
|
|
$
|
90,205
|
|
|
|
|
(1) |
|
Years prior to become a public company are not presented in the
financial highlights because the Company did not record assets
at fair value, therefore the information would not be meaningful. |
(2) |
|
Per share data is not provided as the Company did not have
shares of common stock outstanding or an equivalent prior to the
October 28, 2010 IPO. |
(3) |
|
Annualized. |
86
Horizon
Technology Finance Corporation and Subsidiaries
Notes to
Consolidated Financial
Statements (Continued)
(In thousands, except shares and per share data)
|
|
Note 13:
|
Selected
Quarterly Financial Data (Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
September 30,
|
|
June 30,
|
|
March 31,
|
|
|
2010
|
|
2010
|
|
2010
|
|
2010
|
|
Total investment income
|
|
$
|
4,956
|
|
|
$
|
5,189
|
|
|
$
|
4,270
|
|
|
$
|
3,793
|
|
Net investment income
|
|
|
2,507
|
|
|
|
3,256
|
|
|
|
2,508
|
|
|
|
2,113
|
|
Net realized and unrealized gain (loss)
|
|
|
2,063
|
|
|
|
1,711
|
|
|
|
(366
|
)
|
|
|
202
|
|
Net increase in net asset resulting from operations
|
|
|
4,570
|
|
|
|
5,287
|
|
|
|
2,259
|
|
|
|
2,617
|
|
Earnings per share
|
|
|
N/A
|
|
|
|
N/A
|
|
|
|
N/A
|
|
|
|
N/A
|
|
Net asset value per share at period end
|
|
$
|
16.75
|
|
|
|
N/A
|
|
|
|
N/A
|
|
|
|
N/A
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
September 30,
|
|
June 30,
|
|
March 31,
|
|
|
2009
|
|
2009
|
|
2009
|
|
2009
|
|
Total investment income
|
|
$
|
4,155
|
|
|
$
|
4,169
|
|
|
$
|
3,746
|
|
|
$
|
3,256
|
|
Net investment income
|
|
|
2,492
|
|
|
|
2,393
|
|
|
|
1,998
|
|
|
|
1,673
|
|
Net realized and unrealized gain (loss)
|
|
|
498
|
|
|
|
(55
|
)
|
|
|
143
|
|
|
|
445
|
|
Net increase in net asset resulting from operations
|
|
|
3,343
|
|
|
|
2,004
|
|
|
|
1,884
|
|
|
|
2,083
|
|
Earnings per share
|
|
|
N/A
|
|
|
|
N/A
|
|
|
|
N/A
|
|
|
|
N/A
|
|
Net asset value per share at period end
|
|
|
N/A
|
|
|
|
N/A
|
|
|
|
N/A
|
|
|
|
N/A
|
|
87
|
|
Item 9.
|
Changes
in and Disagreements with Accountants on Accounting and
Financial Disclosure
|
None
|
|
Item 9A.
|
Controls
and Procedures
|
(a)
Evaluation of Disclosure Controls and Procedures
As of December 31, 2010, we, including our Chief Executive
Officer and Chief Financial Officer, evaluated the effectiveness
of the design and operation of our disclosure controls and
procedures (as defined in
Rule 13a-15(e)
of the Exchange Act). Based on that evaluation, our management,
including the Chief Executive Officer and Chief Financial
Officer, concluded that our disclosure controls and procedures
were effective and provided reasonable assurance that
information required to be disclosed in our periodic SEC filings
is recorded, processed, summarized and reported within the time
periods specified in the SECs rules and forms, and that
such information is accumulated and communicated to our
management, including our Chief Executive Officer and Chief
Financial Officer, as appropriate, to allow timely decisions
regarding required disclosure. However, in evaluating the
disclosure controls and procedures, management recognized that
any controls and procedures, no matter how well designed and
operated can provide only reasonable assurance of achieving the
desired control objectives, and management necessarily was
required to apply its judgment in evaluating the cost-benefit
relationship of such possible controls and procedures.
(b)
Managements Report on Internal Control Over Financial
Reporting
This annual report does not include a report of
managements assessment regarding internal control over
financial reporting or an attestation report of the
Companys registered public accounting firm due to a
transition period established by rules of the Securities and
Exchange Commission for newly public companies.
(c)
Changes in Internal Controls Over Financial
Reporting.
There have been no material changes in our internal control over
financial reporting (as defined in
Rules 13a-15(f)
and
15d-15(f) of
the Exchange Act) during our most recently completed fiscal
quarter, that have materially affected, or are reasonably likely
to materially affect, our internal control over financial
reporting.
|
|
Item 9B.
|
Other
Information
|
None
PART III
We will file a definitive Proxy Statement for our 2011 Annual
Meeting of Stockholders with the SEC, pursuant to
Regulation 14A, not later than 120 days after the end
of our fiscal year. Accordingly, certain information required by
Part III has been omitted under General
Instruction G(3) to
Form 10-K.
Only those sections of our definitive Proxy Statement that
specifically address the items set forth herein are incorporated
by reference.
|
|
Item 10.
|
Directors,
Executive Officers and Corporate Governance
|
The information required by Item 10 is hereby incorporated
by reference from our definitive Proxy Statement relating to our
2011 Annual Meeting of Stockholders, to be filed with the
Securities and Exchange Commission not later than 120 days
following the end of our fiscal year.
|
|
Item 11.
|
Executive
Compensation
|
The information required by Item 11 is hereby incorporated
by reference from our definitive Proxy Statement relating to our
2011 Annual Meeting of Stockholders, to be filed with the
Securities and Exchange Commission not later than 120 days
following the end of our fiscal year.
88
|
|
Item 12.
|
Security
Ownership of Certain Beneficial Owners and Management and
Related Stockholder Matters
|
The information required by Item 12 is hereby incorporated
by reference from our definitive Proxy Statement relating to our
2011 Annual Meeting of Stockholders, to be filed with the
Securities and Exchange Commission not later than 120 days
following the end of our fiscal year.
|
|
Item 13.
|
Certain
Relationships and Related Transactions, and Director
Independence
|
The information required by Item 13 is hereby incorporated
by reference from our definitive Proxy Statement relating to our
2011 Annual Meeting of Stockholders, to be filed with the
Securities and Exchange Commission not later than 120 days
following the end of our fiscal year.
|
|
Item 14.
|
Principal
Accountant Fees and Services
|
The information required by Item 14 is hereby incorporated
by reference from our definitive Proxy Statement relating to our
2011 Annual Meeting of Stockholders, to be filed with the
Securities and Exchange Commission not later than 120 days
following the end of our fiscal year.
PART IV
|
|
Item 15.
|
Exhibits
and Financial Statement Schedules
|
(a)(1) Financial Statements
(1) Financial Statements Refer to Item 8
starting on page 61.
(2) Financial Statement Schedules None
(3) Exhibits
|
|
|
Exhibit No.
|
|
Description
|
|
3.1
|
|
Amended and Restated Certificate of Incorporation (Incorporated
by reference to exhibit (a) of the Companys Pre-effective
Amendment No. 2 to the Registration Statement on Form N-2, filed
on July 2, 2010)
|
3.2
|
|
Amended and Restated Bylaws (Incorporated by reference to
exhibit (b) of the Companys Pre-effective Amendment No. 2
to the Registration Statement on Form N-2, filed on July 2, 2010)
|
4.1
|
|
Form of Specimen Certificate (Incorporated by reference to
exhibit (d) of the Companys Pre-effective Amendment No. 3
to the Registration Statement on Form N-2, filed on July 19,
2010)
|
4.3
|
|
Form of Registration Rights Agreement among Compass Horizon
Partners, LP, HTF-CHF Holdings LLC and the Company (Incorporated
by reference to exhibit (k)(3) of the Companys
Pre-effective Amendment No. 2 to the Registration Statement on
Form N-2, filed on July 2, 2010)
|
10.1
|
|
Form of Investment Management Agreement (Incorporated by
reference to exhibit (g) of the Companys Pre-effective
Amendment No. 2 to the Registration Statement on Form N-2, filed
on July 2, 2010)
|
10.2
|
|
Form of Custody Agreement (Incorporated by reference to exhibit
(j) of the Companys Pre-effective Amendment No. 3 to the
Registration Statement on Form N-2, filed on July 19, 2010)
|
10.3
|
|
Form of Administration Agreement (Incorporated by reference to
exhibit (k)(1) of the Companys Pre-effective Amendment No.
2 to the Registration Statement on Form N-2, filed on July 2,
2010)
|
10.4
|
|
Form of License Agreement by and between the Company and Horizon
Technology Finance, LLC (Incorporated by reference to exhibit
(k)(2) of the Companys Pre-effective Amendment No. 2 to
the Registration Statement on Form N-2, filed on July 2, 2010)
|
10.5
|
|
Credit and Security Agreement by and among Horizon Credit I LLC,
WestLB AG, New York Branch, U.S. Bank National Association, as
custodian and paying agent, and WestLB AG, New York Branch, as
agent, dated as of March 4, 2008 (Incorporated by reference to
exhibit (f)(1) of the Companys Pre-effective Amendment No.
1 to the Registration Statement on Form N-2, filed on June 4,
2010)
|
89
|
|
|
Exhibit No.
|
|
Description
|
|
10.6
|
|
First Amendment of Transaction Documents by and among Horizon
Credit I LLC, WestLB AG, New York Branch, U.S. Bank National
Association, as custodian and paying agent, WestLB AG, New York
Branch, as agent, Horizon Technology Finance Management LLC, and
Lyon Financial Services, Inc., dated as of September 30, 2008
(Incorporated by reference to exhibit (f)(2) of the
Companys Pre-effective Amendment No. 1 to the Registration
Statement on Form N-2, filed on June 4, 2010)
|
10.7
|
|
Second Amendment of Transaction Documents by and among Horizon
Credit I LLC, WestLB AG, New York Branch, as the lender and
agent, and U.S. Bank National Association, as custodian, dated
as of October 7, 2008 (Incorporated by reference to exhibit
(f)(3) of the Companys Pre-effective Amendment No. 1 to
the Registration Statement on Form N-2, filed on June 4, 2010)
|
10.8
|
|
Third Amendment of Transaction Documents by and among Horizon
Credit I LLC, Compass Horizon Funding Company LLC, WestLB AG,
New York Branch, as the lender and agent, and U.S. Bank National
Association, as custodian, dated as of June 25, 2010
(Incorporated by reference to exhibit (f)(4) of the
Companys Pre-effective Amendment No. 2 to the Registration
Statement on Form N-2, filed on July 2, 2010)
|
10.9
|
|
Sale and Contribution Agreement by and between Compass Horizon
Funding Company LLC and Horizon Credit I LLC, dated as of March
4, 2008 (Incorporated by reference to exhibit (f)(5) of the
Companys Pre-effective Amendment No. 2 to the Registration
Statement on Form N-2, filed on July 2, 2010)
|
10.10
|
|
Form of Dividend Reinvestment Plan (Incorporated by reference to
exhibit (e) of the Companys Pre-effective Amendment No. 2
to the Registration Statement on Form N-2, filed on July 2, 2010)
|
11.1*
|
|
Computation of per share earnings (included in the notes to the
audited financial statements included in this report)
|
14.1
|
|
Code of Ethics of the Company (Incorporated by reference to
exhibit (r)(1) of the Companys Pre-effective Amendment No.
3 to the Registration Statement on Form N-2, filed on July 19,
2010)
|
14.2
|
|
Code of Ethics of the Advisor (Incorporated by reference to
exhibit (r)(2) of the Companys Pre-effective Amendment No.
3 to the Registration Statement on Form N-2, filed on July 19,
2010)
|
21*
|
|
List of Subsidiaries
|
24
|
|
Power of Attorney (included on signature page hereto)
|
31.1*
|
|
Certificate of the Principal Executive Officer Pursuant to
Exchange Act Rule 13a-14(a) and 15d-14(a)
|
31.2*
|
|
Certificate of the Principal Financial and Accounting Officer
Pursuant to Exchange Act Rule 13a-14(a) and 15d-14(a)
|
32.1*
|
|
Certification of the Chief Executive Officer pursuant to
18 U.S.C. Section 1350, as adopted pursuant to Section 906
of the Sarbanes-Oxley Act of 2002
|
32.2*
|
|
Certification of the Chief Financial Officer pursuant to
18 U.S.C. Section 1350, as adopted pursuant to Section 906
of the Sarbanes-Oxley Act of 2002
|
99.1*
|
|
Privacy Policy of the Company
|
90
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the
Securities Exchange Act of 1934, the registrant has duly caused
this Annual Report on
Form 10-K
to be signed on its behalf by the undersigned, thereunto duly
authorized.
Horizon Technology
Finance Corporation
|
|
|
|
By:
|
/s/ Robert
D. Pomeroy, Jr.
|
Name: Robert D. Pomeroy, Jr.
|
|
|
|
Title:
|
Chief Executive Officer and
Chairman of the Board
|
Date: March 16, 2011
POWER OF
ATTORNEY
KNOW ALL MEN BY THESE PRESENTS, that each person whose signature
appears below constitutes and appoints Robert D.
Pomeroy, Jr., Christopher M. Mathieu and Gerald A. Michaud
as his true and lawful attorneys-in-fact, each with full power
of substitution, for him in any and all capacities, to sign any
amendments to this Annual Report on
Form 10-K
and to file the same, with exhibits thereto and other documents
in connection therewith, with the Securities and Exchange
Commission, hereby ratifying and confirming all that each of
said attorneys-in-fact or their substitute or substitutes may do
or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Exchange Act of
1934, this Annual Report on
Form 10-K
has been signed below by the following persons on behalf of the
registrant and in the capacities and on the dates indicated.
|
|
|
|
|
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
|
/s/ Robert
D. Pomeroy, Jr.
Robert
D. Pomeroy, Jr.
|
|
Chairman of the Board of Directors and Chief Executive Officer
(Principal Executive Officer)
|
|
March 16, 2011
|
|
|
|
|
|
/s/ Christopher
M. Mathieu
Christopher
M. Mathieu
|
|
Chief Financial Officer and Treasurer (Principal Financial and
Accounting Officer)
|
|
March 16, 2011
|
|
|
|
|
|
/s/ Gerald
A. Michaud
Gerald
A. Michaud
|
|
President and Director
|
|
March 16, 2011
|
|
|
|
|
|
/s/ David
P. Swanson
David
P. Swanson
|
|
Director
|
|
March 16, 2011
|
|
|
|
|
|
/s/ James
J. Bottiglieri
James
J. Bottiglieri
|
|
Director
|
|
March 16, 2011
|
|
|
|
|
|
/s/ Edmund
V. Mahoney
Edmund
V. Mahoney
|
|
Director
|
|
March 16, 2011
|
91
|
|
|
|
|
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
|
/s/ Brett
N. Silvers
Brett
N. Silvers
|
|
Director
|
|
March 16, 2011
|
|
|
|
|
|
/s/ Christopher
B. Woodward
Christopher
B. Woodward
|
|
Director
|
|
March 16, 2011
|
92